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ABSTRACT
The liver is an important metabolic sensor relaying humoral and
neural information via the brain stem to the hypothalmus. In response to
fasting or feeding it is the appropriate orchestration of these events that
controls ingestive behaviour and maintains energy homeostasis. In
chronic liver disease, alterations in oxidative metabolism and impairment
of the liver's metabolic role may effect changes in ingestive behaviour and
nutritional status. Liver transplant recipients have lost all hepatic
innervation and the absence of humoral and neural responses relayed via
the hepatic afferents could effect energy balance and contribute to post-
liver transplant obesity. This study examined longitudinal changes in
body composition, dietary intake, macronutrient preference and energy
metabolism in the fasted and fed state.
Sixty-seven patients with chronic liver disease and a group of 18
healthy volunteers were recruited. A sub-group of 23 patients who
underwent liver transplantation were reviewed every three months on
three occasions. Nutritional status was determined using body habitus
measurements and multi-frequency impedance analysis. Indirect
calorimetry was used to determine energy and substrate metabolism in
the fasted and fed state. Basal and post-prandial insulin and glucose
concentrations were measured. Diet diaries were used to estimate energy
and macronutrient intake and macronutrient preference was identified
using food varying in fat and carbohydrate content.
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Patients with cirrhosis of hepatocellular origin (alcoholic liver
cirrhosis, cryptogenic cirrhosis) had the greatest disturbances in substrate
metabolism, depressed dietary intakes and poorest nutritional status
when compared with patients with biliary cirrhosis and control subjects.
These findings suggest that aberrant metabolism may contribute to
anorexia and impact on nutritional status in patients with hepatocellular
cirrhosis. No differential effect was observed when patients were
stratified for severity of disease.
Following liver transplantation, patients weight exceeded pre-
illness values by 7% and this increase in body weight was accounted for
by fat mass but not lean tissue. A decrease in resting energy expenditure
was observed and a 5% increase in the dietary intake of fat derived
energy. No association between immunosuppressive medication and
body weight was seen. Multiple regression analysis revealed that the
strongest predictor of weight gain was resting energy expenditure. These
findings suggest that the liver transplant procedure per se is implicated in
the energy economy and fat hyperphagia observed following liver
transplantation which may be a result of denervation and the loss of
afferent input and efferent outflow.
20
CHAPTER 1
REVIEW OF THE LITERATURE
Effects of Chronic Liver Disease and Transplantation on Fuel
Metabolism and Macronutrient Preference
INTRODUCTION
Throughout history the liver has not only been perceived as an
organ essential to life but also one which possesses mystical powers. In
ancient Rome a priest would use an animal liver in the same fashion as a
modern day crystal ball to predict the outcome of a debate in the Senate
or a major battle. Even today the liver is associated with our emotions
and terms such as "lily livered" or "yellow" are used to describe cowardice
and "gall" arrogance. The liver's predictive abilities and it's relationship
with emotional characteristics are no longer considered important.
However, if the pathophysiological sequelae of liver disease are
considered, it is apparent that these will influence emotional state; for
example milder forms of hepatic encephalopathy can cause changes in
mood and severe cases result in profound confusion and coma.
The liver is the body's largest organ weighing between 1.2 - 1.8 kg.
The liver is pivotal in nutrient and drug metabolism, synthesis and release
of plasma protein as well as playing a key role in the innate immune
system by harbouring Kupfer cells. The liver is fed nutrient rich blood
from the portal vein and designates nutrients to be oxidised, stored or
redistributed into the peripheral circulation. Normal liver function
depends on the appropriate utilisation of nutrients to provide energy for
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its own macromolecular synthesis. As an organ involved in the synthesis
and degradation of nutrients its function must be co ordinated and
regulated in response to metabolic changes. This complex metabolic
interplay may be compromised in liver disease.
In chronic liver disease or cirrhosis, there is progressive and
eventually irreversible liver damage and patients may present with
jaundice, oedema, ascites, central nervous system dysfunction as well as
undernutrition. Causes of cirrhosis include alcoholic liver disease (ALD),
primary biliary cirrhosis (PBC), primary sclerosing cholangitis,
cryptogenic cirrhosis, chronic hepatitis and Wilson's disease.
Alcoholic liver cirrhosis and PBC are the commonest referrals for
elective liver transplantation in Scotland (Scottish Liver Transplant Unit
Annual Report, 1998) and remains the most common causes of cirrhosis in
Europe. In a large Italian study on 1,492 cirrhotics, alcohol-related disease
accounted for over a third (37%) of the patient population (Merli et al,
1996). Similarly an earlier study from the United Kingdom on 463
cirrhotics (Saunders et al, 1981) found that more than half these patients
presented with ALD (245 out of 463).
The origins of ALD are a consequence of long term alcohol abuse
resulting in toxic damage to the hepatocyte. Primary biliary cirrhosis is a
progressive disease generally affecting women between the fourth and
seventh decade of life where continued portal and peri-portal
inflammation and cholestasis leads to the development of cirrhosis, portal
hypertension and liver failure (Kaplan, 1987).
In metabolic studies of chronic liver disease, investigators have
grouped together cirrhotic patients with varying pathologies
(Schneeweiss et al, 1990, Muller et al 1992, Verboeket-van de Venneet al,
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1995). Whilst this may be considered important in improving the
statistical power of studies, it could mask adaptive metabolic differences
between these different pathophysiological populations. For example,
ALD is characteristed by intrinsic hepatocellular damage whereas patients
with PBC present with features of cholestasis. It is only when liver disease
becomes severe that the end-stage features of hepatocellular and
cholestatic disease may be similar.
The progression of chronic liver disease is variable but where
longterm prognosis is poor, orthotopic liver transplantation (OLT) is an
important and worthwhile treatment modality. Belle and colleagues (1997)
in a multi-centred study in 346 OLT patients found that quality of life
significantly improved one year after OLT when compared with
pretransplant values. Prior to undertaking OLT it is essential that
potential recipients are referred early and undergo stringent physical and
psychological assessment. Such rigorous assessment serves not only to
indentify the suitability of patients for transplantation, it also permits
identification of patient's 'needs' and allows these to be met thereby
optimising the patient's pre-operative physical and mental state.
Whilst many of the symptoms of cirrhosis can be adequately
controlled by drugs, one distressing problem affecting many patients is a
continued deterioration in nutritional status. Poor nutritional state in liver
disease is not uncommon (Crawford et al 1993; Thuluvath & Triger 1994;
Mendenhall et al 1995) but improving the quantity and quality of dietary
intake of patients with cirrhosis is difficult.
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Undernutrition in Liver Cirrhosis
The manifestation of under-nutrition in cirrhosis is generally
insidious and rarely requires immediate medical management.
Consequently patients diminishing body mass is often regarded by the
clinician as a natural component of chronic liver disease and frequently
goes unnoticed and untreated. Moreover, the presence of undernutrition
may be masked by ascites and/or peripheral oedema. Factors implicated
in the development of undernutrition in chronic liver disease include:
1. malabsorption - which may occur as a result of reduced bile
secretion or as a direct effect of a high alcohol intake.
2. reduced dietary intake - symptoms of chronic liver disease
such as jaundice, ascites and encephalopathy may detrimentally influence
nutritional intake.
3. increased energy requirements - several investigators have
suggested that chronic liver disease is a hypermetabolic disease
(Shanbhogue et al 1987, Green et al 1991, Muller et al 1994). Although an
area of controversy, a continued negative energy balance could
significantly contribute to undernutrition in chronic liver disease. For
example, Green et al (1991) in a small study of seven patients with PBC
suggested that when compared with a group of age and sex matched
controls these patients were hypermetabolic. Interestingly, extrapolation
of the energy data from the study of Green and colleagues suggests that
the energy deficit experienced by these patients would result in a loss of
body mass of 35 - 75g/day (0.5 kg in one week). Obviously this
calculation is an oversimplification of energy balance dynamics but it does
contextualise the cumulative effect of a negative energy balance on body
mass. In the study of Green and colleagues (1991) patients were energy
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(fat stores) but not protein (muscle stores) depleted suggesting these
patients were exhibiting features of simple starvation. It may be that the
hypermetabolism observed by these investigators may simply reflect a
higher ratio of lean to fat mass.
4. altered metabolism - commonly reported in chronic liver
disease and may be important in the development of undernutrition. For
example, as chronic liver disease progresses, the synthetic capacity of the
liver to store glycogen diminishes, there is a reduction in hepatic glucose
production, enhanced gluconeogenesis and increased lipolysis (Ohyanagi
et al, 1995). In cirrhosis the metabolic fuels used to meet fasting energy
requirements switch from predominantly glucose to increased
mobilisation and oxidation of both endogenous fat and protein stores. A
prolonged and continued reliance on endogenous fat and protein stores
will, if accompanied by a negative energy balance, lead to depletion of
body mass (Owen 1981; Green 1991).
5. role of the liver as a metabolic sensor - there is unequivocal
evidence to support the role of the liver in the control of food intake
(Novin et al, 1985; Friedman et al, 1997) where, as a result of hepatic
substrate oxidation, changes in the hepatocytes membrane potential
occurs causing a reduction in afferent spike frequency and results in
transmission of a satiety signal to the brain (Niijima, 1982) (Figure 1.1). It
could be postulated that in chronic liver disease, where there are
alterations in circulating metabolites this could effect changes in humoral
and neural metabolic signalling, affect satiety mechanisms, influence
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Convincing evidence to support the role of the liver as a metabolic
sensor comes from important small animal work by Niijima (1982), where
electrophysiological studies showed that when glucose was infused into
the portal vein it induced signalling from the hepatic branch of the vagal
afferents and suggests that monitoring of glucose supply to the liver
occurs. Hepatic oxidation of fatty acids also induces afferent signalling
(Langhans, 1996). The role of lipid and glucose sensors in the liver have
been alluded to as separate entities (Mayer 1955; Friedman & Ramirez
1985) but it appears they act synergistically and that altered metabolic
signalling would influence nutritional intake (Langhans & Scharrer 1992).
This area of investigation has been explored in small animal studies but no
significant work has been undertaken in human subjects. Indeed it may
well be inappropriate to translate the findings from small animal work to
humans where the mechanisms involved in ingestive behaviour are not
comparable.
Influence of undernutrition on outcome in liver disease
Although undernutrition is a common feature of chronic liver
disease the evidence to support its effect on outcome remains
inconclusive. A large (n = 352) longitudinal study on patients with chronic
liver disease from the Veterans Administration (Mendenhall, 1986) used
eight nutritional indices (percentage ideal weight, triceps skinfold
thickness (TSF), mid-arm muscle circumference (AMC), creatinine height
index, serum albumin concentration, serum transferrin, total lymphocyte
count and delayed cutaneous hypersensitivity) to determine a protein
calorie malnutrition score. At time of entry into this study, 8%, 33% and
4% of patients were classified as being mildly, moderately or severely
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protein calorie malnourished respectively. Whilst this study highlighted
the relationship between severe protein energy malnutrition and
mortality, which reached 52% at one month and rose to 76% at a year, it
failed to clearly establish a cause and effect relationship between protein
calorie malnutrition and disease progression.
Further work which examined the relationship between the degree
of undernutrition and disease severity came a decade later when Merli
and co-workers (1996) in a five year prospective study of 1053 cirrhotics
examined the influence of under-nutrition on mortality among cirrhotics.
Patients were stratified for disease severity using the Child's Pugh
classification (Table 1.1) (Pugh et al, 1973). This study showed that
cumulative survival was lower in patients with depleted muscle mass in
Child's A and B groups but not those patients assigned to the grade C
group. A low fat mass had no impact on survival in any Child's grade.
However, when data were analysed using multivariate analysis; age, sex,
bilirubin, cholinesterase, ascites and oesophageal varices were selected as
impacting on survival whereas parameters of nutritional status were not.
Conversely, in a study of 80 PBC patients, Wicks et al (1995) showed that
by using simple anthropometric indices a third of this population could be
classified as undernourished and there was an inverse relationship
between nutritional status and disease severity. Therefore those patients
with the lowest fat mass had a higher Child's Pugh score. Whilst this
group observed a significant decrease in fat mass with increasing disease
severity, no similar relationship with muscle mass was observed.
Although, Wicks et al (1995) did not examine outcome measures their
nutritional status data conflicts with that of Merli et al (1996) and suggests
there is a different relationship between nutritional status and disease
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TABLE 1.1 CHILD"S PUGH CLASSIFICATION OF CIRRHOSIS
Points scored for abnormality Grade Scores
Assessment Criteria 1 2 3 Grade Score
Encephalopathy grade None 1-2 3-4 A 5-6
Ascites None Slight Moderate
Bilirubin jimol/1 <35 35-50 >50
Biliary cirrhosis <70 70-170 >170 B 7-9
Albumin g/1 >35
Prothrombin time ratio <1.4 1.4-2.0 >2.0
seconds prolonged 1.4 4-10 >10 C 10-15
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severity in patients with liver disease of hepatocellular and cholestatic
origin.
The inability to isolate nutritional status as an independent marker
of outcome (Merli et al, 1996) may in part be due to the fact that many so
called nutritional indices reflect disease severity rather than nutritional
state. For example, Caregaro and colleagues (1996) in a study of patients
with hepatocellular disease (alcoholic liver disease n = 61, viral related
cirrhosis n = 22) used indices such as retinol binding protein, serum
albumin concentration, serum transferrin, skin antigen testing and
creatinine height index to determine nutritional status. However, these
'nutritional' markers are strongly influenced by the disease process rather
than nutritional state. Not surprisingly these investigators found that
anthropometry was the most reliable method of nutritional assessment
and whilst they showed poorer survival in patients with low TSF and
AMC (< 5th percentile), they failed to demonstrate a relationship between
nutritional status and disease severity.
Energy metabolism in liver cirrhosis
Evidence suggests that the deterioration in body mass found in
chronic liver disease may be accounted for by alterations in energy and
substrate metabolism as well as changes in nutritional intake. Normally
the predominant metabolic pathways in oxidative energy metabolism are
the Krebs cycle and 13-oxidation. These processes determine metabolic
rate which can be measured from the body's heat production or gaseous
exchange.
During the latter part of the 19th century, Rubner, a German
scientist, built a calorimeter and measured heat production in order to
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determine energy production in dogs. Thirty years later Atwater and
Benedict (1903) showed that respiratory gas exchange measurements
could be used to calculate heat production or metabolic rate in humans.
Early calorimetric work was predominantly used in the diagnosis and
follow-up of patients with thyroid disease. The majority of these early
studies used direct calorimetry to measure energy production. This
method involved isolating subjects in an air tight chamber and the heat
dissipated by the body was measured by thermo-couples imbedded in the
walls of the calorimetry room. As subjects are required to remain for
long periods (in excess of 24 hours) direct calorimeters are considered
impractical for use in the clinical situation. In addition, operation of the
analysers and sensors requires considerable expertise and as a result their
use is generally restricted to dedicated nutritional research centres.
Measurement of respiratory gas exchange (oxygen consumption
(02) and and carbon dioxide (C02) production) is termed indirect
calorimetry and remains an accepted method of measuring both energy
production and substrate utilisation. Indirect calorimetry (open circuit
technique) has and continues to be extensively used by metabolic
researchers. Vohra and co-workers (1995) and Takala et al (1989) have
shown that accuracy and reproducibility in gas exchange results can be
obtained when investigators understand the principles of measurement,
pay meticulous attention in setting up the equipment and in preparing the
subject. A limitation of indirect calorimetry is that short periods of
calorimetry (i.e. 40 min) are extrapolated to 24 hour periods and preclude
study of diurnal effects.
The oxidation of substrates (carbohydrate, fat, protein and alcohol)
to yield energy involves the consumption of 02 and production of C02
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and water (H20). Each substrate consumes varying quantities of 02 and
the energy yield per gram of fat, carbohydrate, protein and alcohol are:
39.63 kj (fat), 15.56 kj (glucose), 17.50 kj (starch) and 19.68 kj
(metabolisable energy from protein) and alcohol 29.67 kj (ethanol)
respectively. Fat the richest source of energy yields more than twice the
energy from carbohydrate or protein. Some of the oxygen and carbon of
amino acids remain combined with nitrogen and is excreted as
nitrogenous products in the urine and to a lesser extent in the faeces. The
contribution of protein oxidation to the total 02 and C02 can be estimated
by taking into account the urinary excretion of nitrogen.
Energy expenditure can be derived from gaseous exchange and
nitrogen excretion and one of the most widely used equations is that of
Weir (1949) and is based on measurements of changes in oxygen content
of inspired and expired air. Gas exchange measurements can also be used
to determine substrate oxidation (Elia 1992; Frayn 1983, Acheson et al,
1984). The ratio of expired C02 to consumed 02 is termed the respiratory
quotient (RQ) where the O., consumption and C02 production differs with
each macronutrient oxidised. For example, following complete oxidation
of one molecule of glucose, 6 mols of O0 are consumed and 6 mols of CO.,
are produced and the RQ (CO.,: Oz) of carbohydrate is 1.0.
Measurement of urinary nitrogen excretion over a study period
allows calculation of the non-protein respiratory quotient (NPRQ). The
conversion of total RQ to NPRQ has been shown to represent only a small
change in oxidation rates and as a result is often ignored in metabolic
calculations.
In summary, indirect calorimetry is a useful technique which can
be used to measure energy production and substrate oxidation in human
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subjects so long as its limitations are fully understood (Webber and
Macdonald, 1995).
Energy Expenditure in Liver Cirrhosis
The largest component of total energy expenditure is resting
energy expenditure (REE) accounting for 60 - 70% of energy output.
Other components include physical activity (15-30%), diet induced
thermogenesis (7-13%) and other factors (e.g. smoking, effects of drugs,
thermoregulation (2-7%) (Elia 1992). The lean body mass (LBM) a term
synonymously used with fat free mass (FFM) contains the metabolically
active component of body composition and as such is closely related to
REE.
Several energy predictive formulae use the variables of age, sex,
height and weight to estimate REE and include those of Harris-Benedict
(1919), Kleiber (1932), Fleisch Tables (1951), Robertson-Reid (1952) and
Schofield (1985). These predictive formulae were derived from direct
calorimetry studies performed on healthy subjects. The later work of
Schofield (1985) was derived from a review of predictive data on 7,173
subjects from various nationalities and also included a number of
underweight individuals. The Schofield (1985) equation may therefore be
more applicable to the clinical situation. In a number of disease states
there may be alterations in body composition and estimating REE from
predictive formulae derived from healthy populations may provide
erroneous results by over or under-estimating the size of the metabolic
component of body composition.
In chronic liver disease changes in body composition may be
reflected in a decline in fat and muscle mass (Wicks et al 1995) but the
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presence of fluid retention in some patients makes it difficult to predict the
energy expenditure of this population.
In light of the problems in estimating the size of the metabolically
active component of body composition and the heterogeneity of patients
with chronic liver disease, the energy cost of this pathology remains one
of debate. Nevertheless, the importance of elucidating the energy
requirements in liver disease should not be underestimated where
overfeeding could result in metabolic abnormalities and underfeeding
exacerbate undernutrition. Indeed, clarification of energy requirements in
liver disease would permit clinicians and nutritionists to establish and
meet the nutritional needs of their patients.
Several studies have suggested that liver disease exerts a
hypermetabolic effect (Shanbhogue et al 1987; John et al 1989;
Schneeweiss et al 1990; Muller et al 1991; Muller et al 1994). Conversely,
the work of Owen et al (1983), Jhangiani et al (1986) and Merli et al (1990)
suggest that energy expenditure in liver cirrhosis is not significantly
different from healthy control subjects. A number of criticisms can be
leveled at these studies, many were carried out on small numbers of
patients and REE results were not stratified for pathology or disease
severity. In addition the approach to expressing energy results varied;
some used the relationship of REE to body surface area (Jhangiani et al
1986; Shanbhogue et al 1987), others the relationship of REE to LBM
derived from urinary creatinine excretion (Di Cecco et al 1989; Nielsen et
al 1993) or lean body mass derived by bioelectrical impedance analysis
(BIA) (Muller et al 1991).
For example, a study by Shanbhogue et al (1987) measured REE by
indirect calorimetry in a heterogeneous group of ten patients with end
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stage liver disease and ten healthy controls. In this study urinary
creatinine excretion was used as an index of LBM and results showed that
energy expenditure in patients with liver disease when compared with
control subjects was significantly higher (cirrhotic patients: 1900 ± 610
kcal/g creatinine/day versus controls: 1180 ± 260 kcal/g/creatinine/day).
Similarly John and colleagues (1989) in a study of 20 patients with alcoholic
hepatitis (sub-divided into moderate and severe hepatitis) and control
subjects observed no differences in REE when severity of disease was
considered. However, when REE was related to LBM (estimated by
urinary creatinine excretion) the energy expenditure of patients with
severe alcoholic hepatitis was 55% greater than control subjects (cirrhotic
patients: 1813 kcal/g creatinine/day versus controls: 1043 kcal/g
creatinine/day).
The presence of hypermetabolism in liver disease is also supported
by the work of Schneeweiss and co-workers (1990) who studied 35
patients with acute hepatitis, 22 patients with alcoholic cirrhosis and 20
healthy controls. When compared with the control group they found no
appreciable alterations in energy metabolism among patients with acute
hepatitis whereas those with alcoholic cirrhosis were hypermetabolic
(cirrhotic patients: 1657 kcal/g creatinine/day versus controls: 1007 kcal/g
creatinine/day). In patients where alcoholic hepatitis and cirrhosis co¬
exist, this could add to the metabolic cost of the disease and account for
the observed hypermetabolism. However, Schneeweiss et al (1990) also
stratified these patients using the modified Child's Pugh score (Pugh et al
1973) and noted an inverse relationship between energy expenditure and
severity of disease, in other words the greater the severity of disease the
lower the REE. This finding is at odds with the hypermetabolism seen in
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their patients with alcohol cirrhosis and may in part be explained by a
reduction in oxygen requirements as a result of a decrease in the size of
the body's metabolically active tissue.
In addition, Moreau et al (1988) used haemodynamic studies to
determine oxygen uptake and transport in 35 patients with alcoholic liver
disease graded for disease severity (Pugh et al 1973) and observed a
progressive reduction in 02 uptake. These findings are at odds with those
of Green et al (1991) who observed a positive relationship between
oxygen consumption and disease severity in seven PBC patients
suggesting that as liver disease progresses there is a concomitant increase
in oxygen consumption and REE. The contradictory findings of these two
studies are difficult to reconcile but it may be that differing pathologies
elicit different metabolic responses. In addition, investigators who
classified patients with liver disease as hypermetabolic using creatinine
excretion may be using an inappropriate marker of lean tissue. Urinary
creatinine excretion is used to reflect muscle mass which accounts for
approximately half the lean tissue in healthy adults. However, the origin
of endogenous creatinine is from the synthesis of its precursor creatine
found in the liver and kidney. In health, creatinine is produced non-
enzymatically from creatine at a constant daily rate. Although there is
considerable intra individual variability in daily urinary creatinine
excretion (11- 30%) (Greenblatt et al, 1976, Lykken et al 1980) it has been
shown to significantly correlate with muscle mass and LBM when
compared with N15 isotope dilution techniques (Heymsfield et al, 1983).
However, in wasting diseases such as cancer and chronic liver disease, the
ratio of skeletal muscle mass to other metabolically active organs may
alter where a loss of muscle mass would increase the proportion of LBM
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from the metabolic organs (liver, heart and brain) and would result in an
inappropriately high energy expenditure result. Finally, as creatine is
synthesised in the liver, in cirrhosis there may be alterations in synthesis
and the use of creatinine as a marker of lean body mass in liver disease
seems inappropriate.
Whilst some investigators have suggested liver disease is a
hypermetabolic state, others such as Owen and colleagues (1983) in a
study of nine patients with alcoholic liver disease, Merli et al (1990) in a
study of 25 cirrhotics and Jhangiani et al (1986) in a study of eight ALD
patients have shown their patients to be normometabolic.
There appears to be no consensus as to the energy cost, if any, of
chronic liver disease. Indeed, in one of the largest studies in cirrhotic
patients (n = 123), Muller and colleagues (1994) reported that 18%, 52%
and 31% could be classified as hypometabolic, normometabolic and
hypermetabolic respectively. Difficulties in measuring energy status in
some patients with liver disease are due to problems in determining the
size of the metabolically active tissue. In order to further knowledge of
energy metabolism in liver disease, larger more focused studies are
required that would permit the stratification of patients by pathology e.g.
alcoholic cirrhosis, primary biliary cirrhosis and/or the severity of disease.
In addition, longitudinal nutritional studies of this population could yield
important data on the progression of disease and its effect on metabolism.
Energy Expenditure following Liver Transplantation
Only two studies have examined energy expenditure following
orthotopic liver transplantation (OLT). Green et al (1991), in a small (n = 7)
homogeneous cross sectional study of patients with PBC, compared
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energy metabolism pre- and post-OLT. When compared with OLT
patients and the age and sex matched control group, the PBC group were
hypermetabolic (PBC 4.64 kj/hr/kg body weight, OLT 3.39 kj/hr/kg
body weight and controls 3.65 kj/hr/kg body weight). This group
studied a different cohort before and after OLT and thereby weaken their
findings as the intervariability of energy expenditure are considerable (±
15%) (Webber & MacDonald 1995). In a longitudinal energy expenditure
study of 26 cirrhotic patients subjected to OLT and reviewed 432 days
after surgery (range 103-1022 days) it was suggested that patients who
were hypermetabolic pre-operatively were more likely to develop
postoperative complications (e.g. rejection, infection) (Muller et al 1994).
This study has provided the first evidence to suggest that the presence of
hypermetabolism before transplantation is associated with a poor
postoperative prognosis. These investigators suggest preoperative
hypermetabolism persists for up to three years after OLT. However, this
finding is difficult to understand in the uncomplicated OLT patient where
the presence of an ongoing inflammatory response of three years
duration seems unlikely.
This literature review of studies carried out in patients with chronic
liver disease highlights the difficulties in finding practical, reproducible and
specific indices of body composition that are related to REE. In cirrhotic
patients with ascites or peripheral oedema, significant expansion of the
extracellular water (ECW) space means that estimates of body mass and
four site skinfold measurements may yield erroneous results.
The difficulties of obtaining practical and accurate methods of body
composition in liver disease was addressed by Muller and colleagues in
1992. This group used single frequency bioelectrical impedance analysis
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(BIA) to determine LBM in ten patients with alcoholic liver disease. They
previously validated the use of BIA in 17 patients pre- and post-
paracentesis and compared these results with BCM derived from total
body potassium measurements (r=0.84, pcO.OOl) and noted that their ALD
patients were hypermetabolic. In this study the relationship between total
body potassium (TBK) and LBM estimated by BIA remained significant
even when used among patients with moderate ascites. This group used
BIA equations derived from isotope dilution studies in a heterogeneous
surgical population which included cancer patients where expansion of the
extracellular water compartment is common (Fearon et al 1992).
Bioelectrical Impedance Analysis
Bioelectrical impedance analysis has been used extensively in the
determination of body composition. Impedance analysis does not require
any specific expertise, is non-invasive and therefore acceptable to the
patient. Bioelectrical impedance measures tissue conductivity where the
conductivity of a region of the body is directly proportional to the amount
of electrolyte rich fluid present. It has been suggested that BIA can be
used to measure total body water (TBW) from which LBM may be
estimated and then by subtracting LBM from body weight, fat mass may
be derived. In the healthy individual, these measurements can provide
accurate determinations of body composition (Kushner & Schoeller, 1986;
Lukaski, 1986). Although there is some debate as to the value of the
technique in the clinical situation, where in disease (e.g. cancer, critical
illness) there may be fluid shifts. This may be generalised such as in
peripheral oedema or may be regional as in ascites.
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Before considering the effect of altered fluid distribution on BIA,
there are a number of other factors that could influence impedance results
and may account for some of the disparity found in the literature. These
include:
a. differences in the type of analyser used and the operation
frequency (e.g. single frequency, dual frequency or bioimpedance
spectroscopy).
b. lack of standardisation of:
i. skin preparation
ii. site of electrode placement
c. equations used in the calculation of total body water and
extra-cellular water; use of the manufacturers equations are generally
derived from a healthy population and are inappropriate when used in
the clinical situation.
d. positioning of the subject prior to and the timing of BIA
measurements.
e. recent food/fluid intake.
With BIA, the conductivity of the body's tissue is determined by
passing a small alternating (+ve and -ve reversing charge) electric current
through the body. The greater the frequency, the faster the current will
alternate between positive and negative charges (Figure 1.2). At lower
frequencies (5 kHz), the current is unable to penetrate the cell membranes
and will therefore estimate ECW whereas at higher frequencies (200
kHz) the current can penetrate cell membranes and permit estimation
of TBW. Intra-cellular water (ICW) may be estimated by subtracting ECW
from TBW. From ICW body cell mass (BCM) can be determined (Shizgal,
1983) and is the metabolically active component of the body. The body
40
FIGURE1.2




Insulator( on-conductivema erial) 5kHz 200kHz Capacitor (-vechange
+vecharge)
cellmembrane
cell mass is the oxygen consuming, carbon dioxide producing, work
performing tissue and as such will dictate energy expenditure (Moore,
1980). A reference method used in determining body cell mass is total
body potassium measurements but few hospitals have access to whole
body monitors. In healthy adults the precision of whole body counting is
2-5% (Cohn & Parr 1985) and this method provides the best index of body
cell mass where:
BCM (kg) = 0.00833 x K (mEq)
In order to validate the use of impedance in the clinical situation, a
number of researchers have compared reference method data with BIA
results (Lukaski, 1996). Isotopic techniques are the most commonly used
reference methods for determination of TBW and ECW where deuterium
and radiobromide are used to assess LBM and BCM respectively. The
precision of these isotopic techniques is described as being 1-2% for TBW
and 2-5% for ECW (Schoeller 1996). In patients with fluid retention,
particularly those with severe ascites, accuracy of isotopic techniques may
be affected by difficulties in determining the time to isotope equilibrium
(normally 4 hours for deuterium and 18 hours radiobromide).
Several studies have shown a strong correlation between single
frequency BIA (50 kHz), isotope dilution and densitometric determination
of TBW and LBM (Kushner & Schoeller 1986; Lukaski 1996). Early work
from our own unit (Fearon et al, 1992) used single frequency BIA among a
heterogeneous surgical population (neoplastic disease, irritable bowel
disease and pancreatitis) and compared BIA results with isotope studies
(tritiated water, sodium bromide and TBK) to determine TBW, ECW and
BCM. In the 43 patients studied, there was a significant relationship
between BIA and body habitus measurements for tritium (r2 = 0.862);
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total body potassium (n = 31) (r2 = 0.948). Although BIA tended to under¬
estimate TBW, the standard error of estimate (SEE) was 2.7 litres and the
co-efficient of variation (CoV) was 8.1% in patients compared with 3.4%
for healthy subjects (Lukaski et al, 1986). This suggests that the greater
error found in patients is related to changes in fluid and electrolyte
composition in disease which may alter conductivity of body
compartments. However, when total body potassium was considered the
SEE was 6.3 g and CoV of 6.4% and suggests BIA provides a useful index
of body cell mass. Whilst single frequency BIA cannot detect small
changes in body composition, it does provide a useful method of defining
the characteristics of patient populations or as a method to examine large
changes in body composition in longitudinal studies.
Patients with liver disease may have alterations in fluid distribution
and the non-invasive and simplistic nature of BIA has, as expected,
attracted considerable interest amongst specialists in liver disease.
However, studies in the use of single frequency BIA in liver disease have
been variable and a criticism of some studies is that many investigators
used manufacturers equations based only on body habitus
measurements. These equations were originally derived from a healthy
population and their application seems inappropriate among patients with
chronic liver disease. For example, Prijatmoko et al (1993), in a study of 38
male alcoholic patients, used BIA (50 kHz) and compared results with a
number of body composition reference methods (dual X-ray
absorpitometry, deuterated water, total body nitrogen). In this study
patients were sub-divided by Child's Pugh classification and the presence
of ascites was not considered. Not surprisingly this group found that BIA
was not a useful predictor of body composition.
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Guglielmi et al (1991), in a study in male cirrhotic patients,
considered the use of single frequency BIA among 36 and 22 non-ascitic
and ascitic patients respectively. This group compared whole body
resistance between age and sex matched controls to patients with and
without ascites. As expected, patients with ascites had a lower whole
body resistance when compared to patients without ascites or control
subjects and the lower resistance value suggests that ascitic patients have
higher total body water. An important finding in this study was the
increased error seen in patients with significant ascites where the ascitic
patient's CoV varied substantially over three days (2.2% controls, without
ascites 2.4%, with ascites 11.3%) and suggests that single frequency BIA
cannot be used to determine body water in patients with significant
ascites.
The reason for the inability of BIA to determine the regional
accumulation of fluid may be that single frequency BIA has limitations in
determining TBW as 50 kHz cannot penetrate cell membranes.
Additionally, tetra polar BIA measurements are made from the hand and
foot, the contribution from the trunk to whole body impedance is
approximately 10% (Foster & Lukaski 1996).
It is possible that improvement in the error of prediction for TBW
could be obtained by using higher frequencies that pass through the intra¬
cellular space. Indeed several manufacturers have developed multi-
frequency bioelectrical impedance analysers (MFBIA) that operate from
1kHz to 1MHz.
Early work on MFBIA by Segal and colleagues (1991) used three
frequencies (5, 50,100 kHz) to estimate ECW and TBW in healthy males (n
= 36) and compared these results with isotopic studies. This group found
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that when compared to isotope determination the optimum frequencies
for determining ECW was 5 kHz and for TBW 100 kHz. A logical
progression from this work was to examine the validity of MFBIA in
disease. Hannan et al (1995), in a study of surgical patients with varying
pathologies, showed that when compared with isotopic studies
(radiobromide, tritium) using frequencies of 5 and 200 kHz the technique
provided a useful estimate of ECW (5 kHz) and TBW (200 kHz). These
frequencies provided similar errors when compared with the more
complex use of bioelectrical spectroscopy where resistance and reactance
were measured at a range of frequencies from 5 kHz to 1 MHz. The
results of spectroscopy gave mean CoV for ECW and TBW of 0.9% and
3% respectively whereas for MFBIA at 5 and 200 kHz the corresponding
CoV of variation were 0.9% and 0.6%. This study concluded that an
impedance analyser operating at 5 and 200 kHz compared favourably
with the more complex technique of bioelectrical spectroscopy in body
composition determination.
Cha and co-workers (1995) used impedance among patients with
end stage renal disease and found that the impedance index
(height2/resistance) at 5 kHz correlated most closely with ECW
determined by radiobromide dilution. Total body water measured by
deuterium showed the strongest correlation with resistance
measurements at 500 kHz (r = 0.974). This study provides evidence that
MFBIA may assist in the evaluation of fluid distribution and body
composition in patients with clinical disease.
Bioelectrical impedance compared with neutron activation studies
by Muller et al, 1991, 1994) in liver disease has shown that in patients with
abdominal ascites of up to 4 litres, BIA can provide a useful insight into
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body morphology. It is important, however, that in using BIA the
investigator appreciates factors that will affect the reproducibility of
impedance measurements. In addition, a component of the prediction
errors associated with impedance may in fact be attributed to the
reference methods used. For example, when considering radioisotope
dilution it is often difficult to determine the reproducibility of these
methods in surgical patients because of the relatively long half life of such
isotopes. Hannan et al (1994) suggested that repeated measurements of
TBW in a control population indicates that a component of prediction
error, which can be attributed to radioisotope dilution is significant.
Despite its limitations, the use of MFBIA provides useful information on
body composition in patients where reference methodology is
inaccessible.
The Liver and Substrate Metabolism
The liver is responsible for the flow of substrates between organs
and tissues and in response to humoral and neural input maintains fuel
homeostasis. The metabolic pathways of glucose, lipid and protein are
interdependent and whilst they may be examined individually, they must
also be considered as an entity where the synthesis and breakdown of
macronutrients is inextricably linked (Figure 1.3).
Metabolic sensors detect circulating levels of macronutrients and
depending on the body's immediate energy requirements directs specific
macronutrients for breakdown (e.g. glycolysis) or storage (e.g.
glycogenesis, lipogenesis). These activities are primarily directed by the
nervous, endocrine and vascular systems. In times of long term fasting
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the liver's energy is derived from adipose tissue (fatty acids and glycerol),
skeletal muscle (lactate and pyruvate) as well as alpha-ketoacids produced
by transamination of the branch chain amino acids (leucine, isoleucine and
valine).
The synthesis, transport and breakdown of macronutrients is
predominantly orchestrated by the endocrine system and is related to the
quantity and quality of dietary intake, post-absorptive time as well as the
availability of glucose in relation to the requirements of the body's
glucose oxidising tissues. For example, during short periods of nutrient
deprivation, the liver maintains glucose homeostasis by glycogenolysis
and gluconeogenesis primarily directed by glucagon. However, glycogen
stores are limited and are normally exhausted after a 48 hours fast and
thereafter greater reliance is placed on glucose derived from skeletal
muscle breakdown (e.g. lactate, alanine), glycerol and free fatty acids from
lipolysis. In prolonged fasting (>72 hours) the body, in an attempt to
preserve LBM reduces the requirement for glucose by increasing the
energy derived from endogenous fat reserves.
Conversely, in the fed state, the glucose not immediately required
for energy will be converted to glycogen but once stores are replete
excess glucose will be directed as fatty acids to the adipocytes. In addition,
dispensable amino acids (alanine, glutamate, aspartate) are synthesised in
the liver and are directed to skeletal muscle for incorporation into muscle
proteins.
This brief overview of the liver's role in macronutrient metabolism
has laid the foundations for an appreciation of alterations in substrate
metabolism that may occur in chronic liver disease and effect changes in
nutritional intake and nutritional status.
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Substrate Metabolism in Liver Disease
In chronic liver disease rates of substrate oxidation are altered,
where in the post-absorptive state there is an increase in lipid oxidation
and a decrease in glucose oxidation (Owen et al, 1983; Nosadini et al, 1984;
Merli et al, 1990; Muller et al, 1991; Green et al, 1991; Campillo et al,
1992; Muller et al, 1994). However, the methodological approaches used
by these research groups to determine substrate oxidation rates warrants
further discussion.
Owen et al (1983) examined the type and quantity of substrate
oxidised in eight ALD patients and four unmatched controls. Fatty acid
oxidation and turnover was measured using indirect calorimetry and
simultaneous 14C-tracer analysis (14C palmitate). The most important
finding was that the metabolic profile observed in these patients after an
overnight fast was indicative of a more extended period of fasting (48-72
hours) (cirrhotic patients RQ = 0.74 ± 0.02 compared with controls RQ =
0.88 ± 0.01). This phenomenon could be explained by the diminished
availability of hepatic glycogen. In alcoholic liver disease glycogenolysis
accounts for approximately 33% of glucose production and
gluconeogenesis 67% (Owen et al 1981). This is a twofold increase in
gluconeogenesis when compared with controls. If the increased demand
for glucose derived from skeletal muscle mass (gluconeogenesis)
continued for a prolonged period it would contribute to a deterioration in
nutritional status. In addition, a prolonged up-regulation of the
gluconeogenic pathway would increase dietary protein requirements
(Kondrup and Muller, 1997). However, Merli et al (1990) in a study of 25
patients with liver disease (heterogeneous) reported that protein
oxidation rates and urinary nitrogen excretion were reduced and reflected
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simple starvation. It may be that increased lipolysis and concomitant
reliance on fat oxidation could be an adaptive response which acts to
preserve lean tissue.
Alterations in fasting substrate metabolism are mediated by the
endocrine and sympathetic nervous system (SNS), the influence of which
may be disturbed in liver disease. The effect of chronic liver disease on
hormonal systems is one of debate although hyperinsulinaemia and
hyperglucagonaemia are features of advanced liver disease (Berkowitz,
1969; Bosch et al, 1984; Kabadi et al, 1984; Taylor et al, 1985; Silva et al,
1988). A study by Romijn and colleagues (1991) extended the pioneering
work of Owen et al (1983) and examined glucose and lipid metabolism
after a 16 and 22 hour fast in 16 cirrhotics patients. Following a 16 hour
fast results were comparable with other studies (Owen 1983; Nosadini et
al, 1984; Muller et al, 1992) and showed that in the pre- and post-
absorptive period lipid is the body's predominant energy substrate.
However, the results of the 22 hour fast are of particular interest in that an
extension of the fast by 6 hours depressed glucose oxidation in controls
but this effect was even more pronounced in cirrhotic patients. This
decrease in glucose oxidation may be explained by the liver's
deteriorating function and inability to maintain adequate glycogen
reserves.
The mechanisms underlying the elevation of lipolysis in cirrhosis
have been considered. For example, catecholamines are implicated in the
regulation of lipolysis and elevated concentrations of adrenaline have
been recorded in patients with cirrhosis (Campillo et al, 1992). However,
Romijn et al (1991) observed no difference in fasting concentrations of
catecholamines or insulin following a 16 or 22 hour period of fasting in
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cirrhotic patients or controls. Although, elevated glucagon concentrations
were observed in cirrhotic patients after the 22 hour fast and this increase
would augment lipolysis. Although not a universal finding, elevated
glucagon concentrations in liver disease should act to promote
gluconeogenesis from extrahepatic sites.
It has been suggested that the hyperinsulinaemia observed in
chronic liver disease is unrelated to increased stimulation of pancreatic
beta cells (Greco et al, 1979). This hyperinsulinaemia but may be
accounted for by deficient hepatic insulin extraction or to the shunting of
portal venous blood to the systemic circulation thereby bypassing the
liver (Nolte et al, 1995). Animal studies that support the role of shunting
in cirrhotic hyperinsulinaemia have observed elevated insulin
concentrations after construction of portacaval shunts (Tranberg et al,
1979). However, other researchers have failed to attribute the
hyperinsulinaemia of cirrhosis to portacaval shunting (Smith-Laing et al,
1979).
Taylor et al (1985) and Cavallo-Perin et al (1985) suggest that the
hyperinsulinaemia of cirrhosis is a result of a deficit in binding and post-
binding defects in insulin target organ cells such as adipocytes. Following
an oral glucose tolerance test, Taylor et al (1985) assessed insulin
sensitivity in 16 cirrhotics and 11 controls. The cirrhotic patients had an
impaired glucose response to the glucose tolerance test despite elevations
in insulin secretion when compared with control subjects. In addition,
Taylor et al (1985) also observed differences in the responses to the
glucose tolerance test two hours after ingestion in patients with alcoholic
liver cirrhosis, biliary cirrhosis and cryptogenic cirrhosis. Blood glucose
and serum insulin concentrations were significantly higher in alcoholic
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patients when compared to those with biliary cirrhosis. This finding
suggests that the response to a glucose load will differ depending on the
primary aetiology of cirrhosis. It could be postulated that the improved
glucose and insulin response to the glucose challenge is because
hepatocyte function is better preserved in PBC.
In an attempt to define the response to feeding in cirrhosis, only a
few groups have examined substrate oxidation in the fasted and fed state
(Eriksson et al, 1989; Green et al, 1991; Campillo et al, 1992). These
studies considered small numbers of patients and with the exception of
the work of Green et al (1991) focused on patients with alcoholic liver
disease. These investigators found that, in the fasted state, lipid oxidation
rates were elevated in cirrhotic patients when compared with control
subjects. However, following consumption of a test meal, Eriksson et al
(1989) and Campillo et al (1992) observed significantly enhanced glucose
oxidation in their alcoholic cirrhotic patients when compared with
controls. On the other hand in a study of PBC patients Green et al (1991)
observed no significant differences in glucose oxidation in the transition
from the fasted to the fed state. This is indicative of differential nutrient
handling in patients with alcoholic and cholestatic disease. It is, however,
difficult to make direct comparisons between these studies where the size
of test meals ranged from 41 kj/kg body weight to a prescriptive meal of
4 MJ. In addition the duration subjects were studied for ranged from 3-6
hours postprandially.
Further well controlled studies are required where the length of
study is sufficient to observe the peak and duration of the response to
feeding yet short enough to be acceptable to the patient.
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Effect of Liver Transplantation on Metabolic Status
Little more than a decade ago OLT was considered by many
clinicians to be a dangerous and an almost experimental procedure. In
1980 less than 50 grafts were performed across Europe whereas in 1997,
650 liver transplants were undertaken in the United Kingdom. Outcome
has improved too and in the early 1980's only one patient in three could
expect to survive to one year whereas only one patient out of four does
not survive to one year in the 1990's (McMaster, 1994). This improved
survival has been associated with improvement in the quality of donor
organs, improved organ perfusion and the introduction of the
immunosuppressive drug cyclosporin (CsA). In order to maximise pre-
and post-transplant care, all patients are regularly assessed, evaluated and
monitored by a highly trained multidisciplinary team (surgeon, physician,
nurse, clinical biochemist, physiotherapist, psychiatrist, pharmacist and
dietitian). The transplanted patient's long term management is dependent
on their pharmaceutical regimen where the balance of
immunosuppression is crucial. Too low a dose increases the risk of
rejection and too high a dose could induce toxic effects such as
nephrotoxicity.
Common metabolic problems that occur following transplantation
include diabetes, hyperlipidaemia, hypertension and obesity. The
aetiology of these disorders has predominantly been attributed to
immunosuppressive therapy which is generally given as CsA or
tacrolimus monotherapy, or in combination with prednisolone and/or
azathioprine. Normally steroids are reduced during the first three
months following surgery and may be discontinued shortly thereafter.
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The drug regimen will, of course, be dictated by individual patient
progress.
As the number of surviving longterm transplant recipients
increases, several research groups have examined the prevalence of the
metabolic abnormalities which frequently occur in liver grafted patients.
For example, a number of patients not previously diabetic (DM) exhibit a
DM oral glucose tolerance test although evidence suggests this diabetes is
transient in nature. In a retrospective review of 88 OLT patients (none
with a previous DM history), Navasa et al (1996) noted the prevalence of
diabetes post-transplant was 27%, 9% and 7% at one, two and three years
respectively. Furthermore, Tabasco-Minguillan et al (1993) considered the
diabetogenic effect of the immunosuppressive drug tacrolimus and during
the early postoperative period, seven out of 52 patients became DM but at
a year OLT only one patient required insulin and this was discontinued by
18 months.
Another condition that could indirectly influence longterm survival
in liver transplantation is hyperlipidaemia. Accelerated atherosclerosis has
been observed in patients receiving solid organ transplants and would
increase cardiovascular risk (Munoz et al, 1991; Kasiske 1988). Kasiske
(1988) in a retrospective study of 403 renal transplants found that 15% of
patients developed ischaemic heart disease. Interestingly, age, male sex,
diabetes, smoking, hypertension and plasma cholesterol were
independently associated with post-transplant vascular disease. Over the
next eight years, Kasiske and colleagues (1996) used drugs to treat these
lipid abnormalities in transplanted patients and on re-examination they
found that cholesterol was no longer a predictive factor of ischaemic heart
disease. Whilst no conclusive evidence exists, CsA has been implicated in
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the pathogenesis of hyperlipidaemia, although concomitant steroid
therapy can also adversely effect lipid metabolism in recipients of solid
organ transplants (Becker et al, 1988).
The detrimental influence of CsA on plasma lipids was examined
by Ballantyne (1989) who showed that patients treated with CsA for
psoriasis or amyotrophic lateral sclerosis had elevated plasma lipids
following treatment. It has been suggested that the newer
immunosuppressive drug tacrolimus may improve the lipid profile of
transplanted patients. Indeed Van Thiel et al (1990) has shown that
tacrolimus administration after OLT did not significantly elevate serum
cholesterol levels.
One distressing, common and long term post-operative feature of
OLT is that of progressive and significant weight gain. This seems
somewhat of a paradox since many patients lose weight before transplant
and are frequently prescribed energy dense dietary regimens. The
incidence of obesity following OLT has been reported by several groups
and ranges from 40-64% (Stegall et al, 1995; Munoz et al, 1991; Palmer et
al, 1991). Munoz et al (1991) studied 21 OLT patients for more than 18
months following transplantation and noted that those patients who
became overweight or obese were not different in terms of age, sex,
length of postoperative stay, serum cholesterol or CsA levels than their
weight stable counterparts. Interestingly, this study is one of the few that
examined energy and macronutrient intake following transplantation (18
months OLT). They found no signficant differences in dietary intake
between OLT patients and an age and sex matched control group.
Unfortunately, these important data received little attention by the
authors but it would appear a three day dietary record was kept by
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patients but only on one occasion. Sequential monitoring of dietary
intake and its relationship with weight gain would contribute to
understanding the mechanisms involved in OLT weight gain.
Stegall et al (1995) examined weight status in 123 patients one year
OLT and found that 39% of men and 42% of women had a body mass
index (BMI > 27) and could be classified as being overweight. In this study
the tapering of steroids to 5 mg/day significantly reduced the prevalence
of diabetes, hypertension and hypercholesterolaemia but there was no
change in the prevalence of obesity. Palmer and co-workers (1991)
studied weight gain in 28 patients pre- and post OLT and found that two-
thirds of these patients became overweight (64%) and this occurred
during the second to sixteenth month after OLT. Interestingly in the
study of Palmer et al (1991), all patients who were overweight before OLT
became significantly more overweight after their graft. The rate of
weight gain among the overweight population was 1.5 kg/month
compared with 0.4 kg/month in the non-overweight group. These
workers attributed weight gain to the hyperphagic effect of prednisolone.
However, this seems unlikely as no differences in prescribed drug
regimen in the overweight and non-overweight group were apparent and
does not account for the three-fold increase in monthly weight gain found
only in the pre-OLT overweight population. The findings of this study
suggest that the effect of low prednisolone doses on weight gain may
have been overstated particularly in view of the unique role of the liver as
a metabolic sensor (Friedman, 1997). In addition, the increase in appetite
induced by steroids may be transient and does not not necessarily reflect
qualitative intake (Bruera et al, 1990).
56
A post-OLT period of rapid weight gain could contribute to
increased cardiovascular morbidity and mortality. Furthermore, a
significant increase in body weight among patients transplanted for PBC
could make them even more prone to pathologic fractures. These
debilitating complications contradict the philosophy of transplant surgery
which is to enable recipients to return to a life of normal activity. Whilst
the prevalence of rapid weight gain post-OLT has been reported, body
composition changes and the mechanisms involved in weight gain
following liver transplantation remain poorly understood.
Dietary Intake
A number of methods may be employed to estimate quantitatively
and qualitatively dietary intake. These include the weighed intake
technique, estimated records, dietary history and food frequency
questionnaires (Gibson, 1990). Whilst the weighed record technique is
considered the most accurate method of quantifying dietary intake, this
approach requires a high level of subject co-operation as every
component of the diet must be accurately weighed and meticulously
recorded by the subject, carer or investigator (Pekkarinen 1970). This
approach in estimating dietary intake would prove too demanding for
patients with chronic disease and a more acceptable yet valid method of
estimating nutritional intake may be obtained from the diet diary method.
To obtain valid results of dietary intake it is essential that subjects
are carefully instructed on how to complete their diet diary where detailed
descriptions of all food and beverages (including brand names and
composite dishes) consumed and cooking methods used, is documented.
When using this technique, the investigator must be aware of sources of
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measurement error such as subject bias, and although over- or under¬
reporting has been observed, this has primarily been among individuals
with eating disorders (Goldberg et al, 1991; MacDiarmid and Blundell,
1997; Poppitt et al, 1998). The subject may also incorrectly estimate the
portion sizes of food consumed and with regard to the investigator,
coding and computer errors may occur. However, these errors can be
minimised by carefully instructing subjects on correct recording of food
portion sizes and in the use of household measures. Additionally a
structured dietary record proforma which uses appropriate language will
act to review and reinforce the information given at interview.
The information from three day diet diaries will provide an
estimate of energy and macronutrient intake (Gibson 1990). Nettleton et
al (1980) in a study of 38 subjects showed that when estimated intake,
using household measures, was compared with weighed intake, the
percentage of subjects whose intake was within ± 10% was 92% for
energy, 87% for protein, 71% for fat and 89% for carbohydrate.
The number of days a dietary diary is kept will affect the precision
of the method. It must be long enough to provide valid information but
at the same time not too arduous for the population being studied.
Bingham et al (1982) observed that in a sample size of 500, a 68%
difference in the means would be detectable when single days records
were used but with a three day dietary record, a difference of only 5%
could be detected. There was no improvement in precision when the
period of dietary recording was extended to seven consecutive days. It is,
therefore, accepted that a three day dietary diary, which includes a day at
the weekend, will provide a valid estimate of energy and macronutrient
intake (Bingham et al, 1988). It is difficult to validate dietary diary results
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but a relatively simple approach in healthy subjects is to compare daily
protein intake with nitrogen output as the latter provides an independent
measure of intake (Bingham & Cummings, 1985).
Dietary Intake in Liver Disease
The association of poor dietary intake with under-nutrition among
cirrhotic patients has long been recognised (Morgan 1982). For example,
Egan and colleagues (1985) observed that the spontaneous dietary intake
(hospital diet) of patients with alcoholic liver cirrhosis, was only 50% and
57% of requirements for energy and protein respectively. Conversely, in
a study which examined the influences of liver failure and energy
expenditure on the response to oral nutrition, Campillo et al (1997)
reported an improvement in nutritional status following 30 days of oral
nutrition (unenriched hospital diet). However, the methodology used in
this study for estimating dietary intake was unclear and appeared to lack
formal structure. In this study, reported oral intake "was about" 10.0 MJ
(2,400 kcal) per day and without energy dense supplementation would
constitute a bulky dietary regimen for these patients.
In marked contrast, Cabre et al (1990) undertook a study of 35
patients with hepatocellular cirrhosis, randomised to receive either enteral
tube feeding as the sole source of nutrition or an isocaloric, isonitrogenous
oral diet. They found that only in the tube fed group were improvements
in clinical and metabolic status observed. The dietary intake of the
cirrhotic patients in this study was 5.5 MJ (1,320 kcal) per day which is
approximately half that observed by Campillo et al (1997).
The results from metabolic studies have been used to develop
dietary recommendations for patients with liver disease (Plauth et al,
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1997). Whilst an adequate nutritional regimen can be readily prescribed,
patient compliance is fraught with difficulties and to date no studies have
examined spontaneous unrestrained dietary intake in cirrhotic patients. In
addition, no prospective longitudinal studies have examined longterm
spontaneous oral intake in OLT patients. Given these patients
susceptibility to complications such as hypertension, hyperlipidaemia and
obesity (Munoz et al, 1991), the consumption of an inappropriate diet may
further exacerbate these conditions.
Food Preference
The integration of gastrointestinal derived humoral and neural
information occurs in the brain (hypothalamus). This metabolic
information is interpreted by the hypothalmus which acts to regulate
thermogenesis and determine how much and what sort of food is eaten.
The role the brain plays in influencing nutritional intake is outlined in
Figure 1.4. Evidence from animal and a limited number of human studies
confirm the involvement of a post-ingestive site in food preference. For
example, Elizalde and Sclafani (1988), in a study using rats demonstrated a
learned and longlasting preference for a non-nutritive flavour when
paired with an intra-gastric infusion of glucose. Additionally, the
reinforcing effect of a glucose infusion on the consumption of a
specific flavour was eliminated when glucose oxidation was inhibited.
This highlights the role of post-absorptive influences on ingestive
behaviour. Interestingly, further work from this group has shown that
rats can also acquire preferences based on the post-ingestive, nutritive
properties of fats (Sclafani, 1990).
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FIGURE1.4
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The evidence is unequivocal that hepatic fuel oxidation provides the
unconditioned stimulus for controlling nutritional intake (Novin et al,
1985; Tordoff and Friedman, 1986; Tordoff et al, 1990; Friedman, 1997).
In a study where glucose was infused into the jugular vein or hepatic
portal vein paired with an enteral non-nutritive flavour, Tordoff and
Friedman (1986) showed that portal vein catheterised animals
demonstrated a preference for the non-nutritive flavour paired with
glucose. No flavour preference was exhibited by those animals infused
systemically and emphasises the important role of the liver in feeding
behaviour. Furthermore, hepatic portal glucose infusions decreased
subsequent food intake relative to saline but this effect was not observed
in animals infused via the jugular vein.
A later study by Tordoff et al (1990), examined preference for
fructose and glucose in animals who were tested after selected hepatic
vagotomy or sham vagotomy. This study showed that intact animals
preferred flavoured food eaten with a drink of fructose to the flavour
eaten with either no sweet drink or glucose. Furthermore, preference for
the fructose paired flavour was observed even when fructose and glucose
was administered by gavage. However, preference for the fructose
paired food depended on an intact hepatic vagus as vagotomised animals
exhibited no nutritive preference. This study strongly supports the central
role of hepatic signalling on nutrient intake.
The aforementioned studies have focused on animal work and not
surprisingly those among humans have centred on food preference in
relation to new food product development (Drewnowski and Moskowitz,
1985; Drewnowski, 1995) or in the study of obesity (Mela and Rogers,
1998). There is considerable evidence that the liver controls unconditioned
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aspects of food intake (Friedman and Strieker, 1976; Friedman and
Sawchenko, 1984; Langhans, 1996) where hepatic and oral afferent neural
pathways converge in the hypothalamus and that liver damage alters
nutrient intake (Deems and Friedman, 1988a,b; Deems et al, 1993;
Madden et al, 1997). Events that influence ingestive behaviour have been
considered in isolation and the synergistic effect of metabolic changes that
occur in chronic liver disease on food preference and nutritional intake
have not been considered. Given the central role of the liver in ingestive
behaviour, it seems likely that chronic liver disease would affect the
normal function of this metabolic sensor and the information relayed to
higher centres could affect food preference which as a consequence would
impact on nutritional intake and status. Following OLT the recipient's
liver is denervated resulting in a loss of hepatic afferent signalling and
could impact on nutritional intake.
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Summary
The metabolic features of chronic liver disease and the prevalence
of undernutrition have been widely reported (Crawford et al, 1994;
Prijatmoko et al, 1993; Merli et al, 1990; Greco et al, 1998). Although
there remains some debate as to the impact of disease severity, primary
aetiology and metabolic indices on nutritional status (Gugliemli et al, 1992;
Muller et al, 1992; Crawford et al, 1993; Campillo et al, 1997), it has been
shown that the presence of undernutrition in liver disease will have a
negative effect on clinical outcome (Merli et al, 1996; Selberg et al, 1997).
Given this significance of nutritional status on outcome, it adds impetus to
identifying strategies that would improve nutritional status. The poor
dietary intake of patients with chronic liver disease has been identified as a
major problem yet one that may be difficult to resolve (Egan et al, 1985;
Neilsen et al, 1993). It is surprising that few studies have examined the
relationship of chronic liver disease with factors contributing to poor
nutritional status such as anorexia.
It is clear that the liver plays a central role in ingestive behaviour
(Tordoff and Friedman, 1986) acting as a sensor for the metabolic control
of eating (Friedman, 1995). Under normal conditions hepatic oxidation of
lipid and glucose results in changes in hepatocyte membrane potential and
modulation of spike frequency in afferent pathways, resulting in satiety
(Scharrer et al, 1993). Ultimately it is the convergence in the central
nervous system of these neural signals as well as other humoral and
cognitive influences that determine the size and duration of an eating
episode (Rowlands et al, 1996). Impairment of hepatic neural function
and/or alterations in the fuel mix being oxidised may be present in liver
disease and could contribute to alterations in ingestive behaviour. It has
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also been suggested that impaired functional capacity of the liver may
lead to reduced clearance of humoral mediators of satiety such as CCK
(Budillon et al, 1996) and this may also contribute to a reduced satiety
threshold and result in early meal termination. When considered in the
context of patients with chronic liver disease these mechanisms may
account for sub optimal energy intakes and contribute to anorexia.
The physiological consequences of progressive liver damage
include aberrant metabolism which may cause altered humoral and neural
signalling via circulatory and afferent pathways to higher centres.
Whether this would affect the metabolic control of ingestive behaviour or
development of food preferences is unclear. Conversely, patients who
undergo OLT have a propensity towards obesity (Palmer et al, 1991).
Understanding the mechanisms involved in this OLT weight gain is
important where complications such as diabetes, hypertension and
hyperlipidaemia may be exacerbated in overweight or obese OLT
patients. Following OLT the recipient's liver is denervated and results in
the total loss of extrinsic innervation with no signalling either from or to
higher centres and it could be postulated that this would have a significant
influence on ingestive behaviour.
It is becoming clear that understanding the influence that altered
metabolism may have on nutritional intake may have important
implications for nutritional management before and after OLT. This thesis
sought to examine factors which may be associated with anorexia in
chronic liver disease and weight gain following OLT.
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Specific Aims of the Thesis
The main aims of this thesis were to examine:
(i) the influence of energy and substrate metabolism on dietary
intake, macronutrient preference and nutritional status in
chronic liver disease and following orthotopic liver
transplantation.
(ii) the contribution of factors such as immunosuppressive
therapy, energy expenditure and energy intake on post-
transplant weight gain.
To study this, the specific aims were to:
(a) determine nutritional status in cirrhotic patients and in a
sub group of patients following OLT.
(b) measure substrate oxidation rates in the fasted and fed
state among stable cirrhotic patients and in a sub group of
patients following OLT.
(c) measure the glucose and insulin response to a
standardised test meal in stable cirrhotic patients and in a
sub group of patients following OLT.
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(d) estimate the spontaneous macronutrient intake in stable
cirrhotic patients and in a sub group of patients following
OLT.
(e) assess macronutrient preference in stable cirrhotic
patients and in a sub group of patients following OLT.
(f) determine the relationship between nutrient handling,
nutritional intake/preference and nutritional status in
stable cirrhotic patients and in a sub group of patients
following OLT.
(g) determine the association between OLT weight change





Patients who were referred to the Scottish Liver Transplant Unit
under consideration for orthotopic liver transplantation between
December 1995 and August 1997 were eligible for study. All patients
had histologically proven liver cirrhosis and those with alcohol related
disease had been abstinent for a minimum period of six months.
Patients with known diabetes, renal disease, lung disease, thyroid
dysfunction, active inflammatory bowel disease, sepsis, severe ascites
and grade III/IV encephalopathy were excluded from the study. No
patient had evidence of neoplastic disease before or at surgery. A
group of healthy subjects was recruited from hospital personnel,
friends and relatives of the investigator. No healthy subject had a
chronic illness or was on any medication.
Patients were studied at assessment for transplantation and
those who subsequently underwent liver transplantation were studied
at three, six and nine months following discharge from hospital. All
transplant recipients underwent a conventional OLT and in no patient
was an auxiliary graft undertaken which left part or all of the native
liver. All procedures relating to the study were carefully explained to
subjects who were required to give written consent. The study
protocol was reviewed and approved by Lothian Health Board
Medical/Clinical Oncology Research Ethics Sub-Committee.
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Indirect Calorimetry Studies
Measurement of Energy Expenditure
Energy expenditure was measured using a mobile indirect
calorimeter (Deltatrac Datex Monitor, Engstrom, Kent, United
Kingdom). The Deltatrac is a ventilated (open hood) calorimeter and
measurements during spontaneous breathing are made by sucking air
through a canopy at a known constant rate (approximately 40
litres/minute). The difference between the inspired and expired
oxygen fractions are measured with a para-magnetic oxygen sensor
and the expired C02 fraction is measured with an infra-red C02 sensor.
Flow rate through the canopy is in the first instance determined by the
manufacturer and this value is set in the micro-processor software.
Calculation by the micro-processor of V02, VC02 RQ and energy
expenditure occurs several times a minute. The Weir (1949) formula
was used to determine energy expenditure:-
energy expenditure (kcals) = 3.941 V02 + 1.106 VC02 - 2.17 N
kj = kcal x 4.12
(where gases are expressed in litres and nitrogen (N) in grams and 4.12
kcal/kj)
Calibration
To check the performance of the calorimeter, the manufacturers
alcohol burning kit and protocol was used to check flow rate and RQ,
these checks were carried out on a monthly basis. New flow constant
was determined using the formula:-
new flow = 1.03 x 3820 ml x old flow
VC02ml
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(where a 5 ml dose of 100% ethanol will produce 3820 ml CO-,)
Throughout the study period, the CoV was <3%. Respiratory
quotient validation involved a 30 minute period of burning pure
ethanol (RQ = 0.67) in a lamp with wick and in a glass container to
simulate the canopy mode. In addition to routine performance checks
carried out by the investigator, the calorimeter was also fully serviced
twice yearly by an engineer from the manufacturer.
Calorimetrv Measurements
Prior to each period of measurement, the calorimeter was
switched on and the monitor dimmed at least 12 hours before use to
stabilise analysers. To ensure accurate gas exchange measurements,
calibration of gas sensors using carbogen (5% C02, 95% 02; Quick
CAL, calibration gas, Datex, Helsinki, Finland) were performed at the
beginning and end of each measurement period. Daily calibration for
atmospheric pressure using a barometer (Munro Ltd., London, UK)
was carried out to avoid inaccurate pressure calibration which could
result in an error in flow constant. All calorimetry measurements were
performed on steady state subjects in a quiet area of the ward in
thermally comfortable conditions. Subjects were fully briefed about
the calorimeter's basic operation and to ensure volunteers remained
awake, the researcher (RAR) remained with the subject during
measurement periods. Measurements of energy expenditure in the
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Predicted Energy Expenditure
Predicted energy expenditure was derived from the age specific
Schofield (1985) equation. An example of the equation applied to
subjects aged between 30-60 years of age is as follows:
males REE = (11.4 x weight) + 870
females REE = (8.1 x weight) + 842
Predicted results were expressed as a percentage of measured
energy expenditure.
Respiratory Quotient
The ratio of VC02 and V02 is a useful indicator of the type of
substrate oxidation where the normal physiological range is 0.7 - 1.0
with an RQ of 0.7 representing net lipid oxidation and an RQ of 1.0
indicating net CHO oxidation. In this study, measurement of urinary
nitrogen excretion was performed to permit calculation of NPRQ and
substrate oxidation rates. By subtracting the volume of oxygen
consumed and carbon dioxide produced for every gram of protein
oxidised from total V02 and VC02, then non-protein V02 and VC02
may be derived. The following equation of Jequier et al (1987) were
used to determine NPRQ:-
PVCO, = N x 6.25 x 0.774
PVOz = N x 6.25 x 0.966
NPRQ = VCQ, - PVCCb
vo; - PVOz
where:-
PVC02 = carbon dioxide production rate due to protein metabolism
(litres/min)
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PV02 = oxygen consumption rate due to protein metabolism
(litres/min)
N = urinary nitrogen excretion (g/day)
The above formula was used as it is valid in the presence of
lipogenesis (Ben-Porat et al, 1983) or ketogenesis (Frayn, 1983).
Calculation of Substrate Oxidation Rates
Normally, measurement of respiratory gas exchange is
indicative of all the oxidative processes occurring in the body. By
measuring a subject's V02 consumption, VC02 production and urinary
nitrogen excretion, substrate oxidation rates may be derived.
An index of protein oxidation over the test was obtained from
urinary nitrogen excretion period (6 hour collection). To correct for
changes in the urea pool during the period of study, blood urea
concentrations were measured at baseline and at the end of the study
period. The correction factor described by Jequier et al (1987) was only
used when the change in blood urea concentration exceeded 5%.
urea correction = change urea nitrogen (g) x urea pool
4 x 1000
The oxidation rates for fat, carbohydrate and protein as
calculated using the following stoichiometric equations (Jequier et al,
1987):-
carbohydrate oxidation (g/min) = NPVOz x (NPRO - 0.696)
0.304 x 0.746
fat oxidation (g/min) = NPV02 x (1 - NPRO)
0.304 x 2.012
protein oxidation (g/min) = PVO-,"
0.966 ~
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These formulae are similar to others used in studies of substrate
oxidation (Frayn et al, 1983; Elia & Livesey, 1988) and unlike the tables
of Elia and Livesey (1988) or the more complex formulae of Frayn
(1983) the stoichiometric equations of Jequier et al (1987) were easily
incorporated into the database programme used in the current study
(Filemaker Pro, Claris Corp., USA).
Anthropometry
Height and Weight
Subject's height were measured without shoes using a
stadiometer (Docherty Medical, London) to the nearest centimeter
(0.01 m). Subjects were weighed in light clothing to an accuracy of 100
gms (0-01 kg) on mobile sitting scales (Weymed Ltd., United Kingdom)
and body mass index (weight -s- height2) was calculated and used as a
marker of leanness or obesity where a desirable BMI for men and
women is between 20-25 (Roche et al, 1981). On entry to the study,
patients were asked to subjectively report any weight loss during the
preceding year. This was expressed as a percentage of actual body
weight and reported as recent weight loss.
Arm Anthropometry
As a substantial proportion of the fat mass lies subcutaneously,
skinfold measurements provide a method of quantifying the amount
and in longitudinal studies determines changes in this energy reserve.
Although many sites may be used in assessing fat reserves, only TSF
measurements which correlate strongly with reference techniques of
measuring TSF (Booth, 1966) were used in this study. The upper arm is
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less affected by bed rest or fluid retention (Wicks et al, 1995). In
addition, it has the added advantage of being easily accessed and the
measurement itself is minimally intrusive. This was particularly
important in the current investigation where the subjects continued
support was paramount.
Measurement of TSF was performed using Harpenden Skinfold
Calipers (Holtain Ltd., Bryberian, Crymmych, Pembrokeshire, United
Kingdom) by the author (RAR). Triceps skinfold thickness was
measured by marking the mid-point between the acromion and
olecranon processes in the dependent non-dominant arm with the
elbow joint flexed to 90°. A skinfold 1 cm above this point overlying
the triceps muscle was pinched between first finger and thumb and
three readings of the triceps skinfold thickness was obtained. Readings
were taken three times and the average taken as an absolute value.
In order to make comparisons between males and females, TSF
values were expressed as a percentage of standard where males = 12.5
mm and females = 16.5 mm (Jelliffe 1966). In the current study, these
standards were considered appropriate as all subjects were of a similar
age and the Jelliffe (1966) standards are comparable with the 50th
percentile values from other population studies (Frisancho 1974;
Bishop et al, 1981).
In estimating AMC, indicative of skeletal muscle mass, a
number of assumptions are made: firstly, the upper arm is considered
a perfect circle and no allowance is made for the bone in the arm.
Secondly, this quantitative assessment of skeletal muscle mass is
predictive of LBM. Mid upper arm circumference was measured, at the
mid point of the upper arm, using a flexible measuring tape. From
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measurement of TSF and mid upper arm circumference, AMC is
derived using the formula:-
AMC(cm) = MUAC(cm) - (3.14 x TSF(mm))
in which AMC, mid upper arm circumference and TSF are expressed in
centimetres. To allow gender comparisons, results were expressed as a
percentage of standard, where mean values for AMC were 25.3 cm
and 23.2 cm for males and females respectively (Jelliffe, 1966). These
figures are comparable with other population studies (Frisancho 1974;
Bishop et al, 1981).
Arm anthropometry was performed on subjects at the end of
every study period.
Multi-Frequency Bioelectrical Impedance Analysis
This was performed on the day of investigation using a Xitron
4000B Analyser (Xitron Technologies, San Diego, California, USA)
operated at 200 |iA at the previously defined optimal frequencies of 5
and 200 KHz (Hannan et al 1994). The alternating current was passed
between a set of pre-gelled current injection electrodes (Bodystat, Isle
of Man, United Kingdom). These were placed on the right hand and
foot, just proximal to the third metacarpal and metatarsal bones
respectively. Similar detection electrodes were placed on the right
wrist between the radius and ulnar and on the right ankle between the
malleoli. Measurements were taken on the morning of study with the
subject in the supine position, with legs and leads apart. Total body
water and extracellular water was calculated from predictive equations
previously derived from isotopic studies on surgical patients
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performed in our own unit (Hannan et al, 1995). These equations are
as follows:-
ECW(L) = 0.1782 (Ht2) + 0.0688 wt + 3.771
(Rs)
TBW(L) = 0.2391 (Ht2) + 0.1889 wt + 2.971 Sex (female = 0,
(R200) male = 1) + 5.4641
where: ECW = extra cellular water; TBW = total body water;
Ht = height; wt = weight; Rs = resistance measurement
at 5 Khz;
R200 = resistance measurement at 200 Khz
By subtracting extracellular water from total body water, an estimate
of intracellular water and body cell mass was derived (Shizgal 1983) as
follows:
ICW = TBW - ECW
BCM = ICW
0.70
where: ICW = intracellular water; BCM = body cell mass
In this study, analysis of body composition by total body
potassium measurements or isotopic studies were not possible.
Bioelectrical impedance among patients with mild and moderate ascites
has been validated with total body potassium measurements as a
method of assessing the metabolically active component of body
composition, the BCM in populations of cirrhotics (Muller et al, 1992).
Biochemical Measurements
Blood Samples
At least 40 minutes before investigation, an indwelling cannula
(Venflon 2, BOC Ohmeda AB, Helsingborg, Sweden) was sited in the
brachial vein and kept patent with a minimal infusion of normal saline.
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Blood samples were taken at the time points indicated in the schema
shown in Figure 2.1. Blood samples (lithium heparin x 2, glucose x 7)
were stored in an ice filled flask and serum Gel samples (x 3) were kept
at room temperature. Once investigations were complete, samples
were centrifuged without delay at 2000 g at 2 - 4°C for ten minutes.
Serum and plasma samples were stored at -40°C and analysed in
batches for plasma insulin, serum glucose and blood urea (Clinical
Chemistry, Western General Hospital, Edinburgh).
Plasma glucose
Glucose concentration was measured by the timed end-point
method on the Roche Cobas Mira Plus (Roche Diagnostics Ltd, Lewes,
Sussex, UK) analyser.
D-glucose + ATP Hexokmase ^ glucose-6-phosphate + ADP
D-glucose-phosphate+NAD GfePPH ^D-glucona te-6-phosph a te
+NADH+H+
ADP = adenine di-phosphate
G6P-DH = glucose-6-phosphate-dehydrogenase
NAD = nicotinamide adenine di-nucleotide
NADH= nicotinamide adenine di-nucleotide (reduced form)
The formation NADH is directly related to the glucose
concentration and is measured photometrically at 340 nm. The inter
assay coefficient of variation is less than 1.5%.
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Plasma insulin
Insulin was measured by a two site immunoenzymometric
assay on a the AIA-600 random access automated enzyme
immunoassay system (Tosoh Corporation, Tokyo, Japan). During an
incubation step, insulin in the sample is sandwiched between an
antibody immobilised on magnetic solid phase and an enzyme labelled
monoclonal antibody (alkaline phosphatase). The magnetic beads are
subsequently washed to remove unbound enzyme labelled antibody
and incubated with 4- methylumbelliferyl phosphate which is a
fluorgenic substrate to alkaline phosphatase. The rate of fluroescence
produced is directly proportional to the concentration of insulin in the
sample. The sensitivity of the assay is 2.0 mU/L and the inter-assay
coefficient of variation is less than 5% at all levels.
C-Reactive protein fCRP)
C-Reactive protein was measured by an ELISA (enzyme link
immuno-sorbent assay) procedure using Rabbit Anti-Human CRP as
the detection antibody (Dako, Glostrup, Denmark). After coating wells
with diluted antibody (1 : 5,000), microtitre plates were covered and
incubated overnight. Plates were then blocked with bovine serum
albumin (1%) and washed. Patient samples were diluted (1 : 10,000) in
phosphate buffer and saline and added to each well. In addition, CRP
standards (0.5 jJ.g/1 - 50 ptg/1; Human Serum CRP Calibrator, Deko,
Glostrup, Denmark) (TBS Buffer) were analysed. Duplicates of
samples, standards and blanks were placed in wells using previously
designed plate maps and incubated overnight.
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The plates were washed and the detection antibody (Peroxidase-
Conjugated Rabbit Anti-Human CRP, Dako, Glostrup, Denmark) was
added to each well, incubated and the plates washed. The
chromogenic substrate 5,5*,3,3* tetra methyl benzidine (Dako Patts,
Dako, Glostrup, Denmark) was added to allow colour development,
plates were covered to protect them from light and incubated for 15
minutes. Colour development was stopped by adding 20 pi of 1 M
sulphuric acid to each well and plates were read within one hour using
an automated plate reader (Dynatech, West Sussex, UK). The CRP
concentration was calculated in each patient by reading values from
the standard curve using Absay gap computer software (Biosoft,
Cambridge, United Kingdom). The lower limit of sensitivity taking
into account sample dilutions was 150 pig/P1. The intra-assay
coefficient of variation was 7% and inter-assay coefficient of variation
was 15% at a concentration of 1 : 10,000.
Urinary nitrogen
Prior to investigation, subjects were asked to empty their
bladders. Urine was collected over the 6 hour test period and also over
the subsequent 24 hour period in graduated plastic storage bottles
(2500 ml). The 6 hour urine collection was only taken in those subjects
entered into the test meal limb of the study. This permitted protein
oxidation to be calculated over the study period.
Urine samples were batched, frozen and subsequently analysed
using a nitrogen analyser (LECO-FP328, St. Joseph's, Michigan, USA).
A 200 pi urine sample was placed in a smooth wall tin capsule (LECO,
Michigan, USA) and underwent the analysis cycle. The encapsulated
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sample of urine was purged of any atmospheric gases, dropped into a
hot furnace (850°C) and then flushed with pure oxygen for rapid
combustion. The products of combustion C02, H20, NO and N2 were
passed through the furnace filter and then the thermoelectric cooler to
remove most of the water. A sample aliquot of the gases is then swept
through hot copper to remove oxygen and change NO to N2, then
through Lecosorb (LECO, Michigan, USA) and Anhydrone (LECO,
Michigan, USA) to remove C02 and H20 respectively. The remaining
nitrogen is measured by the thermal conductivity cell.
Results are given as weight percentage of nitrogen and using
the subjects total urine volume, urinary nitrogen may be calculated.
Test Meal
On the day of investigation, the test meal was prepared as
follows:-
Test Meal
20 g Polycal (Nutricia, Trowbridge, UK)
200 ml Fortisip (Nutricia, Trowbridge, UK)
50 ml water
Nutritional Content (volume 250 ml)
Energy 1596 kj (380 kcal)
Carbohydrate 56 g (59% CHO)
Fat 13 g (31% fat)
Protein 10 g (10% protein)
Ingredients for the test meal and subjects prescription (15
kj/kg) were weighed on scales accurate to 0.1 g (Mettler, Instrumente,
Zurich, Switzerland). Following the protocol outlined in Figure 2.1,
subjects were required to consume the test meal over five minutes.
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Nutrient Intake
In order to estimate subjects' dietary intake, food diaries
(recording intake for two week days and one day at the weekend)
were kept by subjects for three days in the week following hospital
discharge. Clear verbal and written instructions were given to all
subjects on how to complete diet diaries. Additionally, in order to test
understanding of diary completion, patients were questioned after the
diet diary interview and where appropriate, further instruction was
given. Subjects who did not return their diaries within ten days were
given one telephone reminder.
Diaries were transposed to a standard data sheet by the
investigator and where required the Food Portion Sizes (MAFF, 1993)
was used to determine portion sizes. Data was analysed using a
dietary computer analysis programme (Comp-eat, Nutrition Systems,
London).
Macronutrient Preference
Using the methodology of Drewnowski and Greenwood (1983)
preference for fat and carbohydrate was determined using four
commercially produced ice creams (a real food combining fat and
carbohydrate) as the test stimuli to determine macronutrient
preference.
Each ice cream varied in macronutrient content (Table 2.1) but
all were vanilla in flavour. The composition of the ice creams
used did not change over the study period. Approximately 15 ml of ice
cream was served in a plastic beaker which was numerically coded
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order to mask any visual differences, eye shades were worn during the
tasting procedure. Hedonic responses (degree of liking) were
recorded for each coded sample on a nine point hedonic scale (Peryam
and Pilgrim, 1955) anchored by the responses "dislike extremely" and
"like extremely" as shown below:
1. = Dislike extremely
2 = Dislike very much
3 = Dislike moderately
4 = Dislike slightly
5 = Neither like or dislike
6 = Like slightly
7 = Like moderately
8 = Like very much
9 = Like extremely
On the morning of study subjects tasted and swallowed samples
and were subsequently asked to elicit pleasantness ratings. Re-tasting
was permitted. Palate cleansing using water (Evian, France) was
performed before each tasting session and following ingestion of each
sample. Macronutrient preference was re-examined in all subjects and
no significant differences between the first and second tasting were
observed (Wilcoxon-Signed Rank test).
Statistics
All statistics were performed on an Apple Macintosh Centris
(616) computer using a commercially available statistics package
StatView 4.02 (Abacus Concepts Inc., California, USA). Where several
groups of data were compared, analysis of variance (ANOVA) was
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used to test whether there were significant differences between
groups. Longitudinal changes were analysed using repeated measures
ANOVA and the post hoc Scheffe's test. The effects of the test meal in
cirrhotic patients was analysed by two factor repeated measures
ANOVA and the post-hoc Scheffe's test was used in comparing means.
In pairwise comparisons, Student's t-tests was used for normally
distributed data and the non-parametric Mann-Whitney U test and
Wilcoxon Signed Rank test was used for pairwise comparisons if data
was not normally distributed. Following OLT, analysis of test meal
data was performed using Friedman's two way analysis of variance
and Wilcoxon Signed Rank test was used to detect differences.
Food preference results were expressed as median and inter¬
quartile range (IQR) and values outwith the 25th percentile and 75th
percentile were represented in the figures individually. In analysis of
food preference data, differences between groups were determined
using Kruskal-Wallis one way analyis of variance and Mann-Whitney
U test. Differences within groups were determined using Friedman's
two-way analyisis of variance and Wilcoxon Signed Rank test.
For descriptive purposes, data has been expressed as mean (±
SEM) to facilitate comparison with other published results. Pearson's
correlation coefficient was used to determine associations between
variables. Multiple stepwise regression was performed using fat mass
as the dependent variable and cumulative drug dose, energy
expenditure and energy intake as the independent variables.
Differences were considered significant when the probability of
their arising by random sampling error was less than 1 in 20 (p<0.05).
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CHAPTER 3
THE CLINICAL AND NUTRITIONAL STATUS IN LIVER
CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS
The poor nutritional status of hospitalised patients with chronic
liver disease has been widely reported (Crawford et al, 1994; Wicks et
al, 1995; Caregaro et al, 1996). However, following OLT sustained and
rapid weight gain has been reported (Munoz et al, 1991). This increase
in body mass could be attributed to a return to pre-illness weight.
However, given the duration of continued weight gain (up to 16
months) and that patients who were overweight prior to
transplantation (40%) became more overweight following surgery,
suggests an increase beyond that of 'usual' body weight (Palmer et al,
1991).
The current study considered the nutritional and metabolic
status of cirrhotic patients not admitted for symptomatic control of
acute exacerbations of their liver disease. This permitted the study of a
population with a chronic rather than an acute on-chronic disease
process. In addition, a sub-group of these cirrhotic patients were listed
for and subsequently underwent OLT. These patients were studied at
three monthly intervals up to one year following liver transplantation
to allow longitudinal study of changes in patients nutritional status.
Patient and Methods
Patients admitted for consideration of orthotopic liver
transplantation, a sub-group of cirrhotic patients who underwent OLT
and a group of 18 healthy volunteers were recruited. Studies were
performed in the Scottish Liver Transplant Unit between January 1996
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and July 1998. Sixty-seven cirrhotic patients with histologically proven
cirrhosis were recruited. Thirty-five patients had cholestatic disease (34
primary biliary cirrhosis, one primary sclerosing cholangitis) and 32
hepatocellular cirrhosis (23 alcoholic cirrhosis, three cryptogenic
cirrhosis and six Hepatitis C). Thirty-three patients from this cohort
were transplanted. Those cirrhotic patients submitted to OLT were
reviewed on a three monthly basis, on at least three occasions after
discharge from hospital. Four patients died in the early postoperative
period and six patients were subsequently excluded because of the
presence of significant complications (prolonged sepsis n = 4; bile duct
stricture n = 1; hepatic vein stenosis n = 1). Therefore, 23 OLT patients
were nutritionally assessed following discharge at three monthly
intervals on at least three occasions.
Methods
Body composition was determined from anthropometric and
MFBIA measurements. Resting energy expenditure was measured
using indirect calorimetry. Serum albumin concentration and C
reactive protein were used as biochemical markers of disease severity
and inflammatory response respectively. A more detailed account of
the methodology is given in Chapter 2.
Results
Cirrhotic Patients
In the cirrhotic patient group, pharmacological regimens during
the assessment period included diuretic therapy (41 patients), vitamin
supplements (13 patients) and lactulose (12 patients). Comparison of
nutritional, clinical and metabolic status of cirrhotic patients are shown
in Tables 3.1 and 3.2.
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TABLE 3.1 NUTRITIONAL AND CLINICAL STATUS OF
CIRRHOTIC PATIENTS AND CONTROLS
Cirrhotic Patients Controls
n 67 18
Male : Female 26:41 9:9
Age 54.5 (1.1) 50.2 (2.7)
Weight (kg) 66.7 (1.7)b 76.9 (2.9)
Ideal body weight (%) 107 (2.8) 117 (3.5)
Recent weight loss (%) -7 (1.2)b 0
Body mass index 24.1 (0.6) 26.4 (0.9)












Serum albumin concentration (g/1) 30.7 (0.6) 35-45
(reference
range)
C-Reactive protein (mg/1) 10.2 (2.1) 9.4 (5.1)
Child's Pugh score
Child's Pugh score A n = 14
Child's Pugh score B n = 26
Child's Pugh score C n = 27
8.7 (0.3)
Mean (± SEM)
a = p<0.05 versus controls
b = p<0.01 versus controls
c = p<0.001 versus controls
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(kcal/kg) 20.6 (0.4) 19.1 (0.5)
(kcal/kg BCM) 59.8 (1.5) 55.8 (1.3)
Predicted energy expenditure (%) 91 (1.9) 94 (2.9)
Non protein respiratory quotient 0.81 (0.01)a 0.84 (0.01)
Urinary nitrogen excretion (g/day) 6.2 (0.5)a 8.6 (0.9)
Mean (± SEM)
a = p<0.05 versus controls
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Cirrhotic patients had lower body weight than controls (p<0.01)
but when weight comparisons between these groups were normalised
for gender using percentage ideal body weight (Statistical Bulletin,
1983) no differences between the cirrhotic patients and control subjects
were apparent. Cirrhotic patients had a reported mean recent weight
loss of 7%. Triceps skinfold thickness and AMC were significantly
lower among cirrhotic patients when compared with controls (TSF =
p<0.05; AMC = pcO.OOl). Arm anthropometry results were
normalised for gender and expressed as a percentage of standard.
Both TSF and AMC were lower in cirrhotic patients when compared
with controls (TSF = p<0.01; AMC = p<0.01). Respiratory quotient and
urinary nitrogen excretion were significantly lower in patients when
compared with controls (p<0.05).
Table 3.3 shows MFBIA results in male and female cirrhotic
patients. Control subjects and percentage values were used to
facilitate gender comparison. Body cell mass was significantly lower in
female cirrhotic patients when compared with female controls (p<0.05)
but when expressed ^s a percentage of body weight, there were no
significant differences between patient groups and controls. Fat mass
was significantly lower in female cirrhotic patients when compared
with female controls (p<0.05). Additionally, when expressed as a
percentage of body weight, fat mass was significantly lower in both
male and female cirrhotic patients when compared to their healthy
counterparts (p<0.05).
In the cirrhotic population, there was a highly significant
relationship between measured energy expenditure and the predicted
energy expenditure estimated by the Schofield (1985) equation
(Figure 3.1). In this study, energy expenditure was measured by
indirect calorimetry and given that BCM is the oxygen consuming
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component of body composition, the relationship between measured
energy expenditure and BCM was examined in both patients and
controls (Figure 3.2). Regression analysis showed a strong positive
relationship between measured energy expenditure and BCM in
cirrhotic patients and controls (r = 0.765; p<0.0001: controls r = 0.957;
p<0.0001). This relationship held in patients with and without ascites
(ascites, r = 0.809; p<0.0001: no ascites, r = 0.732; p<0.0001). This
finding supports the use of MFBIA in determining body composition
in populations of cirrhotic patients with mild and moderate ascites. No
patient in the present study had severe ascites. In order to facilitate
comparisons between cirrhotic patients and controls, MFBIA is used in
the expression of energy expenditure data as per kilogram body cell
mass.
The nutritional, metabolic and clinical status of patients with and
without ascites was compared and there were no significant
differences between these groups.
Cirrhotic Patients Stratified by Disease Severity
Disease severity may also influence patients nutritional and
metabolic status. The nutritional and metabolic status of cirrhotic
patients was stratified according to the Child's Pugh score (Table 3.4).
Triceps skinfold thickness was significantly lower in patients classified
as Child's Pugh C when compared with those patients classified as
Child's Pugh A (p<0.05). Serum albumin concentration was
significantly lower in patients with Child's Pugh B arid Child's
Pugh C when compared with the Child's Pugh A group (Child's Pugh
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FIGURE 3.2
The relationship between measured energy





r = 0.957; p<0.0001 y = 1.477 + 0.181 * BCM
Ascites
r = 0.732; p<0.0001 y = 2.466 + 0.133 * BCM
No Ascites
r= 0.809; p < 0.0001 y = 1.835 + 0.161 * BCM
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TABLE 3.4 NUTRITIONAL, METABOLIC AND CLINICAL
STATUS OF CIRRHOTIC PATIENTS CLASSIFIED BY CHILD'S
PUGH SCORE
A (5-6) B (7-9) C (10-15)
n 14 26 27
Male : Female 2 : 12 9 :17 15 : 12
Age (years) 52.9 (2.2) 54.8 (1.7) 55.0 (1.7)
Weight (kg) 63.5 (3.2) 67.4 (2.6) 67.9 (2.9)
Ideal body weight (%) 105 (4.9) 107 (4.8) 109 (4.7)
Recent weight loss (%) -6 (2.3) -6 (1.9) -7 (2.1)




















expenditure (kcal/kg) 20.2 (0.7) 21.1 (0.7) 20.4 (0.7)
Resting energy expend¬
iture (kcal/kg BCM) 57.2 (7.0) 58.5 (13.2) 54.1 (20.3)
Predicted energy
expenditure (%) 91 (2.8) 95 (2.8) 89 (2.6)
Non-protein
respiratory quotient 0.82 (0.01) 0.81 (0.01) 0.81 (0.01)
Urinary nitrogen
excretion (g/day) 5.7 (0.7) 7.1 (0.9) 5.6 (0.7)
C-Reactive protein (mg/1) 14.2 (6.5) 6.3 (1.3) 12.3 (4.2)
Mean (± SEM)
a = p<0.05 Child's Pugh A versus Child's Pugh C
b = p<0.01 Child's Pugh A versus Child's Pugh C
c = p<0.05 Child's Pugh A versus Child's Pugh B
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A versus B p<0.05; Child's Pugh A versus C p<0.01) but it should be
noted that serum albumin concentration is a discriminatory index of
Child's Pugh classification. No relationship between disease severity
and energy expenditure was observed (Figure 3.1). In this study there
were no differences in energy status between cirrhotic patients when
classified by the Child's Pugh score.
Cirrhotic Patients Stratified by Primary Aetiology
When patients were sub-divided according to primary aetiology
(Table 3.5) patients with biliary cirrhosis (BC) were significantly lighter
than either the control or hepatocellular cirrhotic (HC) group (control
versus BC p<0.001; BC versus HC p<0.01). However, when body
mass was expressed as ideal body weight or when body mass index
(BMI) was calculated no differences were found between patient
groups and controls. Triceps skinfold thickness when expressed either
as an absolute value or a percentage was significantly lower in the HC
patient group when compared with controls (p<0.05). In addition, arm
muscle circumference was significantly lower in both cirrhotic groups
when compared with controls (control versus BC p<0.001; control
versus HC p<0.05) but when expressed as a percentage of standard no
differences in AMC between patient groups and control subjects were
apparent. There was no relationship between measured energy
expenditure and disease severity in either BC or HC patients (Figure
3.1). The NPRQ and urinary nitrogen excretion of patients with HC
was significantly lower than control subjects (p<0.05).
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TABLE 3.5 NUTRITONAL, METABOLIC AND CLINICAL





n 18 35 32
Male : Female 9:9 (NCOCO 23 : 9
Age (years) 50.2 (2.7) 57.6 (1.6) 51.2 (1.7)
Weight (kg) 76.9a (2.9) 62.0b(2.4) 71.9 (2.0)
Ideal body weight (%) 117 (3.5) 106 (4.7) 109 (2.9)
Recent weight loss (%) 0 -7(1.4) -6 (2.0)




















expenditure (kcal/kg) 19.1 (0.5) 20.6 (1.7) 20.7 (0.5)
Resting energy expend¬
iture (kcal/kg BCM) 55.8 (1.3) 58.0 (2.5) 61.7 (2.5)
Predicted energy
expenditure (%) 95 (2.8) 92 (2.6) 91 (1.9)
Non-protein
respiratory quotient 0.84c (0.01) 0.82 (0.01) 0.80 (0.01)
Urinary nitrogen
excretion (g/day) 8.6C (0.9) 6.8 (0.7) 5.5 (0.7)
Child's Pugh score - 8.3 (0.4) 9.0 (0.4)
Serum albumin (g/1) - 31.6 (0.9) 30 (0.9)
C-Reactive protein (mg/1) 9.4 (5.2) 11.4 (2.7) 8.7 (3.4)
Mean (± SEM) a = p<0.001 controls versus biliary cirrhosis
b = p<0.05 biliary cirrhosis versus hepatocellular
c = p<0.05 controls versus hepatocellular
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Orthotopic Liver Transplant Patients
Following OLT, no patient in this cohort (n = 23) had clinical
evidence of ascites and none continued diuretic therapy after discharge
from hospital. The relationship between immunosuppressive therapy
and changes in body composition after transplantation will be
examined later in this thesis. Characteristics of OLT patients are shown
in Table 3.6.
Changes in body weight and arm anthropometry after
transplantation are shown in Table 3.7 and MFBIA results are given in
Table 3.8. Compared with pre-OLT values, there was a significant
increase in body mass (weight, BMI) six months after OLT and this was
reflected in increases in arm anthropometry (TSF and AMC), LBM,
BCM and fat mass estimated by MFBIA. This increase in body mass
continued nine months after OLT and differences were observed
between OLT study time points. For example, from three to nine
months after OLT (Tables 3.7 and 3.8). These increases in body
composition were found in male and female patients where pre OLT
weight in females was 65.4 ± 3.9 kg and by 9 months OLT 71.7 ± 3.5 kg
(p<0.01). In males average pre-OLT weight was 76.6 ± 3.3 kg and at 9
months OLT this had increased to 87.7 ± 3.3 kg (p<0.05). In the present
study, 87% (n = 20) of patients nine months after transplantation had
a BMI greater than 25, 48% (n = 11) and could be classified as being
overweight (BMI = 26 - 30) and 39% (n = 9) were defined as obese (BMI
greater than 30) (Todorovic and Micklewright,1997).
A significant relationship between measured REE and predicted
REE existed at each study time point following OLT (pre-OLT: REE
versus predicted, r = 0.766, p<0.001; 3 months OLT: REE versus
predicted, r = 0.775, pcO.001; 6 months OLT: REE versus predicted,
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TABLE 3.6 CHARACTERISTICS OF PATIENTS FOLLOWING
LIVER TRANSPLANTATION
Age 53.9 (1.9)








TABLE3.7CHANG SIBODYM SSA DRMNTH OPO ETRYEFOREFOLL WING LIVERTRANSPLANTATION(n=23) Pre-OLT3months6months
9months
Controls
Bodyweight BMI %Tricepsskinfold thickness %Armmuscle circumference
70.5(2 8) 24.7(0.90) 82.5(7.8) 95.1(3 )
72.5( 4) 25.5(0.88) 90.6(8 ) 101.7(2.4)a
75.8(2.6)3/C 26.9(0.90)a,c 115(7.8)d,e 104.1(2.1)b
78.3(2.9)b,c,d 27.8(0.87)c,e,f 127(8.1)c'd,e 105.3(1.8)
b'g







CHANGESIBODYOMPOSITIONEFOREANDF LL WINGLIVETRANS LANTATIO Pre-OLT3months69Controls
Leanbodymass(kg)48.11 98.8(2.0)9 72.0)a'b 8.0)c9.9(2.2) Bodycellmass(kg)24.2(1.1)55.7(l.l)d'e25. 1.2)a'f6.6(1.4) Fatmass(kg)24.5(1.8)5.61 38 8(1.5)e's30.6(1 6)^'27.1(1.5) mean(±SEM)a=p<0.05versusr -OLTf13onthOLT b=p<0.01versus3monthOLTg<0.0 0re-OLT c=p<0.05versus3monthOLTh<0.0001re-OLT d=p<0.01versusre-OLTi<0. 0 03monthOLT e=pcO.0001versus3monthOLTj<0.6
r = 0.844, p<0.0001; 9 months OLT: REE versus predicted, r = 0.756,
p<0.001).
Measured REE was compared with predicted values and
significantly lower values in meausred energy expenditure was
observed at post-OLT time point (pre-OLT 0.2 ± 6.1 MJ/day versus
pre-OLT predicted 6.4 ± 0.2 MJ/day, p<0.001; 3 months OLT measured
6.0 ± 0.2 MJ/day versus 3 months OLT predicted 6.6 ± 0.2 MJ/day
(p<0.001; 6 months OLT measured 5.9 ± 0.2 MJ/day versus 6 months
OLT predicted 6.7 ± 0.2 MJ/day, p<0.0001; 9 months OLT measured
6.7 ± 0.2 MJ/day versus 9 months OLT predicted 6.7 ± 0.2 MJ/day,
p<0.001) (Figure 3.3). Compared with pre-OLT values, 43% (n = 10) of
patients had a greater than 10% decrease in predicted energy




In the current study, all patients were elective referrals admitted
for consideration of liver transplantation and as such were not septic
or had a recent haemorrhage. Indeed, only 40% of this population
were stratified as Child's Pugh C whereas 60% presented with Child's
Pugh A and B.
Cirrhotic Patients Nutritional Status
Anthropometric measurements are commonly used as practical
tools of nutritional assessment. In the present study arm
anthropometry was used to estimate fat and muscle reserves as both
are considered reliable assessment tools in chronic liver disease (Wicks
et al, 1995). Whilst arm muscle area has been considered by some
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* = p<0.001 versus predicted
** = P<0.0001 versus predicted
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researchers to be a more accurate marker of lean body mass,
Thuluvath and Triger (1994) have shown that area measurements
are more closely related to radiological assessment of body
composition but no difference between area and circumference
measurements were apparent when detecting under-nutrition.
In the current investigation, cirrhotic patients had depleted fat
and muscle reserves when compared to controls. These observations,
combined with lower fasting NPRQ and urinary nitrogen excretion
exhibited by this group, suggests a prolonged period of nutrient
deprivation. These findings are broadly in line with other studies in
patients with cirrhosis where fasting RQ's less than 0.80 have been
observed (Owen et al, 1983; Merli et al, 1990; Campillo et al, 1995).
Cirrhotic Patients Energy Status
There were no differences in REE between cirrhotic patients and
controls when expressed in relation to body weight, BCM or as a
percentage of predictive values. Several research groups have
reported hypermetabolism among patients with chronic liver disease
(Schneeweiss et al, 1990; John et al, 1990) but considerable debate
surrounds the issue of energy status in cirrhosis as other investigators
have shown that REE was not significantly different from predictive
values (Merli et al, 1990; Owen et al, 1983).
Clearly, it is unreasonable to expect that factors which
contribute to energy expenditure will be the same in all cirrhotic
patients regardless of the patient stratification employed. In the
current investigation predicted energy expenditure was compared
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with measured values for cirrhotic patients and 31% (n=21) could be
considered as hypometabolic, 63% (n=45) normometabolic and only
6% (n=l) hypermetabolic. This distribution of energy status was
almost identical to that found in the control group, where 33% (n=6)
were classified as hypometabolic, 61% (n=ll) normometabolic and 6%
(n=l) hypermetabolic. In addition, the relationship between measured
and predicted energy expenditure in patient groups was similar to that
found in the control group. It should be noted that the predictive
energy equation of Schofield (1985) was derived from a meta-analysis
of earlier studies on basal energy expenditure (Harris and Benedict,
1919; Robertson-Reid, 1952; Kleiber, 1932) and the majority of these
studies were performed on younger populations. In the present
study, 30% of patients and controls were hypometabolic and this may
be a result of a reduced body cell mass and increase in fat mass
consistent with the natural ageing process. Indeed a study on a large
cohort of 123 cirrhotic patients of similar ages, Muller et al (1992) also
found that energy expenditure differed from predictive values in half
this patient population with 31% classified as hypometabolic and 18%
hypermetabolic. Development of a disease specific predictive equation
for this population may be of value in estimating energy requirements
but given the heterogeneity of this population it may lack sensitivity.
This variation in energy expenditure in liver cirrhosis serves to
underline the difficulties when making assumptions about energy
requirements.
Dolz and colleagues (1991) suggested that the presence of
ascites increases whole body energy expenditure in cirrhotic patients.
This group performed a study on ten in-patients with alcoholic liver
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disease with severe ascites requiring paracentesis. Energy expenditure
was measured before and on average 11 days post-paracentesis.
Weight loss following drainage averaged 16.6 (range 5.4 - 37.5) kg and
was paralled by a fall in energy expenditure but this decrease could be
attributed to an improvement in the patient's general condition. In the
present study, no patient's ascites was severe enough to warrant
drainage, additionally a strong association between measured energy
expenditure and BCM was observed in cirrhotic patients. This finding
is supported by a comparative study by Muller et al (1991) which used
TBK measurements to determine LBM and compared results with
those from single frequency BIA to estimate BCM. They found a
highly significant relationship between TBK and LBM and concluded
that in mild-moderate ascites (4 litres), BIA remains valid in
determining body composition.
The recent introduction of MFBIA offers advantages over their
single frequency counterparts where estimates of extra- and intra¬
cellular water can be made. Indeed Cha and co-workers (1993) using
sodium bromide and tritium isotope dilution techniques and MFBIA
demonstrated that in renal patients, MFBIA assisted in the evaluation
of water distribution. Whilst further work is this area is required, the
use of MFBIA as a bedside tool in the presence of mild/moderate
ascites to estimate the metabolically active component of body
composition, seems appropriate. Therefore MFBIA determinants of
body composition are used in presentation of energy data in the
current study.
When patients in the present study were stratified by the
presence of ascites, disease severity or primary pathology no
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significant differences in energy status between patient groups and
controls was observed. It has been suggested that with increasing
severity of liver disease, there may be a positive or negative
association with oxygen consumption. For example, Schneeweiss et al
(1990) in a study of 22 patients with alcoholic cirrhosis, observed an
inverse relationship between oxygen consumption and Child's Pugh
score. Thus, energy expenditure decreases with increasing disease
severity. Conversely, Green et al (1991) in seven PBC patients,
observed a positive relationship with oxygen consumption and Child's
Pugh score so energy expenditure increased with severity of liver
disease. This divergence of results is difficult to reconcile but it is
possible that these differences may be related to the presence or lack
of an acute phase response in patients admitted for an acute
exacerbation of their disease rather than directly to Child's Pugh score.
No relationship between energy expenditure and disease severity was
observed in the current investigation either in the patient group as a
whole or when patients were sub divided by diagnosis.
Disease Severity and Nutritional Status
It is possible that the degree of undernutrition present in a
cirrhotic population is associated with disease severity (Mendenhall et
al, 1986; Lautz et al, 1992). For example, Muller et al, (1992) showed
that Child's Pugh C patients, when compared to Child's Pugh A and B
patients were muscle (determined by creatinine excretion) but not fat
depleted. However, this finding was not supported by Campillo and
colleagues (1997) in a study using anthropometry and creatinine height
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index. They showed no differences in nutritional status when patients
were stratified using the Child's Pugh score.
It is difficult to understand the differences found in the
relationship between disease severity and nutritional status. Although
they could be explained by the dynamic nature and weighting of the
Child's Pugh scoring system where patients presenting with acute
symptoms of their disease will be assigned a high Child's Pugh score.
Following resolution of these symptoms, the score could dramatically
alter over a period 24 - 48 hours and there would be an apparently
dramatic improvement in disease severity. In the present study those
patients stratified as Child's Pugh C had reduced fat reserves when
compared with Child's Pugh A patients but no other metabolic
differences were highlighted. The reason for the significant depletion
of fat mass in Child's Pugh C when compared to Child's Pugh A
patients remains unclear and did not appear to be related to the
aetiology of liver disease (Child's Pugh C: 45% BC, 55% HC). No
differences in energy expenditure were highlighted but there was a
trend in Child's Pugh C patients toward lower energy expenditure
when compared with predictive values or when expressed as a unit of
body cell mass. It could be speculated that the significantly depressed
fat stores found in the Child's Pugh C group may be a reflection of
anorexia and resultant cumulative negative energy balance. As a
result, endogenous fat reserves will be drawn upon to meet energy
requirements, however, NPRQ in Child's Pugh C patients were not
suggestive of an elevated lipid oxidation rate compared with Child's
Pugh A and Child's Pugh B. Measurable changes in nutritional indices
are only evident after time periods in excess of a week.
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The present study showed that Child's Pugh C patients had
depressed serum albumin concentrations when compared to patients
classified as Child's Pugh B and A. This finding is unsurprising as
albumin synthesis rates could be affected by liver dysfunction and
depressed serum albumin concentrations in chronic liver disease are
not directly related to nutritional state but to disease severity.
Primary Pathology and Nutritional Status
Interestingly, when cirrhotic patients were stratified by primary
pathology, patients with HC not only had significantly lower fat stores
but their NPRQ and urinary nitrogen excretion was also depressed
when compared with controls. The metabolic picture shown by
patients with BC suggests these patients have sufficient glycogen
reserves available to sustain an overnight fast. Indeed, Di Cecco and
colleagues (1989) in a study of 74 liver transplant candidates stratified
by disease aetiology, found that patients with BC had improved
nepatic synthetic function (biochemical indices) when compared to
patients with chronic active and acute hepatitis. This finding supports
the hypothesis that metabolic status is related to primary aetiology
rather than severity of disease.
Cirrhotic Patients - Summary
This study has shown that cirrhotic patients have depleted
energy reserves when compared to a control group of similar age. In
the basal state, these patients have a greater reliance on lipid oxidation
to meet energy demands which in the absence of an acute phase
response serves to conserve muscle mass at the expense of
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endogenous fat stores. In cirrhotic patients this is accompanied by a
lower urinary nitrogen excretion and it is likely that this is related to
preservation of lean body mass. These features of simple starvation
(Keys et al, 1950) could be accounted for by the fact that patients in the
present study were not recovering from any acute disease related
episode. The presence of an acute complication could exert a metabolic
effect that would increase gluconeogenesis and in the long term
deplete muscle mass. No significant metabolic differences were noted
when cirrhotic patients were stratified for the presence of ascites and
by Child's Pugh Score.
Irrespective of the limitations of methodologies used to
determine nutritional status, undernutrition is prevalent in liver
disease (Crawford et al, 1993; Prijatmoko et al, 1993; Greco et al,
1998). Previous research has been driven by investigators who sought
to determine the impact of liver disease on nutritional status and the
relationship between primary aetiology and disease severity with
nutritional and metabolic status (Crawford et al, 1994; Green et al,
1991: Campillo et al, 1997). The importance of studies that examine
nutritional depletion in chronic liver disease should not be
underestimated as it permits targetting of nutritional support to those
most at risk.
An original aspect of the present study is that it has highlighted
metabolic differences between cirrhotic patients when stratified by
primary aetiology. Only those patients with cirrhosis of hepatocellular
origin exhibit a post-absorptive metabolic profile indicative of
longterm fasting. This was accompanied by a depletion in the body's
energy reserves as reflected in the TSF results of the HC group. When
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primary aetiology was considered, it is perhaps not surprising that
differences in fasting metabolism and nutritional status have been
highlighted. In biliary related cirrhosis, inflammation and liver
damage from the biliary canniculi and ducts predominates, whereas
the histological profile of alcoholic, cryptogenic and hepatitis C
cirrhosis shows intrinsic hepatocellular damage. The hepatocyte is the
body's single most important functioning metabolic unit and as a
result of extensive hepatic damage, could cause aberrant metabolism
that may contribute to the anorexia (Cabre et al, 1990) and consequent
loss of body mass found in many cirrhotic patients.
Although it has previously been suggested that the metabolic
profile of cirrhotic patients is influenced by primary aetiology (Taylor
et al, 1985; Orrega et al, 1987) there are little comparative data on the
metabolic and nutritional status of homogeneous, pathology specific
groups. Since a focus of this thesis is to examine the role of the liver in
ingestive behaviour, the metabolic differences identified between
patients with BC or HC are important. The differential effect of
pathology may impact on the liver's role as a metabolic sensor and
effect changes in ingestive behaviour and body composition.
Orthotopic Liver Transplant Recipients
An increase in body weight following OLT has previously been
reported (Palmer et al, 1991; Stegall et al, 1995). In the current study
body weight increased by an average of 7.8 kg in the nine months
after OLT but may merely reflect weight recovery following a
prolonged reduction in energy intake as well as the impact of major
surgery. The re-establishment of body composition following a period
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of semi-starvation was eloquently demonstrated in The Minnesota
Experiment (Keys et al, 1950). Keys work was subsequently revisited
by Dulloo et al (1996) who documented that the observed suppression
of thermogenesis resulted in accelerated replenishment of body mass
and more specifically in fat mass 20 weeks after refeeding (12 weeks
on a restricted dietary regimen). Certainly, re-establishing pre-illness
or "set-point" body weight could contribute to early post-OLT weight
gain. However, given that an individual's "set-point" for body weight
is a tightly regulated system where the average adult's weight
increases by only 10% over two decades (Leibel et al, 1995), the
magnitude of weight gain following OLT exceeds pre-illness values.
The present study has shown a significant and rapid increase in
adipose tissue rather than lean body mass and it seems unlikely for a
number reasons that this is simply a return to "set-point" body
weight. Firstly, the duration of weight gain which continues to
increase to the nine month study time point rather than four months
after refeeding as reported by Keys et al (1950). Secondly, although
the nutritional intake of cirrhotic patients may be depleted (Cabre et al,
1998) they are not in an overtly starved state and recent evidence
suggests that refeeding after moderate starvation does not
disproportionatly increase fat mass (Dedrock et al, 1998). Thirdly, in
the present study patient's body weight exceeded reported pre-illness
values by 7.5 ± 2.1% at nine months. This was significantly higher than
the pre-illness values observed six months after OLT and demonstrates
that these patients are over-shooting their "set-point" body weight.
Whilst criticisms may be levelled at the use of self reported past body
weight (pre-illness weight), a recent study by Klipstein-Grobusch et al
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(1998) has demonstrated that short and long-term recall of body
weight is valid when compared with measured values.
The rapid and dynamic weight gain observed after OLT is an
important finding where six patients previously "normally" nourished
became overweight and eight patients previously overweight became
obese within the study period. Whilst Palmer et al (1991) has shown
that pre-OLT overweight patients became more overweight after OLT,
this study did not relate post-OLT weight to pre-illness values.
Additionally, examination of changes in body composition following
OLT have not been considered by previous investigators who have
only highlighted increased body mass following liver transplantation.
The current longitudinal study permitted OLT subjects to be used as
their own controls and, although after OLT lean body mass had
stabilised by six months OLT, fat mass continued to increase up to the
nine month study time point.
The increase in TSF following OLT suggests an increase in
peripheral fat reserves and not a redistribution of fat stores from
peripheral to abdominal sites which is characteristic of body
composition changes associated with high dose prolonged steroid
therapy (Horber et al, 1986). No other comparable body composition
studies on OLT patients are available. However, Steiger et al (1995)
studied kidney transplanted patients and found that fat mass increased
by 4.9 kg in males and in females 0.1 kg over a 16 month period and is
considerably less than that found in the current study. Furthermore,
the level of immunosuppressive therapy following OLT is normally
substantially lower than that prescribed to renal recipients. However,
comparisons between the nutritional status of renal transplant
recipients and OLT patients have not been performed but does suggest
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that absolute amounts of immunosuppressive drugs may not be
predictive of weight change following OLT.
Summary OLT Patients
Results of the current study suggest there is a failure of
regulatory systems that control body weight and this is particularly
worriesome given the susceptibility of the patient undergoing liver
transplantation to develop metabolic complications which may be
further exacerbated in the presence of excessive weight gain. Clearly
elucidation of the mechanisms involved in post-OLT weight gain has
important implications for the longterm management of these "at
risk" patients. Long term energy balance is tightly controlled (Leibel
et al, 1995) and small deviations from "normal" in any single
component of energy metabolism (dietary intake, exercise,
thermogenesis, basal energy expenditure) will in the long term result
in changes in body mass. In the current study there was a significant
decrease in energy expenditure at each post-OLT study time point
when compared with predictive values. However, this finding may
merely reflect a disproportionate rise in fat compared to lean body
mass following OLT. This decrease in REE will be explored more fully
in the next chapter (Chapter 4).
An uninvestigated dimension of OLT weight gain is the
influence of denervation and loss of hepatic neural signalling to the
brain stem. It could be postulated that central effector pathways may
induce suppression of energy expenditure. A decrease in basal energy
expenditure is a phenomenon associated with starvation and if latent
signalling through hepatic afferents is absent it may be interpreted by
central controllers of ingestive behaviour as nutrient deprivation.
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CHAPTER 4
DIET INDUCED THERMOGENESIS IN LIVER CIRRHOSIS AND IN
LIVER TRANSPLANT RECIPIENTS
Loss of body mass in liver cirrhosis has been widely reported
(Merli et al, 1990; Prijatmoko et al, 1993; Greco et al, 1998). In order for
changes in body composition to occur there may be alterations in, energy
intake, resting energy metabolism, physical activity and/or diet induced
thermogenesis. The resting energy profile of cirrhotic patients and liver
transplant recipients was described in Chapter 3. Generally, patients with
liver cirrhosis lead a sedentary lifestyle, therefore it seems unlikely that
increased activity levels would contribute to loss of body mass. It is not
unreasonable to suggest that there may be changes In dietary
thermogenesis in liver disease where loss of body mass, impaired liver
function and altered humoral responses could affect the metabolic
response to feeding.
Only a handful of metabolic studies have considered the effect of
feeding in liver cirrhosis. These investigations have predominantly been
performed in small groups of patients presenting with alcohol related
disease and have produced conflicting results suggesting no change
(Eriksson et al, 1989) or a blunting in the thermic response to feeding
(Campillo et al, 1992). The magnitude of any change in thermogenesis in
cirrhotic patients is of quantitative importance in energy balance and the
longterm regulation of body mass.
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In contrast with the pre-operative situation where weight loss
predominates, patients who undergo liver transplantation have been
shown to gain weight progressively for at least two years after surgery
(Davidson et al, 1998). It is possible that a reduction in dietary induced
thermogenesis might contribute to such weight gain.
This study considered the effect of a mixed meal on energy




The sex, age and BMI of the 36 cirrhotic patients were randomly
selected to enter the test meal limb of the study (Table 4.1). Twenty-three
of the 36 patients underwent OLT. Following OLT, five patients sustained
complications (1 deep vein thrombosis; 1 hepatic duct stenosis; 1 biliary
stricture; 2 long-term sepsis) which did not permit them being studied
further. Therefore data from the remaining i8 OLT patients was analysed
in the pre-operative test meal limb of the study and compared with data
obtained at 3, 6 and 9 months postoperatively. Eighteen healthy
volunteers were also recruited and studied on a single occasion.
Methods
To determine the thermogenic response to feeding a test meal (10%
protein, 31% fat and 59% carbohydrate) was prescribed at 15 kj/kg body
weight and consumed within five minutes. Indirect calorimetry was used
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to measure energy expenditure at study time points shown in Figure 2.1.
The thermogenic effect of the meal was calculated and results expressed
as a percentage above baseline fasting values. The integrated thermic
response to feeding was determined from the area under the curve (AUC)
which was calculated using the trapezoid method and expressed as
arbitrary units. The methods used are described in detail in Chapter 2.
Results
Cirrhotic Patients
Characteristics of the cirrhotic patient population and control group
are shown in Table 4.1. As might be expected, there was no significant
difference in the energy value of the test meal in relation to measured
resting energy expenditure between cirrhotic patients and control subjects
(cirrhotics: 18.3 ± 0.4%; controls: 18.9 ± 0.4%) or when patients were
stratified for disease severity (Child's Pugh A: 18.6 ± 0.6%; Child's Pugh
B: 17.9 ± 0.5%; Child's Pugh C: 18.8 ± 1.2%) or primary aetiology (BC:
18.9 ± 0.8%; HC: 18.0 ± 0.5%).
No overall differences in the thermic effect of feeding was
observed when all 36 cirrhotic patients were compared with the healthy
controls (Figure 4.1). Flowever, when cirrhotic patients were stratified
according to the modified Child's Pugh score, the change in energy
expenditure from baseline values was significantly higher at the first post
prandial time point (5-15 min) in Child's Pugh A patients when compared
with Child's Pugh C patients (Child's Pugh A: 14.1 ± 2.4% versus Child's
Pugh C: 6.1 ± 1.3%, p<0.05). There was a trend for diet induced
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n Sex Age BMI Expenditure
(M: F) (years) (kcal/kg BCM)
Controls 18 9:9 50.2(2.7) 26.4(0.9) 56.2 (1.2)
Cirrhotic patients 36 15:21 53.4 (1.6) 24.6 (0.8) 59.2 (1.6)
Child's Pugh A 10 2:8 54.0 (2.9) 24.1 (1.4) 58.9 (2.1)
Child's PughB 16 7:9 53.6 (2.4) 23.8 (0.9) 58.0 (1.7)
Child's Pugh C 10 6:4 52.2 (3.3) 21.6(2.1) 55.3 (1.8)
Biliary cirrhosis 18 0:18 55.9 (1.7) 23.8(1.3) 60.1 (2.0)




FIGURE 4.1 THERMOGENIC RESPONSE TO FEEDING































thermogenesis in Child's Pugh A patients to be higher than Child's Pugh B
and C patients up to 85 minutes following meal ingestion. In Child's Pugh
B and C patients the diet induced thermogenic response curves were
similar. The integrated thermic response (AUC) was greater in the
Child's Pugh A group compared with Child's Pugh C patients (Child's
Pugh A: 1543 ± 140.6 AUC versus Child's Pugh C: 835 ± 204.8 AUC,
p<0.05) (Figure 4.2).
When patients were stratified by primary aetiology, the thermic
response was significantly higher in cholestatic (BC) patients when
compared with HC patients (BC: 12.7 ± 1.5% versus HC: 7.0 ± 1.0%,
p<0.05) at the first time point. In addition, the integrated meal response
was also greater in the BC patients when compared with the HC group
(BC: 1472 ± 123.6 AUC versus HC: 984 ± 137.1 AUC, p<0.05) (Figure 4.3).
When patients were stratified by Child's Pugh score, seven out of
the ten Child's Pugh A patients had cholestatic disease. Given this
potential source of bias primary aetiology was used when examining
oxygen consumption in response to feeding. No differences in the
integrated reponse between BC, HC and control subjects was observed
(Figure 4.4). There was an early increase in oxygen consumption in BC
patients which was marginally significant (p=0.06) when compared with
the HC group. This increase in oxygen consumption was not indicative of
substrate utilisation as shown by NPRQ (Figure 4.5).
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FIGURE 4.2 THERMOGENIC RESPONSE TO FEEDING
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** = p<0.0001 controls versus hepatocellular cirrhosis
§ = p<0.001 biliary versus hepatocellular cirrhosis
* = p<0.05 controls versus hepatocellular
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OLT Patients
The response to feeding was studied in seven male and 11 female
patients (mean age 52.8 ± 2.4 years) following OLT. All ten BC patients
were female and seven of the eight HC patients were male. Following
OLT, no significant changes in the thermogenic response (% energy
above baseline values) to feeding were observed (Figure 4.6).
Furthermore, after transplantation pre-OLT pathology had no differential
effect on thermogenesis.
At each study time point OLT resting energy expenditure (per unit
body cell mass) and the response to feeding was also examined. A
progressive decrease in REE occurred after OLT which reached
significance nine months after liver transplantation. In addition, the
calculated area under the curve when compared with pre-OLT values
were significantly lower at 9 months OLT (Table 4.2).
A comparison of the energy response o feeding between control
and OLT patients suggested that the postprandial energy response to
feeding was lower 9 months after OLT when compared with controls at 5-
15, 85-95 and 125-135 minutes after meal ingestion. Baseline values 9
months after OLT tended to be lower than those observed in controls
(p=0.06). No significant differences in the AUC between control subjects
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In liver cirrhosis, the influence of the thermic effect of food and its
impact on energy balance remains ambiguous (Eriksson et al, 1991; Green
et al, 1991; Campillo et al, 1992). The current study examined the thermic
effect of a mixed meal (15 kj/kg body weight; 59% carbohydrate, 31% fat,
10% protein) in 36 cirrhotic patients and is to date the largest cohort
studied.
It has been suggested that antecedent diet may influence
measurements of metabolic rate (Dauncey; 1980) but this remains an
area of contention. Whilst Dauncey (1980) suggests that the previous
day's dietary intake influences metabolic rate for at least 14 hours after the
last meal, this finding has not been consistently replicated by other
investigators (Stock, 1980; Lammert et al, 1987). In the current study,
due to the clinical and practical constraints imposed it was not possible to
control diet prior to the study and therefore the influence of this factor
cannot be resolved.
The liquid test meal in the present study was used to facilitate
gastric emptying and permit the peak meal response to be observed
within a two hour post-prandial period. All subjects were investigated
over a four hour period and when questioned, patients felt that any time
extension to this study would prove too onerous. This caveat was
particularly important for patients entered into the longitudinal limb of
the study.
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In the current study the energy content of the test meal was related
to body weight. It has previously been suggested that test meals should
be related either to body weight (Sharief & Macdonald, 1982) or to resting
energy expenditure (Segal et al, 1990). Previous investigators have used
either a standard meal (unrelated to body weight) (Eriksson et al, 1989) or
related meal size to body weight (Green et al, 1991; Campillo et al, 1992).
In the present study no significant difference in the energy value of the
test meal when prescribed in relation to resting energy expenditure was
found between cirrhotic patients and control subjects.
There was no difference in the thermic response to feeding when
cirrhotic patients were compared with control subjects. When patients
were stratified by disease severity an early and significant increase in
energy expenditure in Child's Pugh A patients (p<0.05) was observed
although this was also reflected in the reponse elicited by BC patients.
Seven of the ten patients presenting with Child's Pugh A cirrhosis had
cholestatic disease and it seems reasonable to suggest that the early
increase in thermogenesis is related to aetiology rather than severity of
liver disease.
The majority of patients with Child's Pugh C cirrhosis presented
with HC disease (seven out of nine, 78%). In comparison to BC patients,
the HC group had a blunted thermogenic response. Alternatively it
could be said that BC patients had a significantly higher thermogenic
response than their HC counterparts. Despite these differences neither
patient group's thermogenic response was significantly different from
control subjects. Green et al (1991) in a study of seven BC patients
129
observed a significant increase in the thermogenic response to a test meal
in BC patients when compared to controls. These patients were studied
over a four hour post-prandial period and the test meal was three times
larger than that administered in the present study. In addition, the time
allowed for consumption of the test meal by Green and colleagues (1991)
was 45 minutes compared with 5 minutes in the present study.
Furthermore, calorimetry was first performed 30 minutes after meal
consumption and as a result the early and significant post-prandial
increase in thermogenesis (5 - 15 minutes) seen in the current study would
be missed. Given the significant differences in study design, direct
comparisons between these two studies are difficult.
This early increase in oxygen consumption seen in response to
feeding in BC patients is not seen in the HC patient group and it is
unlikely that utilisation of the meal would be evident five minutes after
ingestion. This is confirmed by the NPRQ results where no early increase
in respiratory quotient was observed in BC patients and does not infer
meal utilisation at this time point. The reason for this early increase in
thermogenesis seen in BC patients cannot be fully explained from present
results and would require determination of humoral events, sympathetic
nervous system activity as well as the rate of gastrointestinal nutrient
uptake. Though speculative it could be that the early thermogenic
response observed in BC patients may be an adaptive response acting to
offset the effects of insidious fat malabsorption through maximising
nutrient absorption by active transport mechanisms. In other words,
when a meal enters the gastrointestinal tract there may be an increase in
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both obligatory and facultative thermogenesis, the former reflecting
enhanced transport mechanisms and the latter up-regulation of the
sympathetic nervous system. This early increase in thermogenesis is
transient and at the 45 minute post-prandial time point, the thermic
response to the meal in BC patients is similar to control subjects. To date
no studies have examined facultative thermogenesis in BC patients but
given that diet induced thermogenesis in BC patients was not significantly
different from control subjects it is unlikely to contribute to long term
changes in energy balance. Indeed, nutritional assessment data in BC
patients has shown that nutritional status is well preserved in this group
(see Chapter 3).
The thermogenic response of HC patients tended to be lower than
controls but did not reach statistical significance, either in terms of time
point comparisons or the integrated meal response. This finding is
supported by the work of Campillo et al (1992) who also observed a
depression of dietary induced thermogenesis in HC patients but the effect
was not different to that seen in control subjects. In addition, Campillo et
al (1992) examined the humoral response to feeding including
catecholamine measurements in HC patients. Paradoxically, although this
group observed an increase in sympathetic tone during feeding (increased
noradrenaline), there was a blunting of thermogenesis in HC patients.
This group concluded that insulin resistance could be implicated in the
blunting of the thermogenesis. However, this is clearly an over¬
simplification of a complex phenomenon where, for example, counter
regulatory hormones such as glucagon play an important role in
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metabolic regulation. Moreover, Campillo et al (1992) observed no
correlation between noradrenaline levels and metabolic rate, suggesting
that the apparent thermogenic blunting found in HC cirrhosis cannot be
attributed to any single factor.
In the present study, the blunting of the thermogenic response
seen in HC patients when compared with BC patients may, in the long
term, exert an energy sparing effect in a population who have depleted
endogenous energy reserves (see Chapter 3). To fully understand the
importance of this differential effect related to thermogenic response and
aetiology, further studies are required that examine concurrent humoral
events as well as the thermogenic response to feeding.
In summary, the current study has generated important and
original findings. In particular the early thermogenic peak in patients with
BC disease has not previously been reported and warrants further
investigation. Additionally, the difference in thermogenesis between
patients with BC and HC cirrhosis suggests their metabolic response to
feeding is different. Neither patient group's thermogenic response was
different to controls but if the blunting of the thermogenic response in the
HC patients is considered cumulatively, this may exert an energy sparing
effect. It is unlikely that the early and transient increase in thermogenesis
would have a cumulative effect on energy balance in BC patients given
their preserved nutritional status (see Chapter 3).
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OLT Patients
Few studies have considered the metabolic effects of feeding in
OLT patients (Green et al, 1991). None have considered that the loss of
hepatic afferent innervation could have an effect on energy metabolism
which in the longterm may impact on nutritional status.
In the current study, no significant differences in the thermogenic
response to feeding was seen after transplantation. In patients followed
up to nine months following transplant, the thermogenic response to
feeding mirrored that found in control subjects. An important finding in
OLT patients was the decrease in REE initially highlighted in Chapter 3.
There was a sequential decrease in REE at each three monthly OLT time
point, reaching significance six months after transplantation. This
reduction in REE also resulted in a significantly lower integrative energy
response (AUC) at nine months after OLT when compared to pre-
transplant values. The post prandial response to feeding nine months
after OLT was lower than controls at the 5-15, 85-95 and 125-135 minutes
study time points (Table 4.2).
Nine months after transplantation, there was an 11% decrease in
REE compared to pre-OLT values. This extrapolates to an energy
economy of approximately 20 MJ in three months (approximately 0.75 kg
fat plus associated lean tissue; Mela and Rogers, 1998). Clearly this is an
over-simplification of energy dynamics and its subsequent translation to
the impact on body energy reserves but it does contextualise the effect of
down regulation of energy metabolism. Obviously other factors such as
dietary intake and activity levels, which normally account for some 30% of
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total energy expenditure (Ravussin and Bogardus, 1989) will also
contribute to the energy balance equation.
In the current study activity levels were not determined but it
should be highlighted that lethargy is one of a number of established
indications for OLT. However, 83% of transplanted patients had returned
to employment implying that following OLT patients activity levels
increase and would consequently result in a rise in REE. Given that OLT
activity levels have increased, then the energy economy elicited in these
patients following OLT is in fact more pronounced than observed.
Interestingly, in the only other metabolic study on pre- and post
OLT patients, Green et al (1991) examined the energy response to feeding.
They noted that REE in patients was significantly lower in BC patients
seven months following transplantation when compared with pre-OLT
BC patients. The discussion in Green and colleagues paper (1991) focused
on the hypermetabolism of the BC patients rather than what may have
been the hypometabolism of the post-OLT patients. Nevertheless the fall
in energy expenditure seen in these OLT patients does support the
reduction in REE evident in the present longitudinal study.
If the mechanisms involved in post-OLT weight gain are to be
elucidated, the reason for the down-regulation of energy metabolism
following transplantation requires further investigation. Resting energy
expenditure includes that required to drive various metabolic processes
such as protein turnover, substrate transport recycling, ion gradient
maintenance, heart and diaphragm contraction. All of these processes
may be involved in changes in resting metabolic rate but to date the exact
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mechanisms involved in down-regulation of energy metabolism are not
fully understood.
In OLT patients appropriate integration of metabolic information in
the hypothalamus will be lost. It could be hypothesised that the lack of
information relating to fuel oxidation and satiety signalling may mean
that the brain stem assumes that the body is undergoing a period of
energy restriction and as a consequence reduces REE in an attempt to
conserve body mass. Rather than weight loss, these patients are
undergoing a period of rapid weight gain reflected in an increase in fat
mass rather than lean tissue (Chapter 3). Normally, a rise in fat mass
should result in an increase in circulating levels of the hormone leptin
produced in the adipocyte which acts to increase energy expenditure and
reduce energy intake (Zhang et al, 1994). Leptin has been shown to be
pivotal in energy balance (Campfield et al, 1996) although circulating
leptin levels have not been examined in OLT patients but their
determination may add to the understanding of post OLT energy
economy.
In summary, this is the first study in OLT patients that has
examined the energy response to feeding in the fasted and fed state. The
observed energy conservation in the presence of increasing body mass
may be a result of metabolic and splanchnic bed denervation resulting in
absence of the integrative control of energy balance.
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CHAPTER 5
FASTING SUBSTRATE UTILISATION IN LIVER CIRRHOSIS AND
LIVER TRANSPLANT RECIPIENTS
In chronic liver disease, disturbances in fasting nutrient metabolism
were first documented some 15 years ago (Owen et al, 1983). The increase
in fat oxidation observed in cirrhotic patients following an overnight fast
was comparable to that found in normal subjects after a 72 hour fast
(Romijn et al, 1991). However, most studies that have examined fasting
metabolism in cirrhotic patients have been performed in HC patients
recovering from an acute complication of their liver disease. This study
examined fasting substrate oxidation rates in stable cirrhotic patients and
in a sub-group of patients following OLT.
Patients and Methods
Patients
Patients were studied in the fasting state and are fully described in
Chapter 3. Sixty-seven cirrhotic patients with histologically proven
cirrhosis were recruited (Table 3.1). Twenty three of these patients
underwent liver transplantation and were studied at three, six and nine
months after discharge from hospital. A group of 18 healthy controls
were also recruited (see Chapter 3).
136
Methods
Following an overnight fast indirect calorimetry was used to
measure subjects oxygen consumption and carbon dioxide production. In
addition urinary nitrogen excretion was measured from subjects 24 hour
urine collection. These physiologic measurements allowed calculation of
fasting substrate oxidation rates. Methods and calculations used to
determine NPRQ and substrate oxidation rates are shown in Chapter 2.
Results
Cirrhotic Patients
Demographic and clinical details of cirrhotic patients are shown in
Table 3.1. Fasting NPRQ was significantly lower in cirrhotic patients when
compared with control subjects (controls: 0.85 ± 0.01 versus cirrhotics:
0.81 ± 0.01, p<0.001). The lower NPRQ exhibited by cirrhotic patients
when compared with controls was reflected in an increased rate of lipid
oxidation and decreased rate of glucose oxidation (Lipid: controls: 40.9 ±
3.6 mg/min versus cirrhotics: 54.9 ± 2.2 mg/min, p<0.01; Glucose:
controls: 120.8 ± 10.7 mg/min versus cirrhotics: 86.7 ± 3.8 mg/min,
p<0.001). Given the gender bias in this patient population post-absorptive
substrate oxidation rates in control subjects and cirrhotic patients are are
presented per unit of BCM to normalise data (Figure 5.1). Rates of
glucose oxidation were significantly lower and fat oxidation significantly
higher in cirrhotic patients compared to control subjects (Glucose:
control: 4.67 ± 1.6mg/kg BCM versus cirrhotics: 3.86 ± 1.50, p<0.05;
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FIGURE 5.1 SUBSTRATE OXIDATION IN CONTROL













* = p<0.05 versus controls
**= p<0.001 versus controls
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Lipid: control: 1.55 ± 0.4 mg/kg BCM versus cirrhotics: 2.48 ± 0.9
mg/kg BCM, p<0.001).
Cirrhotic Patients Stratified by Disease Severity
Demographic and clinical details of patients stratified by disease
severity are shown in Table 3.4. When patients were classified using
modified Child's Pugh score no difference in NPRQ or in fasting oxidation
rates of glucose or lipid were observed (Figure 5.2). Protein oxidation
rates were significantly lower when Child's Pugh C cirrhotic patients were
compared with the Child's B Pugh group (Child's Pugh B: 1.39 ± 0.23
mg/kg BCM versus Child's Pugh C: 0.80 ± 0.1 mg/kg BCM, p<0.05).
Cirrhotic Patients Stratified by Primary Aetiology
Demographic and clinical details of patients stratified by primary
aetiology are shown in Table 3.5. Non protein respiratory quotient was
significantly lower in HC patients when compared with control subjects
(controls: 0.85 ± 0.01 versus HC: 0.79 ± 0.01, p<0.0001). Additionally,
NPRQ was significantly lower in HC patients than in the BC patients (BC:
0.82 ± 0.01 versus HC: 0.79 ± 0.01, p<0.01). Differences in post absorptive
macronutrient oxidation rates were also observed when primary
pathology was considered. The fasting rate of glucose oxidation was
lower in HC patients when compared with control subjects (p<0.01) and
when HC patients were compared with the BC group (p<0.01). The
fasting rate of lipid oxidation was significantly higher than controls in both
patient groups (controls versus BC, p<0.01; controls versus HC,
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FIGURE 5.2 SUBSTRATE OXIDATION IN CIRRHOTIC
PATIENTS STRATIFIED BY DISEASE
SEVERITY
□ Child's Pugh A (n=14)
1111 Child's Pugh B (n=26)
H Child's Pugh C (n=27)
IB Controls (n= 18)
Mean (±SEM)
* = p>0.05 versus Child's Pugh B
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pcO.OOl). The rate of protein oxidation was lower in HC patients when
compared with controls (p<0.05) and BC patients (p<0.05) (Table 5.1).
OLT Patients
Characteristics of the 23 patients who underwent OLT are shown in
Table 3.6. No differences in post absorptive NPRQ or substrate oxidation
rates were seen between OLT study time points (Table 5.2). Additionally,
the influence of pre-OLT pathology (BC, HC) on fuel metabolism was not
sustained after the first three months following OLT. When post-
absorptive OLT fuel oxidation rates at 3 months were compared with
control subjects, lipid oxidation rates were found to be higher in OLT
patients (p<0.05). Compared with controls, no differences in lipid and
glucose oxidation rates were seen 6 and 9 months after OLT. However,
protein oxidation rates at 6 (p<0.05) and 9 (p<0.05) months post OLT were
lower than control subjects.
Discussion
Cirrhotic Patients
The fasting metabolic profile of patients in the present study is
characterised by enhanced lipid oxidation, a feature of liver cirrhosis that
is well documented (Owen et al, 1983; Merli et al, 1990; Romijn et al, 1991:
Muller et al, 1992). In the current study the rate of lipid oxidation in
cirrhotic patients was found to be 25% greater and carbohydrate oxidation
30% less than fuel oxidation rates in control subjects. This finding is
similar to the shift in fuel oxidation documented by other investigators
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(Eriksson et al, 1989; Green et al, 1991). Although in previous studies the
fasting lipid oxidation rates tended to be higher than that found in the
present study but the majority of research in this area has been
performed in patients with alcohol related cirrhosis (Eriksson et al, 1989;
Merli et al, 1990; Owen et al, 1993). Therefore, given the heterogeneity of
the population in the current study, it seems unreasonable to assume that
the variables that determine the rate and type of fuel oxidation should be
the same in all cirrhotic patients regardless of the origin of primary
pathology. Additionally, in the few studies that have included patients
with cholestatic disease, no account was made for the influence of gender
(Eriksson et al,1989; Campillo et al,1992). For example, fasting fuel
utilisation rates as a unit of body weight may be higher in males because
of their greater proportion of lean to fat mass. In the present study,
cirrhotic patients were stratified by disease severity and primary diagnosis
and all results expressed in relation to body cell mass to normalise fuel
oxidation rates.
"It has also been- suggested that disease severity is associated with
concomitant disturbances in energy and fuel metabolism (Muller et al,
1992). This was not apparent in the present study where no association
between energy metabolism and disease severity was observed nor were
there any differences in rates of lipid or glucose oxidation in relation to
disease severity. However, the fasting rate of protein oxidation was
found to be significantly lower in those patients classified as Child's Pugh
C when compared with Child's Pugh B patients and this may be explained
by the decrease in urinary nitrogen output seen in Child's Pugh C patients
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(see Chapter 3). This finding may be indicative of reduced protein
breakdown as evidenced by Neilsen et al (1995) who observed increased
nitrogen retention in patients with liver cirrhosis. However, the anomaly
that these differences arise between patients with Child's Pugh B and
Child's Pugh C cirrhosis and not between patients with Child's Pugh A
and C, is difficult to explain and cannot be accounted for by any
aetiological bias.
The differences in fasting fuel utilisation observed when patients
were stratified by primary aetiology, is an important yet hitherto
unreported finding. As indicated by the NPRQ results, patients with HC
cirrhosis exhibit a greater dependence on endogenous lipid fuel reserves
when compared with controls or BC patients and this finding is confirmed
when fasting substrate oxidation rates were calculated. Although, both
patient groups exhibited enhanced post-absorptive lipid oxidation rates
when compared with controls these were highest in HC patients. In
addition, only HC patients exhibited a depressed post absorptive rate of
glucose oxidation when compared with both control subjects and BC
patients.
These results suggest that BC patients have some remaining
capacity for glycogen storage following an overnight fast but this is not
apparent in HC patients. This finding is supported by Green et al (1991)
who in a study of only seven BC patients and healthy controls observed
an increase in post-absorptive lipid oxidation rates but no differences in
glucose and protein oxidation. Furthermore, no differences in total free
fatty acids in BC patients were observed whereas in studies in HC
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patients, elevations in fasting free fatty acids and glycerol have been
reported (Owen et al, 1983; Meril et al, 1985; Romijn 1991) and suggests
the rate of lypolysis in BC disease may be limited. The only other study
which stratified for primary aetiology was conducted by Muller and
colleagues(1992) who noted no differences in fasting substrate oxidation
rates between patients with BC, alcoholic liver disease and hepatic
cirrhosis. However, it is worth noting that although not reaching
statistical significance the rate of carbohydrate oxidation was highest and
lipid oxidation lowest in the BC group.
In conclusion, the fasting metabolic profile of patients with HC
cirrhosis is indicative of a longer period of fasting. This current study on
post-absorptive substrate oxidation rates in cirrhotic patients has
highlighted important metabolic differences between patients with BC
and HC cirrhosis and suggests re-evaluation of previous generalisations
on fuel utilisation in chronic liver disease.
OLT Patients
This is one of the first longitudinal metabolic studies on patients
subjected to liver transplantation. It is not unreasonable to suggest that
following OLT, the fasting profile of oxidative metabolism will normalise.
In the present study, three months after OLT neither disease severity or
primary pathology had any influence on substrate oxidation rates. Whilst
no differences in NPRQ or fuel oxidation rates between OLT study time
points were apparent, the fasting lipid oxidation rate was significantly
higher in OLT recipients three months after transplantation when
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compared with controls. This finding could be attributed to the
continuing consequences of the surgical trauma of the OLT procedure.
This view is supported by the oxidation rates for lipid and glucose which
were comparable to control values at six and nine months after
transplantation.
Interestingly, six and nine months following OLT protein oxidation
rates decreased between patients and controls. No difference in protein
oxidation rates patients three months after OLT and controls was
observed. It could be suggested that as a result of OLT and subsequent
lack of co-ordinated metabolic regulation, there may be a decrease in
protein turnover analagous to that of starvation (Rennie, 1995). Therefore
the loss of hepatic afferent signalling relaying messages to the
hypothalamus may be interpreted as reduced nutrient availability
(Niijima, 1982) and may also be reflected in a fall in urinary nitrogen
excretion (Frayn, 1997).
In summary, the post-absorptive availability of the major energy
providing macronutrients is comparable to control subjects from three
months OLT. There is, after all, no physiological reason why OLT patients
oxidative processes would in the long term be different from normal.
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CHAPTER 6
SUBSTRATE UTILISATION IN RESPONSE TO FEEDING IN LIVER
CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS
The observations on nutrient metabolism in fasted cirrhotic
patients are interesting but limiting in that they give a static view of
substrate oxidation. Clearly metabolism is a complex and dynamic
process involving a system of substrate flow and integration. Metabolic
information derived from neural and hormonal signalling will be relayed
to and integrated in the brain or to be more precise in the hypothalmus,
the ultimate controller of energy homeostasis. In response to the
availability of endogenous substrates the brain acts to regulate both short
and longterm energy intake and expenditure. Given the hypothesis that
altered fuel metabolism in liver cirrhosis could influence nutrient intake, it
is important to examine the integrated response to feeding.
To date substrate utilisation in either the fasted or fed state has not
been examined in OLT patients.
Patients and Methods
Patients
Thirty-six patients with chronic liver disease were entered into the
feeding limb of the study. Eighteen patients were submitted to OLT and
had an uncomplicated recovery and were entered into the feeding limb of
the study. These OLT patients were reviewed on a three monthly basis on
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three occasions. Eighteen healthy volunteers were also recruited. Patients
and controls are fully described in Chapter 4.
Methods
Following determination of post absorptive energy expenditure
and substrate oxidation rates. All subjects were prescribed a liquid meal
(15kJ/kg body weight) and required to consume the meal within five
minutes (time 0). Indirect calorimetry was performed at five, 45, 85 and
125 minutes after meal ingestion. In addition a six hour urine collection
was taken for urinary nitrogen determination. Results of indirect
calorimetry and urinary nitrogen were used in the calculation of substrate




Characteristics of ine cirrhotic patients and control subjects is given
in Table 4.1. Glucose and lipid oxidation rates in all control subjects and
cirrhotic patients are shown in Figures 6.1 and 6.2. When compared with
controls the fasting rate of glucose oxidation was lower in cirrhotic
patients (controls: 4.80 ± 0.30 mg/min/kg BCM versus cirrhotics: 3.40 ±
0.23 mg/min/kg BCM, p<0.001). In response to feeding, no differences in
glucose oxidation was observed between controls and the cirrhotic
patients. The peak response was seen 45 minutes postprandially in the
control group. Fasting lipid oxidation rates were significantly elevated in
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FIGURE 6.2 LIPID OXIDATION IN CONTROLS
AND CIRRHOTIC PATIENTS
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* = p<0.05 versus controls
** = pcO.OOOl versus controls
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cirrhotic patients when compared with control subjects (controls: 1.49
± 0.11 mg/min/kg BCM versus cirrhotics: 2.34 ± 0.13 mg/min/kg,
p<0.0001) and at the first post-prandial time point (controls: 1.92 ± 0.17
mg/min/kg BCM versus cirrhotics: 2.39 ± 0.14 mg/min/kg BCM,
p<0.05). Protein oxidation rate was lower in cirrhotic patients when
compared to control subjects (controls: 1.52 ± 0.15 mg/min/kg BCM
versus cirrhotics: 1.12 ± 0.11, p<0.05).
When patients were classified by the modified Child's Pugh score,
no differences in glucose and lipid oxidation rates were observed in the
fasting state or in response to the test meal (Figures 6.3, 6.4). The peak
glucose responses were at 85, 85 and 125 minutes in Child's Pugh A, B and
C patients respectively. However, when patients were stratified by
primary aetiology, those with HC cirrhosis had depressed rates of glucose
oxidation in the fasted state when compared with controls and BC patients
(Glucose: controls: 4.83 ± 0.30 mg/min/kg BCM versus HC: 2.89 ± 0.28
mg/min/kg BCM, p<0.001; HC versus BC: 4.03 ± 0.31 mg/min/kg BCM,
p<0.05) and at the first post-prandial time point (Time point 1: Glucose:
controls 4.79 ± 0.42 mg/min/kg BCM versus HC: 3.30 ± 0.35 mg/min/kg
BCM, p<0.05; HC versus BC: 4.84 ± 0.37 mg/min/kg BCM, p<0.05)
(Figure 6.5).
Complementary to this reduction in glucose oxidation, HC patients
exhibited significantly elevated rates of lipid oxidation in the fasting state
when compared with control subjects and BC patients (controls: 1.49 ±
0.11 mg/min/kg BCM versus HC: 2.75 ± 1.81 mg/min/kg BCM,
p<0.0001; HC versus BC: 1.95 ± 0.15 mg/min/kg BCM, p<0.01).
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FIGURE 6.3 GLUCOSE OXIDATION IN PATIENTS
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FIGURE 6.5 GLUCOSE OXIDATION IN PATIENTS WITH
BILIARY AND HEPATOCELLULAR CIRRHOSIS
Time (min)
Mean (±SEM)
* = p<0.05 versus controls
** = pcO.OOl versus controls





Additionally, the HC patients demonstrated increased rates of lipid
oxidation at 5 (controls: 1.89 ± 0.15 mg/min/kg BCM versus HC: 2.68 ±
0.24 mg/min/kg BCM, p<0.05) and 45 (controls: 1.18 ± 0.15 mg/min/kg
BCM versus HC: 1.90 ± 0.21 mg/min/kg BCM, p<0.05) minutes after
meal ingestion (Figure 6.6). The change in glucose and lipid oxidation
rates in response to feeding are shown in Figure 6.7. The HC group
showed an early and rapid switch to glucose oxidation when compared
with control subjects (controls: 43 ± 12.9% compared with HC: 184 ±
44.6%; <0.001) and patients with BC (HC compared with BC: 79 ± 12.7%;
p<0.05). Hepatocellular cirrhotic patients exhibited significantly lower
protein oxidation rates in response to feeding when compared with
controls (controls: 1.50 ± 0.15 mg/min/kg BCM versus HC: 0.93
mg/min/kg BCM, p<0.05). Protein oxidation rates were similar in BC and
control subjects during the test meal study period.
OLT Patients
Seven male and 11 female patients (mean age 52.8 ± 2.4 years) vvere
studied following OLT. All ten BC patients were female and seven of the
eight HC patients were male. Non-protein respiratory quotient, glucose
and lipid oxidation rates in OLT patients and control subjects are shown in
Table 6.1. The fasting profile of pre-OLT patients, when compared with
controls, was similar to that described in the preceding Chapter.
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FIGURE 6.6 LIPID OXIDATION IN PATIENTS WITH

























* = p<0.05 versus controls
** = p<0.0001 versus controls
§ = p<0.01 versus controls
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FIGURE 6.7 CHANGE IN LIPID AND GLUCOSE OXIDATION
RATES IN PATIENTS WITH BILIARY AND
HEPATOCELLULAR CIRRHOSIS
Mean (±SEM)
** = pcO.OOl versus controls





TABLE 6.1 NON-PROTEIN RESPIRATORY QUOTIENT, GLUCOSE




Pre-OLT Baseline 0.81 (0.01)b 3.8 (0.25)c 2.4 (0.18)a
5-15 min 0.81 (0.01) 4.2 (0.39) 2.7 (0.18)d
45-55 min 0.88 (0.01) 7.2 (0.46) 1.5 (0.18)
85-95 min 0.90 (0.01) 7.8 (0.59)e 1.3 (0.20)
125-135 min 0.91 (0.01) 7.6 (0.60) 1.2 (0.22)
3 month OLT Baseline 0.83 (0.01) 4.4 (0.56) 2.2 (0.21)
5-15 min 0.83 (0.02) 5.3 (0.73) 2.3 (0.24)
45-55 min 0.89 (0.01) 7.3 (0.89) 1.6 (0.28)
85-95 min 0.88 (0.01) 7.1 (0.69) 1.7 (0.18)f
125-135 min 0.89 (0.01) 8.3 (0.87) 1.4 (0.18)
6 month OLT Baseline 0.83 (0.01) 4.2 (0.44) 2.0 (0.18)
5-15 min 0.85 (0.01) 5.1 (0.50) 2.0 (0.18)
45-55 min 0.89 (0.01) 6.6 (0.53) 1.4 (0.17)
85-95 min 0.91 (0.01) 6.8 (0.45) 1.1 (0.14)
125-135 min 0.92 (0.01) 7.6 (0.33) 1.0 (0.12)
9 month OLT Baseline 0.83 (0.01) 4.1 (0.42) 2.1 (0.19)
5-15 min 0.82 (0.01) 4.4 (0.49) 2.3 (0.20)
45-55 min 0.88 (0.02) 6.2 (0.58) 1.6 (0.22)
85-95 min 0.89 (0.01) 6.6 (0.47) 1.6 (0.22)
125-135 min 0.90 (0.01) 7.0 (0.53) 1.4 (0.21)
Control-Baseline 0.85 (0.01) 4.8 (0.30) 1.9 (0.10)
5-15 min 0.83 (0.01) 4.9 (0.37) 1.6(0.30)
45-55 min 0.89 (0.01) 6.9 (0.59) 1.2 (0.15)
85-95 min 0.89 (0.01) 6.9 (0.50) 1.2 (0.13)
125-135 min 0.89 (0.01) 6.7 (0.40) 1.1 (0.12)
Mean (± SEM)
a = p<0.001 versus controls d = p<0.01 versus 6 months OLT
b = p<0.01 versus controls e = p<0.05 versus 9 months OLT
c = p<0.05 versus controls f = p<0.05 versus 6 months OLT
159
Overview
No differences in lipid and glucose oxidation rates were seen
between control subjects and patients three, six and nine months after
OLT. During the observation period, protein oxidation was significantly
lower three and six months OLT when compared to the control group
(Controls: 1.52 ± 0.14 mg/min/kg BCM versus 3 month OLT: 1.26 ± 0.10
mg/min/kg BCM; p<0.05 : Controls versus 6 month OLT: 1.11 ± 0.80
mg/min/kg BCM; p<0.05).
Six Months
At six months following OLT patients exhibited a significantly
lower lipid oxidation rate five to 15 minutes after meal ingestion when
compared with pre-OLT values. In addition by six months OLT, lipid
oxidation rates were significantly lower 85-95 minutes after meal ingestion
when compared to the same post ingestive time point three months after
transplantation.
Nine Months
Nine months following OLT, a significant decrease in glucose
oxidation rate was observed only at the 85-95 min post-prandial study
time point when compared with the same time point before
transplantation (Table 6.1). During the post-meal observation period, no





The current study is one of the few that has examined substrate
flux from the fasting to the fed state in cirrhotic patients. This study has
allowed stratification of patients by disease severity and primary
aetiology.
The response to feeding observed in cirrhotic patients suggests
there is an early switch to glucose oxidation and this is mirrored by a
depression of lipid oxidation rates. Campillo and colleagues (1992), in a
study of only ten patients with alcoholic cirrhosis also observed this early
switch to glucose oxidation but the magnitude of change
appeared much greater than that found in the current study. There were
differences in experimental design in Campillo's work and the current
study. The test meal employed by Campillo et al (1992) was much larger
(63 kj/kg) and the period of investigation was twice that of the present
study (6 hours compared with 3 hours). Furthermore, the study by
Campillo et al (1992) was only in HC disease whereas in the present atudy
there were an equal number of HC and BC patients.
The finding that disease severity did not elicit a clear metabolic
demarcation in this stable patient group is not surprising given the
arbitrary nature of the Child's Pugh scoring system. Differences between
patient groups and control subjects and within patient groups were
observed when patients were stratified by primary aetiology.
Interestingly no differences were observed between the BC group and
controls in response to feeding. The only other comparable study (Green
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et al, 1991) to examine the response to feeding looked at seven BC
patients and they observed no differences in substrate metabolism
between patients and controls in the basal state or four hours following
meal ingestion. In this study, substrate utilisation was only measured at
two time points, nevertheless the work of Green and colleagues' (1991)
does support the findings of the current investigation where the response
to feeding in BC patients was similar to controls.
In the present study HC cirrhotic patients exhibited differences in
fuel utilisation in both the fasting and fed state when compared with
controls and BC patients. Following ingestion of the meal HC patients
showed an early and rapid switch to glucose oxidation when compared
with control subjects and BC patients. In response to the increase in
glucose oxidation rate there was a concommitant decrease in lipid
oxidation rate. These observed differences between BC and HC patients
in response to feeding may have important implications in the prescribing
of nutritional regimens since alterations in metabolism could influence
ingestive behaviour. It may be postulated that in HC patients, the rapid
and early switch to glucose oxidation could, through hepatic neural
signalling, reduce satiety thresholds bringing about early meal
termination. This phenomena could contribute to the poor spontaneous
oral intake found in patients with cirrhosis (Cabre et al, 1990).
In the present study the shift from lipid to glucose oxidation
highlights differences between patients with cholestatic and hepatocellular
cirrhosis. It has been suggested that the avid utilisation of ingested
carbohydrate is an adaptive response to the reduced synthetic storage
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capacity of hepatocytes and a reduction in the activity of the enzyme
glycogen synthetase (Kruszynska et al, 1988). It would seem likely that
given this rapid increase in glucose oxidation there may be a significant
and uncontrolled elevation in blood glucose but hyperglycaemia in
cirrhosis is generally avoided. For example, Eriksson et al, 1991 has shown
that following ingestion of a carbohydrate rich meal, circulating insulin
concentrations increase. This may facilitate maximal glucose oxidation in
patients who have defective storage mechanisms (Petrides and De
Fronzo, 1989). The decrease in lipid oxidation rates will facilitate storage
and availability for utilisation in the post absorptive period.
This study has identified hitherto unreported metabolic
differences to feeding in cirrhotic patients with different primary
pathologies. This finding may have important implications in prescribing
nutritional support for cirrhotic patients where high carbohydrate
regimens may indirectly act to induce early satiety and are perhaps
inappropriate for patients with HC cirrhosis.
OLT Patients
Following OLT, the rates of glucose and lipid oxidation were
comparable to the control group. This finding is not unexpected given
that the glycogen storage capacity in uncomplicated OLT patients should
be normal. The recipients healthy hepatocytes are, of course, now able to
designate macronutrients delivered by the portal vein to be synthesised,
stored or oxidised.
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The depressed rate of protein oxidation found in patients at three
and six months after transplantation compared with controls cannot be
easily explained. It could be associated with hepatic denervation where
central processors may interpret the lack of hepatic neural signalling as
nutrient deprivation. In addition immunosuppression may reduce protein
turnover rates. In the present study, neither of these possibilities that
may account for the reduced rate of protein oxidation found in patients six
and nine following OLT can be confirmed.
The only other study that has examined fuel utilisation in response
to feeding among OLT patients was by Green and colleagues (1991). This
group observed no differences in fuel oxidation rates between seven
patients and seven control subjects. In order to allow examination of the
progressive impact of meal ingestion on lipid and glucose oxidation, the
present study determined calculated rates of oxidation on four occasions
over a two hour postprandial period. This methological approach was
considered important as the postprandial profile of substrate utilisation
may be implicated in the aisproportionate increase in fat mass observed in
OLT patients (Chapter 3). Glycogen storage capacity is limited and when
replete the rate of glucose oxidation will increase concomitantly with
intake thereby suppressing mobilisation and oxidation of lipid and lead to
expansion of body fat stores (Tremblay et al, 1991; Thomas et al, 1992).
There was a tendency for NPRQ to increase during the later
postprandial period at six months OLT when compared with controls.
Whilst the difference in NPRQ failed to reach significance it does suggets a
tendancy for the six month OLT patients to oxidise glucose relative to
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lipid. When pre-OLT patient vaues were compared to the nine month
OLT group, a decrease in glucose oxidation was seen but only at the 85-95
min study time point (p<0.05). This may in part be explained by the
transient elevation in glucose oxidation seen in cirrhotic patients.
In the present study there is no substantive evidence to suggest
that following OLT, qualitative differences in fuel metabolism could
contribute to the increase in fat mass seen in this OLT population.
However, it is possible that they may be masked by the composition of
the test meal prescribed, that is the meal given may have been insufficient
both in terms of energy density and composition (Raben et al, 1994;
Larson et al, 1995). For example, Astrup et al (1994), who examined the
effect of diet on RQ, only found an increase in lipid oxidation rates on a
diet that comprised 50% of the energy derived from fat. Ingestion of
large amounts of fat promotes fat oxidation but only to a limited extent
(Flatt, 1995). The prescription of the test meal in the current study was
dictated by the acceptability of the meal to the cirrhotic population.
The findings of the present study do riot preclude the possibility
that weight gain following OLT may be associated with a reduced capacity
to raise fat oxidation in parallel with moderate to high fat intakes and
would promote fat storage. Currently, the understanding of the
mechanisms involved in weight gain following liver transplantation is
limited but further studies that focus on the use of high fat/energy dense
meal challenges are required to confirm or refute any association between
fuel utilisation and fat storage.
165
CHAPTER 7
INSULIN AND GLUCOSE RESPONSE TO FEEDING IN LIVER
CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS
The presence of glucose intolerance in liver cirrhosis has been
recognised for sometime (Berkowitz, 1969) but the mechanisms involved
in defective insulin mediated glucose metabolism have not been attributed
to any single factor (Nolte et al, 1995). It has been suggested that insulin
resistance resulting in defective glucose disposal is implicated in the
glucose intolerance reported in liver cirrhosis (Petrides et al, 1994). The
presence of portasystemic shunting may cause diminished hepatic insulin
and glucose clearance (Bosch et al, 1984) and other investigators suggest
that defects in peripheral insulin receptor/post-receptor function also
plays a significant role in glucose intolerance (Cavallo-Perin et al, 1985;
Kruszynska and Mclntyre, 1991). There is, however, no consensus as to
the exact mechanisms involved in the hyperglycaemia/
hyperinsulinaemia of cirrhosis. However, what is clear is that in cirrnosis
glucose storage capacity (i.e. hepatic and muscle glycogen formation) is
significantly reduced and this may increase circulating glucose
concentrations.
Following solid organ transplantation, a proportion of patients
develop post-transplant hyperglycaemia (Roth et al, 1989; Tabasco-
Minguillan et al, 1993). The aetiology of new onset DM after
transplantation is considered multifactorial but the diabetogenic effects of
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the immunosuppressive reagents are thought to play a major role
(Tabasco-Minguillan et al, 1993).
In Chapters 5 and 6 the substrate utililisation in the fasted and fed
state was examined in cirrhotic patients and control, subjects. This
Chapter focuses on the insulin and glucose profiles under basal conditions
and in response to feeding in stable cirrhotic patients and a group of
healthy controls. A sub-group of patients with liver cirrhosis were




Thirty-six patients with chronic liver disease were entered into the
feeding limb of the study. Eighteen patients were submitted to OLT, had
an uncomplicated recovery and were entered into the feeding limb of the
study. These OLT patients were reviewed on a three monthly basis on
three occasions. Eighteen healthy volunteers were also recruited. Patients
and controls are fully described in Chapter 4.
Methods
Blood samples were taken for determination of plasma glucose
concentration at baseline and every 20 minutes for two hours following
ingestion of the test meal. Plasma insulin concentration was determined
at baseline, 60 and 120 minutes (see Figure 2.1). The integrated glucose
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and insulin and glucose response to the test meal was calculated using the
trapezoid method. Methods are fully described in Chapter 2.
Results
Cirrhotic Patients
Characteristics of the cirrhotic patient population and control group
are shown in Table 4.1. Basal plasma glucose concentrations and the two
hour response to a mixed meal in cirrhotic patients and controls is shown
in Figure 7.1 and 7.2. Whilst there were no significant differences in
fasting blood glucose concentrations between cirrhotic patients and
controls, plasma glucose values were significantly elevated in cirrhotic
patients at the 100 and 120 minute post-prandial time point (100 min:
controls 5.6 ± 0.24 mmol/1 compared to cirrhotics 6.8 ± 0.30 mmol/1,
p<0.05; 120min: controls 5.3 ± 0.28 mmol/1 compared to cirrhotics 6.5 ±
0.23 mmol/1; p<0.05).
In addition, when compared with controls, cirrhotic patient's
fasting plasma insulin concentrations were significantly higher (basal:
controls 5.8 ± 0.62 mU/1 compared to cirrhotics 13.5 ± 1.8 mU/1, p<0.01).
Insulin concentrations remained significantly elevated one and two hours
after meal ingestion (60 min: controls 27.9 ± 2.9 mU/1 compared to
cirrhotics 64.4 ± 12.5 mU/1, p<0.05; 120 min: controls 13.9 ± 1.9 mU/1
compared to 54.4 ± 12.2 mU/1, p<0.05) (Figure 7.2).
When patients were classified by Child's Pugh modified score no
differences in glucose (Figure 7.3) or insulin concentration (Figure 7.4) was
apparent in either the fasted or fed state. Patients were also sub-divided
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FIGURE 7.1 GLUCOSE RESPONSE TO FEEDING IN
CONTROLS AND CIRRHOTIC PATIENTS
Mean (±SEM)









* = p<0.05 versus controls
** = p<0.01 versus controls





























by the presence or not of portal systemic shunting evidenced by the
presence of varices (shunting n = 14; no shunting n = 22). Those patients
with evidence of shunting had significantly higher blood glucose values
than the control group at 60 through to 120 minutes post-prandially (60
min: no shunting 6.7 ± 0.31 mmol/1 compared to shunting 8.2 ± 0.52
mmol/1; p<0.05; 80 min: no shunting 6.2 ± 0.27 mmol/1 compared to
shunting 8.0 ± 0.56 mmol/1; p<0.01; 100 min: no shunting 6.0 ± 0.24
mmol/1 compared to shunting 8.1 ± 0.58 mmol/1, p<0.01; 120 min: no
shunting 5.7 ± 0.30mmol/l compared to 7.6 ± 0.55 mmol/1, p<0.01) (Figure
7.5). No differences in the basal or post-prandial insulin response was
observed in patients with or without portal hypertension (Figure 7.6).
Patients were also classified by primary aetiology and plasma
glucose concentration was higher in HC patients than controls at 80, 100
and 120 minutes post-prandially (80 min: controls 6.1 ± 0.25 mmol/1
compared to HC 7.5 ± 0.38 mmol/1, p<0.05; 100 min: controls 5.6 ± 0.24
mmol/1 compared to HC 7.4 ± 0.38 mmol/1, p<0.01; 120 min: controls 5.3
± 0.23 mmol/1 compared to HC 6.9 ± 0.36 mmol/1, p<0.01) (Figure 7.7). In
addition, 80 minutes after meal ingestion differences in blood glucose
concentrations were seen between patients with cholestatic and
hepatocellular cirrhosis (80 min: BC 6.2 ± 1.7 mmol/1 compared to HC 7.5
± 1.6 mmol/1; p<0.05).
Insulin profiles were also significantly different when patients were
stratified by primary aetiology (Figure 7.8). The HC patients had
significantly elevated basal plasma insulin concentrations when compared
to control subjects or BC patients (controls: 5.8 ± 0.62 mU/1 compared
173
7.5 GLUCOSE RESPONSE TO FEEDING IN


















* = p< 0.05 versus controls
** = p<0.01 versus controls
*** = p< 0.001 versus controls
AUC = p<0.05 versus no shunting
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FIGURE 7.6 INSULIN RESPONSE TO FEEDING IN
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* = p<0.05 versus controls
** = p <0.01 versus controls
§ = p <0.05 versus biliary cirrhosis
AUC = p<0.05 hepatocellular versus controls
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FIGURE 7.8 INSULIN RESPONSE TO FEEDING IN CONTROLS











* = p<0.05 versus controls
** = p< 0.01 versus controls
§ = p<0.05 versus biliary cirrhosis
§§ = p<0.01 versus biliary cirrhosis
AUC = p<0.01 hepatocellular versus controls
AUC = p<0.05 hepatocellular versus biliary cirrhosis
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with HC 17.2 ± 2.6 mU/1; pcO.Ol; BC 9.6 ± 2.2 mU/1 compared with HC,
p<0.05). Following ingestion of the test meal, plasma insulin
concentrations remained elevated in HC patients compared to controls at
60 and 120 minutes (60 min: controls 27.9 ± 2.9 mU/1 compared to HC
84.2 ± 21.8 mU/1, p<0.05; 120 min: controls 14.0 ± 1.8 mU/1 compared to
HC 85.4 ± 20.9 mU/1; p<0.01). Two hours post-meal ingestion, a
significant difference in insulin concentration between patient groups was
also observed (120 min: BC 21.5 ± 3.5 mU/1 compared to 85.4 ± 20.9
mU/1; p<0.01).
Area under the curve was calculated to determine the integrated
glucose and insulin response to the test meal. The insulin AUC in cirrhotic
patients was significantly higher than control values (insulin: controls
2261 ± 937 AU compared to cirrhotics 5575 ± 6090 AU, p<0.05). In addition
the glucose AUC was significantly higher in patients with evidence of
portal hypertension (glucose: no shunting 753 ±112 AU compared to 868
± 198 AU, p<0.05).
Differences in both the integrated glucose and insulin meal
response was evident when patients were stratified by primary aetiology.
In HC patients when compared with control subjects the AUC was
significantly higher for both glucose and insulin (glucose: controls 711 ±
93.2 AU compared to HC 832 ± 151 AU, p<0.05; insulin: controls 2261 ±
937 AU compared to HC 7749 ± 7429 AU, p<0.01). Furthermore, the
insulin AUC in HC patients was significantly greater than found in the BC
group (insulin: BC 3191 ± 2523 AU compared to 7749 ± 7429 AU, p<0.05).
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OLT Patients
Seven male and 11 female patients (mean age 52.8 ± 2.4 years) were
studied following OLT. All ten BC patients were female and seven of the
eight HC patients were male. There are no differences in basal blood
glucose values between control subjects and patients at OLT study time
points. Within the OLT group, analysis revealed that at three, six and nine
months after transplantation, basal blood glucose values were
significantly higher than pre-OLT values (pre-OLT: 4.8 ± 0.1 mmol/1
compared to 3 months OLT: 5.8 ± 0.4 mmol/1; p<0.05 : pre-OLT
compared to 6 months OLT: 5.4 ± 0.1 mmol/1; p<0.05 : pre-OLT
compared to 9 months OLT: 5.2 ± 0.1 mmol/1; p<0.05).
From the 60 - 120 min post-prandial period, blood glucose
concentration was significantly elevated in patients three months after
OLT when compared to control subjects (60 min: Controls: 6.4 ± 0.2
mmol/1 compared to 3 month OLT: 8.3 ± 0.3 mmol/1; p<0.05: 80 min:
Controls: 6.1 ± 0.2 mmol/1 compared to 3 month OLT: 8.1 ± 0.5 mmol/1;
p<0.05: 100 min: Controls: 5.6 ± 0.2 mmol/1 compared to 7.9 ± 0.6
mmol/1; p<0.01: 120 min: Controls: 5.3 ± 0.3 mmol/1 compared to 7.6 ±
0.6 mmol/1; p<0.01).
Significant differences in blood glucose concentration was also
observed between OLT study time points (Figure 7.9). Forty and 60
minutes after meal ingestion, blood glucose concentration at three months
following OLT was significantly higher than values found six and nine
months after transplantation (40 min = 3 month OLT: 8.0 ± 0.5 mmol/1
compared to 6 month OLT: 6.9 ± 0.3 mmol/1; p<0.05: 3 month compared
179
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* = p<0.05 versus 6 and 9 months OLT
§ = p<0.05 versus 9 months OLT
@ = p<0.05 versus 9months OLT
# = p<0.05 versus 9 months OLT
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to 9 month OLT: 6.9 ± 0.3 mmol/1; p<0.05) (60 min: 3 month OLT: 8.3 ±
0.5 mmol/1 compared to 6 month OLT: 7.3 ± 0.4 mmol/1; p<0.05: 3
month OLT compared to 9 month OLT: 7.1 ± 0.4 mmol/1; p<0.05). At the
80 minute post-prandial time point, blood glucose values were
significantly elevated at 3 months OLT compared to 9 months after
transplant (80 min: 3 month OLT: 8.1 ± 0.5 mmol/1 compared to 9
month OLT: 6.8 ± 0.4 mmol/1; p<0.05). In addition, 100 minutes after
meal ingestion, blood glucose concentration was significantly higher three
and six months OLT when compared to 3 month OLT (100 min: 3 months
OLT: 7.9 ± 0.6 mmol/1 compared to 9 months OLT: 6.6 ± 0.3 mmol/1;
p<0.05: 6 months OLT 7.1 ± 0.3 mmol/1 compared to 9 months OLT).
Post-absorptive and post-prandial plasma insulin values are shown
in Figure 7.10. Basal insulin concentration was significantly elevated in
pre-OLT patients when compared with controls (controls: 5.8 ± 0.6 mU/1
compared to pre-OLT: 15.9 ± 3.8 mU/1; p<0.01). Sixty minutes after meal
ingestion, insulin levels in pre-OLT patients remained significantly higher
than control subjects (controls: 28.9 ± 2.9 mU/1 compared to 87.1 ± 29.2
mU/1; p<0.05).
Differences in basal plasma insulin concentrations pre- and post-
OLT were observed where elevated levels pre-transplant normalised. In
response to feeding, no differences were apparent when compared pre-
and post-OLT. When patients were sub-divided by primary aetiology, no
difference in glucose or insulin values at three months OLT was observed.
In addition, the calculated area under the curve for glucose and insulin
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was not significantly different from the control population or in the same
patients either prior to or following transplantation.
Discussion
Cirrhotic Patients
In the current study, fasting cirrhotic patients were
hyperinsulinaemic when compared with controls. In the late post¬
prandial period, blood glucose concentrations were also elevated (100 and
120 minutes). Blood glucose concentrations whilst significantly higher
than controls were not indicative of DM. The incidence of DM in liver
cirrhosis has been cited at 10 to 30% (Petrides and De Fronzo, 1989;
Petrides et al, 1994). However, in the present study only four patients
presented with DM and were excluded. The low incidence of diabetes in
this study may be explained by the Scottish Liver Transplant Unit's active
policy of early referral and it may be that these stable cirrhotic patients
who are amenable to assessment represent a different cohort to those
those admitted for management of a disease related complication.
Indeed, no patient in the present study was admitted for management of
an acute complication of their liver disease and this finding may account
for the more moderate disturbances of carbohydrate metabolism than
previously reported.
The impact of portasystemic shunting on glucose and
hyperinsulinaemia remains one of debate. Kruszynska et al (1993)
suggests the early elevation in blood glucose, seen in response to an oral
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glucose tolerance test is a consequence not only of reduced hepatic mass
but of a reduced parasympathetic endocrine response. In the present
study patients were sub-divided by the presence or not of portasystemic
shunting and those with portal hypertension were shown to be
hyperglycaemic from 60 - 120 minutes when compared to those patients
without portal hypertension. However nine out of the 14 (65%) patients
with shunting had HC and this may bias results as a significant
disturbance in the glucose response to feeding was seen in HC patients.
No significant differences were observed in the insulin response to
feeding when portasystemic shunting was considered.
The effect of portasystemic shunting on carbohydrate metabolism
is equivocal and Bosch et al (1984) used hepatic vein catheterisation to
assess the contribution of portasystemic shunting and impaired hepatic
extraction to the hyperinsulinaemia of cirrhosis. These investigators
reported that hyperinsulinaemia was the result of the shunting of
pancreatic venous blood to the systemic circulation. Whilst portasystemic
shunting may contribute to the hyperinsulinaemia and hyperglycaemia of
cirrhosis, its impact may have been overstated given that postprandial
hyperinsulinaemia is not observed in patients with portal vein thrombosis
and normal liver function (Johnson et al, 1978). This view is supported by
Taylor et al (1985) who in an euglycaemic/hyperinsulinaemic clamping
study suggested that receptor/post-receptor defects are more important
than portal hypertension in the pathogenesis of insulin resistance.
Many studies have considered the cause of glucose intolerance in
cirrhotic populations but generally these have been performed in small
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heterogeneous groups. Stratification of cirrhotic patients is important as
disease severity and aetiology could influence glucose and insulin
metabolism. In the current study when patients were stratified for disease
severity using the modified Child's Pugh score, no significant differences
in glucose or insulin concentrations were observed and could be related to
the stable clinical state of this population. Interestingly, Muller et al
(1992b), in a euglycaemic/hyper-insulinaemic clamping study which
examined the mechanisms of insulin resistance, observed no differences in
glucose and insulin responses between patients classified as Child's Pugh
A and Child's Pugh B. In this study no patients were classified as Child's
Pugh C.
The primary aetiology of cirrhosis was also examined in the
present study. This stratification highlighted differences in the insulin and
glucose in the fasted and fed state. Hepatocellular cirrhotic patients
exhibited an elevation in blood glucose concentration in response to the
test meal that were significantly different from controls and BC patients.
However, when the integrated glucose meal response was determined
only differences between HC patients and control group were apparent.
It should be emphasised that whilst HC patients blood glucose
concentrations were elevated, the response curve was not indicative of
overt DM. The glucose dose given in the test meal was comparable to a
oral glucose tolerance test and supplied 3.6 g of carbohydrate per kg body
weight. Plasma insulin concentration and the integrated meal response
was also shown to be significantly higher in HC patients compared to
controls as well as between HC and BC patients. This suggests that
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disturbances of glucose metabolism are of a greater magnitude in patients
whose primary aetiology is associated with intrinsic hepatocellular
damage but this cannot be confirmed. Few metabolic studies have
examined groups large enough to stratify their patients by disease,
although Taylor et al (1985), in a study that examined insulin action in
cirrhosis found that patients with cholestatic disease were less insulin-
resistant than patients with alcoholic or cryptogenic cirrhosis. In the
present study the increased basal insulin and glucose/insulin response to
feeding in the HC patients may reflect an adaptive response to defective
glycogen storage. Results suggest that in HC patients the glucose in the
meal must be immediately oxidised resulting in a concomitant but short
term decrease in lipid oxidation (Eriksson et al, 1989).
Whilst the understanding of altered glucose metabolism in
response to feeding has previously been explored (Nolte et al, 1995) what
has not been considered is the effect of hyperinsulinaemia on ingestive
behaviour. Normally, the presence of food in the gastrointestinal tract
stimulates the release of gastrointestinal hormones (i.e. gastric-inhibirory-
peptide, CCK, gastrin, secretin). The cephalic and post ingestive humoral
response to feeding includes the release of insulin. These humoral
messengers reinforce neural signals which converge in the brain stem and
subsequently act to influence ingestive behaviour. Insulin has been
shown to act through the central nervous system as a satiety mediator
and acts by reducing meal size (Van der Weele et at, 1980; Posner, 1987).
Whether the satiety effect of insulin depends upon glucose is not known
but insulin infusions in rats fed low carbohydrate, high fat diet did not
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depress food intake and suggests glucose may be involved (Arase et al,
1988).
It may be postulated that the disturbed glucose/insulin response to
feeding seen in cirrhotic patients and in particular those with disease of
hepatocellular origin could contribute to reductions in food intake.
OLT Patients
Hyperglycaemia and new onset DM (insulin dependent) is a well
recognised complication of solid organ transplantation with the
prevalence reported as ranging from 4 - 20% (Jindal, 1994). Usually
transient in nature, post-transplantation DM (Tabasco-Mingullan et al,
1993) has been related to immunosuppressive drug therapy and more
precisely to the dose and duration of steroid therapy (Navasa et al, 1996).
It is now widely accepted that the incidence of post-transplantation DM
can be decreased by the early withdrawal of steroid therapy and this has
been shown to be a safe treatment strategy in OLT patients (Gomez et al,
1998). Interestingly, the success rate of early steroid withdrawal in
transplantation appears to be more successful in OLT compared to other
solid organ transplants (heart, lung, kidney) and may be related to the fact
that the liver is an immunologically privileged organ (McDiarmid et al,
1995). In the 18 patients studied longitudinally, basal OLT blood glucose
values were higher after transplantation but it should be emphasised that
following OLT these values (3, 6 and 9 months OLT) were not significantly
different from the control group. Roth et al (1989) diagnosed post-
transplant diabetes using fasting blood glucose concentrations and
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reported a prevalence twice that of the present study. In the current
study there was a trend for fasting blood glucose concentrations to
decrease from the third to the ninth month after transplantation.
During the second half of the post-prandial period (60 - 120
minutes), the blood glucose response was significantly elevated in patients
three months after OLT when compared with control subjects. In
addition, this three month OLT post-prandial elevation in blood glucose
was also significantly greater than that observed in the same patients nine
months after transplantation. It is likely that the increased glucose
response to feeding seen in the early post-operative period is attributable
to introduction of steroid therapy (Pirsch et al, 1983). It has been shown
that early steroid withdrawal results in improved glucose tolerance and
for those patients with post-transplant DM a significant reduction in
insulin requirements (Hricik et al, 1991).
The synergistic effect of immunosuppression on glucose tolerance
cannot be overlooked. For example, in a study of renal transplant
recipients, it was suggested that CsA (cyclosporin A) may reduce the
clearance of steroids (Ost, 1984). Cyclosporin A, tacrolimus (FK506) and
steroids have been implicated in the development of post-transplantation
DM and appears to be the result of decreased insulin secretion, insulin
resistance and damage to the pancreatic beta - cells (Jindal, 1994).
However, in the present study, in uncomplicated OLT transplant
recipients from six months OLT, fasting and fed glucose values were not
significantly different to control subjects.
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No differences in pre- and post-OLT plasma insulin concentrations
were observed and may be accounted for by the fact that of those patients
submitted to OLT, ten had cholestatic disease and eight HC disease. In the
present study, an elevated basal and post-prandial response to feeding
was observed in HC patients. Following transplantation, plasma insulin
concentrations were not significantly different from controls or in the
same patients at different OLT time points.
In the preceding section focusing on cirrhotic patients, it was
suggested that the centrally mediated satiety effects of insulin may be




ENERGY AND MACRONUTRIENT INTAKE IN
LIVER CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS
Few studies have quantitatively examined nutritional intake in
patients with liver cirrhosis and these have almost exclusively focused on
patients with hepatocellular cirrhosis (Morgan et al, 1982; Egan et al, 1985;
Cabre et al, 1990; Campillo et al, 1997). However, with the exception of
the study by Campillo and co-workers (1997), suboptimal spontaneous
nutritional intakes have been observed in the majority of studies that
have considered nutritional intake in liver cirrhosis (Cabre et al, 1990).
Neilsen et al (1993) reported that in undernourished cirrhotic patients,
dietary intakes were only 61% of a comparable control population. They
concluded that ensuring cirrhotic patients consume an adequate
nutritional intake is a major problem when attempting to improve
nutritional status.
The increased understanding of the metabolic demands of liver
disease has resulted in the publication of European Dietary Guidelines
(Plauth et al, 1997) on nutritional requirements in liver disease. As a
consequence nutritionists can now quantify dietary targets for patients
with liver disease and if consumed, these regimens should prove clinically
effective.
The mechanisms involved in the aetiology of anorexia in liver
disease are unknown but may in part be due to the fact that the complex
interactions between altered metabolism and nutritional intake are not
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well defined. The physiological sequelae of progressive liver damage and
consequent aberrant metabolism may result in alterations in the role of
the liver as a metabolic sensor and may effect changes in ingestive
behaviour and influence nutritional intake. In order to examine factors
associated with anorexia in chronic liver disease, spontaneous dietary
intake was estimated in a group of stable cirrhotic patients.
Following transplantation, obesity has been reported in OLT
patients and the magnitude of weight gain has been shown to exceed that
of patients pre-illness weight (Davidson et al, 1998). The presence of
obesity in OLT may exacerbate other common post-transplantation
complications such as hyperlipidaemia, hypertension and cardiovascular
disease (Munoz et al, 1991) and given the central role of hepatic afferent
signalling in ingestive behaviour, it is surprising that the nutritional intake
of denervated OLT patients has not been examined. This study also
examined the dietary intake of a sub-group of patients with cirrhosis who




Sixty seven cirrhotic patients (35 BC patients and 32 HC patients)
were recruited.
Twenty three cirrhotic patients were submitted to OLT and had an
uncomplicated post operative recovery these patients were reviewed on a
191
three monthly basis on three occasions after discharge from hospital.
Eighteen healthy volunteers were also recruited.
Methods
Food diaries were used to estimate energy and macronutrient
intake (recording two week days and one day at the weekend) and were
kept by subjects in the week following discharge from hospital. The
methods used fully described in Chapter 2. No patient with chronic liver
disease was on a therapeutic diet.
Results
Cirrhotic Patients
Characteristics of this cohort are shown in Table 3.1. Three day
dietary diaries were analysed on 52 of the 67 cirrhotic patients and 16 of
the 18 controls, a return rate of 78% and 89% for patients and controls
respectively. The validity of the dietary diary technique was determined
in the control group by comparing protein intake (expressed as nitrogen)
with nitrogen output. A significant relationship between these variables
was observed (r = 0.562; p<0.05).
The cirrhotic patients had significantly lower intakes of energy
when compared with control subjects (controls: 9.0 (2145kcal) ± 0.45
MJ/day versus cirrhotic patients: 5.8 (1617 kcal) ± 0.29 MJ/day; pcO.Ol),
protein (controls: 81.3 ± 5.0 g/day versus cirrhotic patients: 58.3 ± 2.9
g/day; p<0.001), fat (controls: 83.7 ± 6.2 g/day versus cirrhotic patients
61.1 ± 3.2 g/day; pcO.Ol) and carbohydrate (controls: 259.4 ± 11.4 g/day
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versus cirrhotic patients 202.3 ± 10.1 g/day; p<0.01) (Figure 8.1). Resting
energy balance (energy input minus resting energy expenditure) was
significantly lower in cirrhotic patients when compared with the control
subjects (controls: 2.4 (584 kcal) ± 0.36 MJ/day versus cirrhotic patients:
1.0 (245 kcal) ± 0.30 MJ/day; p<0.05).
When patients were stratified for severity of liver disease by
Child's Pugh score, no significant differences were shown in energy and
macronutrient intake between Child's Pugh A (n = 12), B (n = 23) and C (n
= 17) patients (Figure 8.2). In addition, there were no differences in
energy balance between these groups (Child's Pugh A = -0.228 ± 1.24;
Child's Pugh B = -1.03 ± 1.18; Child's Pugh C = 1.44 ± 1.11; ns).
The energy and macronutrient intake of control subjects and
patients classified by primary aetiology was examined. When compared
with controls, the energy intake in both BC (n = 26) and HC (n = 26)
cirrhotic patients was significantly lower (controls versus BC: 7.0 (1678
kcal) ± 0.40 MJ/day; p<0.05: controls versus HC: 6.5 (1565 kcal) ± 0.39
MJ/day; p<0.01). Protein intake was also significantly lower in patient
groups when compared with controls (controls versus BC: 61.4 ± 3.9
g/day; p,0.05: controls versus HC: 55.6 ± 4.1 g/day; p<0.001). However,
the dietary intake of fat and carbohydrate when compared with the
control group was significantly lower only in the HC group (fat: controls
versus HC: 61.3 ± 4.4 g/day; p<0.05) (carbohydrate: controls versus HC:
195.1 ± 13.3 g/day; p<0.05) (Figure 8.3). Additionally, resting energy
balance was significantly lower in the HC patients when compared with
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FIGURE 8.2 ENERGY AND MACRONUTRIENT INTAKE IN CIRRHOTIC
PATIENTS STRATIFIED BY DISEASE SEVERITY
Energy intake in cirrhotic patients
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FIGURE 8.3 ENERGY AND MACRONUTRIENT INTAKE IN CONTROL
SUBJECTS AND PATIENTS STRATIFIED BY AETIOLOGY
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* = p < 0.05 versus control subjects
** = p < 0.01 versus control subjects
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controls (controls versus HC: 0.51 (124 kcal) ± 0.42 MJ/day; p<0.05)
(Figure 8.4).
When energy and macronutrient intakes were expressed as a unit
of body weight (per kg body weight), although depressed when
compared with controls, they were not significantly different.
Additionally there were no differences in nitrogen balance (including 3 gm
insensible losses) when disease severity or primary aetiology was
examined (Figure 8.5). There was no difference in the number of eating
episodes between control subjects (controls = 4.9 ± 0.23 /day), BC patients
(BC = 4.5 ± 0.22/day) and F1C patients (HC = 4.4 ± 0.21).
OLT patients
Characteristics of OLT patients are shown in Table 3.7. For each
study time point, the return rate for dietary diaries was 91% (n = 21 out of
23). Compared with pre-OLT values, significant increases in energy and
macronutrient intakes were observed (Table 8.1). Additionally six months
after OLT, these patients consumed significantly more energy than control
subjects (Controls: 9.0 ± 0.45 MJ/day versus 10.2 ± 0.62 MJ/day, p<0.05).
The intake of dietary fat was greater from three months post-OLT (Fat:
Controls 83.7 ± 6.2 g/day versus three months OLT: 106.2 ± 10.1 g/day,
p<0.05; Controls versus six months OLT: 110.4 ± 7.5 g/day, p<0.01;
Controls versus nine months OLT: 101.6 ± 7.1 g/day, p<0.05).
Differences in energy and macronutrient intake were also apparent
when dietary intake data were normalised for body weight (Figure 8.6).
Compared with pre-OLT values, there were significant increases in energy
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FIGURE 8.5 NITROGEN BALANCE
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(pre-OLT: 96.6 ± 10.4 kj/kg versus three months OLT: 139.9 ± 12.1 kj/kg,
p<0.01: pre-OLT versus six months OLT: 137.7 ± 9.7 kj/kg, p<0.01: pre-
OLT versus nine months OLT: 123.5 ± 9.7 kj/kg, p<0.05), protein (pre-
OLT; 0.89 ± 0.10 g/kg versus three months OLT; 1.12 ± 0.09 g/kg, p<0.05:
pre-OLT versus six months OLT: 1.14 ± 0.07 g/kg, p<0.05), fat (pre-OLT:
0.93 g/kg ± 0.11 versus three months OLT; 1.50 ± 0.15 g/kg, pcO.001:
pre-OLT versus six months OLT; 1.48 ± 0.11 g/kg, p<0.001: pre-OLT
versus nine months OLT; 1.34 ± 0.12 g/kg, p<0.01) and carbohydrate
(pre-OLT: 2.97 ± 0.32 g/kg versus three months OLT: 4.06 ± 0.39 g/kg,
p<0.01: pre-OLT versus six months OLT: 3.92 ± 0.29 g/kg, p<0.05). Six
and nine months after OLT dietary fat intake expressed as a unit of body
weight exceeded that of control subjects (Controls: 1.0 ± 0.10 g/kg versus
six months OLT: 1.48 ± 0.11 g/kg, p<0.01: Controls versus nine months
OLT: 1.34 ±0.12 g/kg, p<0.05).
Prior to and following OLT the profile of energy derived from
macronutrients was also examined and nine months after OLT a
significant increase in the contribution from fat to total energy intake was
observed and was accompanied by a significant decrease in the energy
derived from carbohydrate (Figure 8.7). When OLT patients were
compared with controls, the percentage energy derived from fat was
significantly higher in patients at three (controls: 34.9 ± 5.2% versus three
months OLT: 40.4 ± 6.8%, p<0.01), six (controls: versus six months OLT:
40.5 ± 4.2%, p<0.01) and nine months after transplantation (controls:
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At the six month study time point, 17 out of 23 (74%) patients were
prescribed an energy restricted dietary regimen.
Discussion
Cirrhotic Patients
The present study examined spontaneous food intake in a group of
stable cirrhotic patients. In order to minimise the environmental and
behavioural influences of hospitalisation, subjects recorded their dietary
intakes at home and a day at the weekend was also included in the diary
period to allow for any day of the week effect (Beaton et al, 1979). The
use of the three day dietary diary in the current study was valid as is
evidenced by the relationship between nitrogen output and nitrogen
input (p<0.05) and has previously been shown to be of value in the
estimation of energy and macronutrient intake (Gibson, 1990).
As with other studies, the current investigation demonstrated that
cirrhotic patients had a significantly lower nutritional intake than control
subjects. The average daily energy intake was only 75% of that achieved
by the control group but was greater than that found by Neilsen et al
(1993) and Egan et al (1985) where energy intake of their hospitalised
patients was 61% and 50% of their control groups respectively. The
reason for the higher energy intake in the present study may be that
patients were documenting their intakes at home and were therefore
consuming familiar and acceptable foods. Additionally, no patient in the
current study was admitted for an acute exacerbation of their disease nor
an infective complication which could have affected appetite.
204
When patients were stratified using Child's Pugh classification, to
examine the effect of disease severity on nutritional intake, no differences
in energy or macronutrient intake were evident. It should be
remembered that the Child's Pugh score is a dynamic clinical index of
disease severity but not nutritional status. Indeed the studies of Campillo
et al (1997) and Neilsen et al (1993) have also shown that disease severity
had no effect on nutritional intake.
However, when patients were examined by primary aetiology,
differences in energy and macronutrient intakes were observed. When
compared with controls, energy intakes were significantly lower in the BC
group but the level of energy intake was lowest in the HC cirrhotic group.
It is unlikely that female bias in the BC cirrhotic group has influenced the
differences in energy intakes observed between patients group. Indeed it
might be expected that the BC rather than the HC patients would have
the lowest energy intake, as females have a lower lean body mass than
males and as a result a lower energy requirement. Furthermore, it could
be inferred that when compared with controls the depressed energy
intakes in BC cirrhotic and HC group is merely a reflection of the reduced
body mass that may accompany chronic liver cirrhosis. However, in the
present study, body mass index was not different between patient groups
and controls and, although fat mass was significantly lower in the HC
group, lean body mass was preserved (Chapter 3). When energy and
macronutrient intake was expressed as a unit of body mass (kg body
weight), although intakes of HC patients were lower than controls, they
failed to reach significance. However, their depressed intake per unit
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body mass, if considered cumulatively, may result in a negative energy
balance and consequent depletion of endogenous energy reserves as seen
in the present study.
The level of patient activity was not examined in the current study
as completion of exercise diaries was thought to be too onerous for the
patient group. Further studies that consider activity levels in these
patients would improve our understanding of energy dynamics in liver
disease (energy balance = energy in - energy out (resting + thermogenesis
+ activity)).
During assessment for OLT, the SLTU dietitian gives patients
dietary advice and uses ESPEN Guidelines (European Society of Parenteral
and Enteral Nutrition) (Plauth et al, 1997) as the template for prescribing
individual dietary regimens for patients with liver disease. These
guidelines suggest that 40 kcal/kg body weight would provide sufficient
energy to improve nutritional status and a protein intake of 1.4 g/kg
body weight would achieve nitrogen balance in patients with chronic liver
disease. Despite professional dietary advice cirrhotic patients in this study
and in particular those with HC disease were unable to achieve target
prescriptions for either energy or protein. Although dietary protein is an
important constituent of structural, functional and transport proteins, it is
not considered a major contributor of total energy intake and will not be
examined in depth in this thesis.
The mismatch between patient's actual and prescribed intakes
serves to highlight the fact that whilst a nutritionally adequate diet
(including energy dense supplements) may be prescribed for these
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patients, their ad libitum intake is suboptimal as is evidenced by the HC
group and may contribute to undernutrition. Interestingly, Kondrup and
Muller (1997) in a review of eight studies on patients with chronic liver
disease concluded that when nutritional support (parenteral, enteral and
oral regimens) was implemented a decrease in mortality was associated
with increased energy and protein intakes. However, in this review oral
nutritional intakes were suboptimal. These findings are in agreement
with the present study but at odds with the work of Campillo et al (1997)
who examined oral intake in a group of 55 alcoholic cirrhotics. In
Campillo and colleagues (1997) study all patients were hospitalised for a
disease related complication and a third had evidence of an infective
complication. Patients were included in the study up to five weeks after
admission and then followed for a 30 day study period. The investigators
observed small improvements in nutritional status (Child's Pugh A, B and
C) defined by anthropometric indices over the study period despite half of
the patients being prescribed a low sodium diet, which in itself is
unpalatable. The reason for the improved nutrient intake and nutritional
status in this study could merely be a reflection of an improved clinical
state. The average weight of these patients was 59.5 kg and energy
consumption averaged 10.0 MJ/day (2391 kcal/day) which equates to
around 40kcal/kg and is a substantive intake for these hospitalised
patients. Indeed, the majority of studies in this area support our own
findings in that undernutrition in cirrhosis is common and patients find it
difficult or impossible to maintain an adequate nutritional intake (Achord,
1987; Cabre et al, 1990).
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A unique aspect of the present study is that it has not solely
examined patients with alcoholic or HC disease but also considered
patients with cholestatic cirrhosis. In the current study the energy and
macronutrient intake of the HC group was lowest. Whilst the metabolic
sequelae of chronic liver disease has been widely investigated, few studies
have quantitatively and qualitatively examined the nutrient intake of
patients with cirrhosis and their ability to meet prescribed intakes. One
study that has gone some way to examining a nutritional strategy that
may improve intake was by Verboeket et al (1995) which considered the
shorterm metabolic effect of the pattern of food intake on cirrhotic
patients. They found that a nibbling pattern of food intake (four small
meals compared with two large meals) which included a late evening
snack, improved nitrogen balance when compared to the gorging pattern
(two large meals per day) but no difference in energy balance was
demonstrated. Normally humans consume four to six meals/snacks per
day (Langhans 1992) and in the present study there was no significant
difference in the number of eating episodes found in control or patient
groups.
The mechanisms involved in anorexia that occurs in patients with
cirrhosis requires further investigation. Only then will clinically effective




The nutritional management of patients listed for OLT presents
clinicians with a dichotomy. In cirrhosis, poor dietary intake may be
driven by altered metabolism and negates consumption of a nutritionally
adequate diet but following OLT these patients have a propensity toward
obesity (Stegall et al 1995; Munoz et al, 1991) and many patients are asked
to restrict their energy intake. Weight gain following OLT has not been
extensively investigated but it now seems unlikely that this increase in
body mass is solely attributable to immunosuppressive drug regimens
(Davidson et al, 1998). It could be argued that in the present study the
increase in energy and macronutrient intake observed after
transplantation is merely a reflection of refeeding mechanisms acting to
return the patient's body weight to "set-point" values (Harris, 1990;
Dulloo et al, 1996). In the current longitudinal study, fat mass continued
to increase even after lean body mass and arm muscle circumference
values were comparable to standard values. However, this
morphological picture does not parallel refeeding where once the lean
body mass is repleted, increases in fat mass stabilise (Dulloo 1997). Nine
months after OLT, these patients were 7.5% heavier than their pre-illness
"set-point" weight which was reflected in an increase in fat mass.
Whilst no differences in energy intake per kilogram body weight
were evident between patients and controls, there was a trend for post-
OLT patients to have higher energy intakes. This could exert a cumulative
effect on energy intake. For example, six months after transplantation,
OLT patients were on average consuming 1.2 MJ/day more than control
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subjects (6 months OLT 10.2 MJ/day versus controls 9.0 MJ/day). If
extrapolated over a period of a month this would equate to an additional
22 MJ in the OLT group and equates to 0.75 kg of adipose tissue (30 MJ =
1 kg adipose tissue; Mela and Rogers, 1998). This, added to the observed
energy economy, would account for a weight gain of 7.5 kg 6 months
after transplantation (dietary intake 0.75 kg/month x 6 = 4.5 kg, energy
economy 0.5 kg/month x 6 = 3.0 kg). Clearly this is an over-simplification
of the impact of dietary intake on body weight where activity levels are
not considered. Nevertheless, these observed differences in energy intake
would contribute to post-OLT weight gain. Interestingly, the magnitude
of energy intake at nine months was less than that observed at three and
six months after transplantation but this is reflective of the restricted
energy diets prescribed to over three-quarters of this OLT population.
Transplant recipients appear to be able to restrict their intake of
carbohydrate but not fat and this is surprising in that reducing fat intake is
the cornerstone of weight reduction dietary programmes.
In post-OLT patients, there was a significant increase at nine
months in the energy contribution from dietary fat. In addition, at all
study time points the energy derived from fat was greater than that
consumed by control subjects where at nine months OLT, the percentage
energy derived from fat was 40.9% whereas the contribution was 5% less
in control subjects. It could be suggested that the control population were
biased where two-thirds worked in a hospital or academic environment
and may have been conscious of what constitutes a "healthy diet"
(Department of Health, 1992). The most important finding from this
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study was the qualitative shift in dietary intake found in those patients
studied sequentially where a 5% increase in fat derived energy and a
concomitant decrease in carbohydrate derived energy was observed. A
particular strength of this longitudinal study is that domestic and
environmental factors relating to food preparation were inherently
controlled and further underlines the importance of increased
consumption of fat derived energy.
The disproportionate increase in dietary fat seen in the current
study may be driven by the loss of hepatic innervation and inactivation of
hepatic afferent pathways (Friedman, 1988). Following OLT, an absence
of hepatic neural signalling to the higher centres could induce
hyperphagia and more specifically an increase in fat intake where
humoral lipid signalling from CCK and enterostatin, normally acting via
hepatic afferents to the brain, will be lost. Paradoxically, following OLT
lipid oxidation in both the fasting and fed state was found to be
comparable with control subjects but the lack of lipid signalling in OLT
patients may result in these patients becoming hyperphagic and more
specifically lead to the development of a fat appetite (Sclafani, 1990).
Interestingly, Belle et al (1997) in a quality of life study on 346 patients
performed one year after OLT, found these patients experienced a
significant level of distress due to excess appetite (one of only three
distress factors). The OLT time point used in this study would not
implicate refeeding mechanisms or drug regimens in the reported 'excess
appetite'.
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In OLT patients, the proportion of energy derived from dietary fat
exceeded recommended intakes after transplatation but this was not so
with carbohydrate. However, in these patients glucose gastrointestinal
satiety signalling from gastric inhibitory peptide (GIP), glucagon-like
peptide (GLP) and insulin remains intact. No difference in the number of
eating episodes between control and OLT patients was seen. This
suggests that given their higher intakes, that the duration of an eating
episode may be prolonged in OLT patients. Furthermore, a diet rich in fat
has been shown to extend the intermeal interval (Blundell et al, 1993). This
increased consumption of fat observed in liver transplant recipients may
be a result of altered macronutrient preference.
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CHAPTER 9
MACRONUTRIENT PREFERENCE IN LIVER CIRRHOSIS AND IN
LIVER TRANSPLANT RECIPIENTS
In the presence of chronic liver disease, it is apparent that bizarre
food preferences exist, where the development of cravings for specific
foods such as grapefruit have been documented (Deems et al, 1993). In
light of reports of aberrant metabolism in chronic liver disease and
increased weight following OLT, the development of preferences, not for
specific food types but for the macronutrient composition of that food
may contribute to these conditions.
The organoleptic properties of fat and carbohydrate mixtures as
"real" food is more appropriate in studies which examine macronutrient
preference (Drewnowski et al, 1989) rather than methodologies which
examine detection and recognition taste thresholds (Smith et al, 1976;
Madden et al, 1998) or food frequency questionnaires which provide
limited quantitative information (Bingham et al, 1988; Deems et al, 1993).
Nine months following OLT there is a qualitative shift in dietary
profile whereby the percentage energy derived from fat is 5% greater
than that found in a comparable control group (see Chapter 8). To date
no studies have examined macronutrient preference in cirrhotic patients
or OLT recipients using mixtures of fat and CHO, the major metabolic
fuels.
This study assessed macronutrient preference and the impact of
disease severity and primary aetiology in patients with chronic liver
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disease. Macronutrient preference was also examined in a sub-group of
OLT patients at three, six and nine months following transplantation.
Patients and Methods
Patients
Sixty seven cirrhotic patients (35 BC patients and 32 HC patients)
were recruited. Twenty three patients were submitted to OLT and were
reviewed on a three monthly basis on three occasions after hospital
discharge. Eighteen healthy volunteers were also recruited.
Methods
Preference for fat and CHO was determined using four
commercially produced ice creams, referred to as test stimuli.
Approximately 15ml of each test stimuli was served in a coded beaker to
all subjects (Table 2.1). Hedonic responses were recorded for each sample
on a nine point hedonic rating anchored by the responses 'dislike
extremely' and 'like extremely'. This methodology is extensively
described in Chapter 2.
Results
Between group analysis
The demographic and clinical data of cirrhotic patients and control
subjects are fully described in Chapter 3.
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Macronutrient preference between cirrhotic patients and control
subjects
The control group exhibited a greater preference for the high fat,
moderate carbohydrate (HF mod CHO) test stimuli (controls: median =
7.0, IQR = 1.0) than either of the two patient groups (controls versus BC:
median = 5.0, IQR = 4.7, p<0.05) (controls versus HC: median = 6.0, IQR =
4.0, p<0.05) (Figure 9.1). No differences in macronutrient preference
between the BC and the HC group were apparent.
Within group analysis
Macronutrient preference within cirrhotic patients and control subjects
Macronutrient preference was also examined within each group
studied. The control group showed no significant preference for any
macronutrient combination.
Patients were stratified using Child's Pugh score and no
macronutrient preference was apparent within Child's Pugh A, B or C
groups. Furthermore, no specific preference was seen when cirrhotic
patients were classified by gender.
When patients were stratified by primary aetiology, the BC group
demonstrated a greater significant preference for the high fat, high
carbohydrate (HF/HCHO) test stimuli (median = 7.0, IQR = 3.0) than the
low fat, high carbohydrate (LF/LCHO) test stimuli (median = 5.0, IQR =
4.0, p<0.05). Biliary cirrhotic patients also preferred the HF/ HCHO test
stimuli (median = 7.0, IQR = 3.0) to the HF/mod CHO (median = 5.0, IQR























FIGURE 9.1 PREFERENCE FOR HIGH FAT










= p<0.05 versus biliary cirrhosis
= p<0.05 versus hepatocellular cirrhosis
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On the other hand, HC patients demonstrated a preference for low
fat, moderate CHO (LF/mod CHO) (median = 7.0, IQR = 2.0) test stimuli
when compared with HF/mod CHO (median = 6.0, IQR = 4.0, p<0.01).
This preference for LF/mod CHO was apparent when compared with the
LF/HCHO (median = 6.0, IQR = 3.0, p<0.05) test stimuli. In addition, the
HC group preferred HF/HCHO (median = 7.0, IQR = 2.0) to HF/mod
CHO (p<0.05) (Figure 9.2) test stimuli.
In order to examine the association between fuel oxidation and
macronutrient preference the relationship between oxidation rates and
hedonic ratings was examined. In the control group a significant
association was observed between the LF/mod CHO product and post
absorptive rates of glucose oxidation (r=0.58, p<0.05). In other words the
higher the rate of glucose oxidation the greater the preference for the
food product with the lowest energy content (LF/mod CHO) (Figure 9.3).
In the BC group a significant relationship was observed between
the rate of lipid oxidation and preference for the LF/HCHO food (r=0.36,
p<0.05). Therefore as the rate of lipid oxidation increases the preference
for HF/HCHO increases (Figure 9.3).
In HC patients no relationship between lipid or CHO oxidation
rates and macronutrient preference were observed. In addition, no
relationship between substrate oxidation rates and dietary intake was
seen in any study group. Similarly, no association between dietary intake
and macronutrient preference was observed in control subjects or any
patient group.
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FIGURE 9.2 MACRONUTRIENT PREFERENCE IN
CIRRHOTIC PATIENTS










































= p<0.05; preferred to low fat, high carbohydrate
**=p<0.01; preferred to high fat, moderate carbohydrate



































= p<0.05; preferred to low fat, high carbohydrate
**=p<0.01; preferred to high fat, moderate carbohydrate
§ = p<0.05; preferred to high fat, moderate carbohydrate
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FIGURE 9.3 ASSOCIATION BETWEEN SUBSTRATE
OXIDATION AND TEST STIMULI
Association between glucose oxidation and
LF mod CHO test stimuli in controls
glucose oxidation (mg/kg BCM)
Association between lipid oxidation and LF HCHO




Characteristics of OLT patients are shown in Table 3.6.
Macronutrient preference between OLT patients and control subjects
Compared with control subjects the hedonic ratings assigned to
each of the four test stimuli were not significantly different from those
given by OLT patients at 3, 6 and 9 months after transplantation (Table
9.1). Additionally, no difference in preference was seen when
comparisons were made between patients transplanted for BC or HC
cirrhosis (Table 9.1).
Within group analysis
Macronutrient preference within OLT patient groups and control
subjects
No alteration in preference was observed when test stimuli were
examined individually or as a composite group (four test stimuli) at 3, 6
and 9 months OLT (Figures 9.4 and 9.5). In patients transplanted either
for BC or HC disease, no difference in preference for individual test
stimuli were apparent at any OLT time point. For example, comparison of
the hedonic rating for HF/HCHO at 3 months compared with HF/HCHO
at 9 months. However, when preference was considered within the
group of four test stimuli by nine months OLT those patients transplanted
for cholestatic disease exhibited a greater degree of "liking" for the
HF/HCHO test stimuli when compared with the LF LCHO test stimuli
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TABLE 9.1 HEDONIC RATINGS FOR TEST STIMULI IN CONTROL
SUBJECTS AND PATIENTS FOLLOWING LIVER
TRANSPLANTATION
Low Fat Low Fat High Fat High Fat
Low CHO Mod CHO Mod. CHO High CHO
Controls 6.5 6.0 7.0 7.0
(n = 18) (1.0) (2.0) (1.0) (2.0)
3 months OLT 6.0 5.0 6.0 6.0
(n = 23) (4.0) (4.0) (4.0) (3.0)
6 months OLT 7.0 6.0 6.0 7.0
(n = 23) (2.0) (2.0) (4-0) (2.0)
9 months OLT 6.0 7.0 6.0 7.0
(n = 23) (3.0) (1.5) (3.0) (2.2)
3 months OLT BC 7.0 5.0 6.0 6.0
(n = 23) (4.7) (4.5) (4.0) (2.7)
6 months OLT BC 7.0 7.0 4.5 7.5
(n = 13) (2.0) (4.0) (4.0) (4.0)
9 months OLT BC 5.5 6.5 4.0 7.5
(n = 13) (4.0) (2.0) (3.0) (1.5)
3 months OLT HC 5.5 5.5 6.0 6.5
(n = 10) (2.0) (2.0) (3.0) (3.0)
6 months OLT HC 6.5 6.0 6.0 7.0
(n = 10) (2.0) (1-0) (1.0) (2.0)
9 months OLT HC 7.0 7.0 7.0 7.0
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(HF/HCHO: 7.5 (IQR = 1.5) versus LF/LCHO: 5.5 (4.0), p<0.05) or the
HF/HCHO test stimuli (HF/HCHO = 7.5 (IQR = 1.5) versus
HF/modCHO; 4.0 (IQR = 3.0), p<0.05) (Figure 9.6). No specific
preferences were seen in patients transplanted for HC disease (Figure 9.7)
although there was a general increase in preference ratings (Figure 9.8).
Following OLT no relationship between substrate oxidation rates
and macronutrient preference was seen, nor was there any association
between preference and dietary intake.
Discussion
Cirrhotic patients
Normally the dietary components, carbohydrate and fat, account
for approximately 80% of the energy intake in the United Kingdom
population (Department of Health, 1991). Although neither sugar nor fat
are consumed individually, it is combinations of these macronutrients that
are eaten in foods and at meals. For example, butter is normally
consumed along with foods such as bread and jam. The current study
adapted methodology traditionally used in food product development or
in the study of food preferences, where fat-sugar mixtures based on dairy
products (i.e. milk shakes, ice creams), are rated on a nine point hedonic
scale.
It has been suggested that animals can learn to associate the
sensory properties (palatability) of foods that are metabolically satisfying
(Elizalde and Sclafani, 1988). Several studies have shown that changes in
physiological state lead to alterations in fat preference and these have
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shown that with nutrient deprivation and weight loss, there is an
increased preference for fat (Reed et al, 1988; Temple et al, 1989;
Drewnowski et al, 1992). These studies were performed among healthy
individuals and whilst evidence from both animal and human studies
confirms that food preference is metabolically driven (Sclafani et al, 1990;
Tordoff et al, 1990; Lucas and Sclafani, 1996), consideration of food
preference using fat and carbohydrate mixtures has not yet been
elucidated in patients with liver disease.
In chronic liver disease, aberrant metabolism may result in altered
signaling by afferent pathways to the brain stem, but it is unclear whether
this affects the metabolic control of eating including food preferences. In
the present study, between group analysis revealed that fasted control
subjects exhibited a preference for the HF/modCHO test stimuli when
compared with cirrhotic patients but this may simply reflect the highly
palatable properties of fat to this healthy population (Mela, 1995).
When macronutrient preference was considered within patient
groups, the BC group showed a preference for the HF/HCHC test
stimuli. This finding that patients with cholestatic disease exhibited a
preference for the high fat food was surprising, as the dietary intake of fat
is often prescriptively reduced. However, it may speculated that the
insidious malabsorption of fat in BC could lead to the development of an
appetite for high fat foods. The results of the present study are in contrast
to those of Deems and Friedman (1988) who reported a reduction in fat
intake in bile ligated rats when compared with a control group of animals.
However, it should be emphasised that whilst ligation of the common bile
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duct will induce cholestasis it does not mimic the slow progressive
cholestatic picture found in BC patients.
In the present study, the preference for the HF/HCHO test stimuli
evident in BC patients may reflect a drive to consume sufficient energy to
maintain endogenous energy reserves (Mela and Rogers, 1998).
However, the energy intake of BC patients was significantly lower than
control subjects and suggests that in liver disease sensory food preference
is not reflected in quantitative intake.
The macronutrient preference was somewhat different in HC
patients. A significant preference for the LF/mod CHO test stimuli was
observed and only a marginal preference for the HF/HCHO test stimuli
when compared with the HF/mod CHO product. The latter finding could
be due to the palatability attributes of the HF/HCHO test stimuli which
act by masking the CHO content of the food (Drewnowski and
Greenwood, 1983) and may not directly be associated with quantitative
intake. This is supported by the finding that dietary analysis showed that
the CHO and fat intake of the HC group was significantly lower than
controls and implies that these patients may consume energy dense foods
but only in small quantities. This finding may reflect a physiological
inability by HC patients to normally metabolise these energy providing
macronutrients and calls into question the effectiveness of the high energy
dietary regimen traditionally prescribed for patients with cirrhosis.
The relationship between substrate oxidation and macronutrient
selection has been an area of considerable interest in obesity research
(Astrup et al, 1996). The present study revealed that an association
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between fasting glucose oxidation rate and preference for the LF/LCHO
test stimuli in control subjects. This suggests that as the availability of
glucose increases this preference for the low energy food product
increases but his is not reflected in the dietary intake of these unrestrained
eaters. In addition a significant relationship was found between the rate
of fat oxidation and preference for LF/HCHO food in BC patients.
The significant relationship between rates of oxidative metabolism
and food preference observed in the current study is impressive. After all,
substrate oxidation is dictated by the body's requirement to regenerate
ATP (Astrup et al, 1996) and it seems likely that in the present study,
fasted control subjects would continue to rely on hepatic glycogen
reserves as an important and efficient ATP provider. This continued
availability of glucose may account for the association between CHO
oxidation and the preference for the LF/mod CHO test stimuli.
It is not surprising that no relationship between fasting substrate
oxidation and dietary intake was seen as the relationship between these
variables is only observed when oxidation rates are determined over a 24
hour period (Thomas et al, 1992). Clearly further studies are required to
examine the relationship between substrate utilisation and intake in this
group with chronic disease. However, acceptability of the required
methodology may prove an obstacle to patient recruitment.
It is well documented that a period of overnight fasting in cirrhotic
patients reflects a more prolonged period of fasting (72 hours) (Owen et
al, 1982). It should be noted that to date the majority of metabolic studies
have been performed on patients with HC disease but work from the
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current investigation suggests the response to feeding may be different in
patients with BC or HC disease (Richardson et al, 1999). The significant
association with lipid oxidation and LF HCHO seen in BC patients may be
suggestive of a metabolic drive to minimise lipolysis/gluconeogenesis and
thereby preserve fat stores.
In HC patients no association between oxidative metabolism and
preference was seen and this may be a consequence of a more disturbed
metabolic picture, where for example severe glycogen depletion,
enhanced lipolyisis and gluconeogensis may be present. This melee of
biological processes which may accompany cirrhosis may serve to distort
the relationship between oxidative metabolism and qualitative and
quantitative components of ingestive behaviour. The findings of this
study suggest that metabolically driven changes in ingestive behaviour
are acting to stimulate consumption of a nutritionally inadequate diet.
Macronutrient preference following OLT
Research in the area of macronutrient preference has focused on fat
preference and its relationship with obesity (Pangborn et al, 1985;
Drewnowski et al, 1987). However, little is known about the central
processing of afferent information generated by food that will dictate
macronutrient preference. This thesis has underlined the importance of
the liver as a metabolic sensor and given that hepatic fuel oxidation can
provide unconditioned learning for macronutrient consumption (Tordoff
et al, 1990), it would seem feasible that denervation resulting from
transplantation may effect changes in food preference and alter central
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processing. Following OLT, there is an increase in body mass (Chapter 3)
and it may be that alterations in the profile of the macronutrients ingested
could contribute to increases in body weight that exceed pre-illness values.
OLT patients versus controls
No differences between control subjects and OLT patients was
observed following OLT. This "normalisation" of macronutrient
preference was also quantitatively reflected by an increase in OLT patients
total energy intake (Chapter 8). In addition, the preferences for HF and
LF/modCFIO test stimuli exhibited by BC and HC cirrhotic patients
respectively were no longer evident three months after transplantation
and suggest that pathology specific food preferences have been lost. This
is further supported by the fact that differences in dietary intake found in
BC and HC patients also disappeared after transplantation (Chapter 8).
Macronutrient preference within OLT groups
Hedonic ratings for individual test stimuli were compared at 3,6
and nine months OLT. In addition, hedonic ratings assigned within the
group of four test stimuli presented at each OLT study time point were
compared. No macronutrient preference for individual test stimuli or the
composite group of four ice creams were evident after OLT. This again
suggests that following transplantation, there is a normalisation of
macronutrient preference.
Interestingly, when patients were classified by primary pathology,
those patients transplanted for cholestatic disease demonstrated a
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significant preference for the high fat test stimuli 9 months after
transplantation. No significant change in preference was observed within
the HC group.
It is difficult to explain the preference for the HF/HCHO test
stimuli found within the BC group but not in HC patients. Although, it
should be emphasised that the hedonic rating assigned to HF/ HCHO test
stimuli by HC patients at nine months OLT was similar to BC patients at
nine months. It may be that the discrimination for HF/HCHO within BC
patients nine months after OLT is a reflection of the gender bias in this
now healthy group. In the BC post-OLT group, there was a
predominance of females (1 male : 12 females) and in the HC post-OLT
group, there was a predominance of males (9 males : 1 female).
However, when macronutrient preference was examined between male
and female controls no differences were seen but this could be related the
small numbers when patients were sub divided by gender (9 males : 9
females).
Drewnowski and colleagues (1992) in their study on food
preferences, revealed specific gender differences and showed that men
had a preference for savory sources of fat and CHO, i.e. meat, sausages,
hamburgers, margarine/butter whereas women preferred fat/CHO
mixtures of ice cream, cakes and cookies. This phenomenon could
account for the nine month OLT BC patients greater degree of liking for
the HF/HCHO stimuli where their preference for ice cream and the
mixture of fat and CHO may be exaggerated in this predominantly female
group. However, these differences were not reflected in dietary intake
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(Chapter 8) so whilst women prefer "sweeter" fat/CHO mixtures, there
appears to be no differential effect on the profile of total energy intake
derived from dietary fat.
It is important, however, to emphasise that no differences in
preference were seen between BC and HC OLT groups. Indeed there was
a general increase in the hedonic ratings assigned to the test stimuli nine
months after OLT. This increase in "liking" particularly for the test stimuli
high in energy could, if translated into dietary consumption may impact
on total energy intake. Interestingly, the preceding chapter has focused
on dietary intake and has highlighted the fact that following OLT, there is
not only a significant increase in total energy consumption but more
importantly the increase in the energy derived from dietary fat which was
not only significantly greater than pre-OLT values, but was 5% greater
than those found in control subjects.
At present no longitudinal studies in patients in a dynamic
nutritional state has systematically tracked individual ratings for
macronutrient preference to examine the relationship between
preference, dietary intake and body composition. In that respect the
current study is unique and shows that the deficit of fat mediated satiety
signaling following OLT and the trend to increase hedonic ratings for fat
and sugar mixtures may influence dietary consumption. This study has
important practical implications where following OLT these patients are
routinely given advice on "healthy eating" yet despite the availability of
this information, the majority of patients continue to eat a diet rich in fat.
It has previously been alluded to that preference for nutritive fat is
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enhanced in the presence of food deprivation (Kern et al, 1993). It may be
that the lack of fat satiety signaling has deceived central effector
mechanisms into believing that the body is in a state of semi-starvation.
Clearly further feeding studies that not only consider preference but also
the duration of an eating episode will be important to validate this
hypothesis.
Despite the complexities of understanding ingestive behaviour, the
present study has provided important information that has a practical
application. If the reason for high fat consumption is metabolically driven,
it seems unlikely that in the short term dietary advice could effect
quantitative changes in fat intake. However, given this group's high risk
of developing atherosclerosis (Stegall et al, 1995) it may be worthwhile
implementing a formal programme of dietary management for these
patients. The fat in the diet may be modified to reduce the intake of
saturated fats and increase that of mono-unsaturated fats. Clearly the
investigation of macronutrient preference gains significance in patients




THE INFLUENCE OF DRUG REGIMENS ON BODY MASS
FOLLOWING LIVER TRANSPLANTATION
Liver transplantation may be a life saving surgical procedure in the
management of liver disease but the prolonged survival of patients is
dependent upon appropriate immunosuppressive medication. Drugs that
prevent rejection of solid organ transplants include prednisolone
(Prednisol, Glaxo Laboratories, Middlesex, UK), azathioprine (Imuran
Generics Ltd., Hertfordshire, UK), cyclosporin A (Sandimmun, Sandoz
Pharmaceuticals, Basel, Switzerland) and tacrolimus (Prograf, Fujisawa
Ltd., London). These drugs may be administered as monotherapy or in
combination and are associated with metabolic complications such as
diabetes, hypertension, hypercholesterolaemia and obesity (Stegall et al,
1995). The influence of immunosuppressive drugs on metabolic
complications has been considered in renal (Roth et al, 1989; Esmatjes et
al, 1991; Johnston et al, 1993; Tabasco-Minguillan et al, 1993) and liver
transplantation (Munoz et al, 1991; Palmer et al, 1991; Stegall et al, 1995).
It would seem logical that administration of comparable
immunosuppressive regimens to solid organ transplant recipients would
result in a similar prevalence of metabolic complications. However, given
that the dose of immunosuppressive therapy administered to liver
transplant recipients is substantially less than for renal transplants (Steiger
et al, 1995), direct comparisons cannot and have not been made. In
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addition the early withdrawal of steroids in OLT has been shown to be a
safe treatment modality (Padbury et al, 1993) whereas steroid therapy for
renal transplanted patients in most centres continues beyond one year
following transplantation. The risk of metabolic complications in OLT
may be attenuated by the administration of newer immunosuppressive
agents such as tacrolimus (Mor et al, 1995).
Following OLT, the development of obesity may exacerbate any
other pre-existing metabolic complications. Furthermore, for the
transplant recipient the most visible and often most distressing
complication is undesirable weight gain. The fact that the liver transplant
recipient has lost all hepatic innervation has ostensibly been ignored and
as a result the normal integration of metabolism in higher centres will be
lost. This study examined the contribution of OLT immunosuppressive
medication, REE and dietary intake on OLT weight change and specific
markers of fat mass.
Patients and Methods
Patients
Twenty-three cirrhotic patients were submitted to OLT and had an
uncomplicated postoperative recovery. These patients were reviewed on
a three monthly basis on three occasions after discharge from hospital.
Eighteen healthy volunteers were recruited as controls.
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Methods
Energy expenditure was measured by indirect calorimetry, dietary
intake by diet diaries and body composition was assessed using
anthropometry and MFBIA. Cumulative immunosuppressive regimens
of prednisolone (Prednisol, Glaxo, Middlesex, UK), azathioprine (Imuran,
Generics Ltd., Hertfordshire, UK), cyclosporin (Sandimmun, Sandoz
Pharmaceuticals, Basel, Switzerland) and tacrolimus (Prograf, Fujisawa
Ltd., London) were confirmed from drug prescription charts. Patients
with acute cellular rejection were prescribed intravenous hydrocortisone
(500 - 1000 mg/day) for three days during their first admission to hospital.
Methods are fully described in Chapter 2.
Results
Patient characteristics are shown in Table 3.7.
Body composition before and following OLT are shown in Table
10.1. Compared with pre-OLT values, there was a significant increase in
body habitus measurements at six and nine months after transplantation.
A significant increase in lean body mass and a highly significant increase in
fat mass and triceps skinfold thickness was seen three to six months after
OLT. There was a significant increase in fat mass and triceps skinfold
thickness from six to nine months OLT.
Daily immunosuppressive regimens are shown in Table 10.2. No
relationship between change in body weight at nine months OLT and
corresponding cumulative doses of prednisolone (r = 0.03, NS),
azathioprine (r = 0.31, NS), cyclosporin (r = 0.17, NS) and tacrolimus
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OLT->Discharge (averagestay20.7±1.3) 3monthspost-OLT 6monthspost-OLT 9monthspost-OLT
23
63.9±15 3 11.7±0 97 5.4+1 7 0.89±37
21
121±31.9 119±6.9 106±7.4 104±7.9
12
275±0.9 265±15.0 280±16.9 286±1.
11
5.4±0.45 5.6±0.41 5.3±0.36 5.6±0.42
Mean(±SEM)
(r = 0.11, NS) were apparent. No relationship between triple dose
immunosuppressive therapy and weight gain following OLT was seen in
the 12 patients receiving prednisolone, azathioprine and cyclosporin (r =
0.28, NS) or the 11 prescribed prednisolone, azathioprine and tacrolimus (r
= 0.42, NS). In addition, there was no association between weight gain
and the 11 patients treated with steroids for acute cellular rejection
(rejection r = 0.093, NS; no rejection r = 0.27, NS). Other factors
determined in the present study that may impact on post-OLT weight
gain include dietary intake and energy expenditure.
Total energy and fat intake was significantly greater than pre-
transplant values. Energy at six months OLT and fat intake at six and nine
months OLT was significantly greater than controls.
A significant inverse relationship between fat mass and REE body
weight was observed nine months after transplantation (Figure 10.1).
Multiple stepwise regression analysis revealed that nine months following
liver transplantation, the strongest predictor of increased fat mass was
REE (Table 10.3).
Discussion
Excessive weight gain after kidney transplantation has also been
reported (Johnston et al, 1993). Substantive evidence now supports the
early withdrawal of steroid therapy following OLT and this has influenced
pharmacological practice in the 90's (Padbury et al, 1993; McDiarmid et al,
1995; Gomez et al, 1998). In the SLTU, steroid therapy is normally
tapered down and withdrawn three to four months following
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FIGURE 10.1
ASSOCIATION BETWEEN REE AND FAT MASS 9
MONTHS FOLLOWING LIVER TRANSPLANTATION
■
r=-0.49, p<0.05
30 40 50 60 70
REE/Kg body weight
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transplantation. The success rate of early steroid withdrawal in
transplantation appears to be more successful in OLT patients compared
to other solid organ transplants (heart, lung, kidney) and may be related
to the fact that the liver is an immunologically privileged organ
(McDiarmid et al, 1995).
Longterm steroid administration produces changes in body mass
reflected by an increase in truncal fat deposits, normal peripheral fat
content, and a reduction in skeletal muscle mass (Hobber et al, 1986).
Although cyclosporin and tacrolimus have been implicated in disturbances
in glucose and lipid metabolism (Starzl et al, 1990; Munoz et al, 1991;
Stegall et al, 1995), there is no direct evidence to implicate these drugs and
the steroid sparing immunosuppressant azathioprine in post-OLT weight
gain. An important study by Steiger et al (1995) examined the effect of
longterm steroid therapy on body composition up to 16 months after
kidney transplantation. This group found no difference in fat mass in
females and in males an increase of 0.3 kg fat mass per month was seen.
This compares with an increase in body weight of 0.8 kg fat mass per
month found in the present study and this increase was seen in both male
and female patients (see Chapter 4).
In the present study, no association between the cumulative
immunosuppressive medication and body weight was seen when drugs
were considered individually or in combination. The lack of association
between immunosuppression and weight gain does suggest that the
effects of hepatic isolation in terms of autonomic regulatory control may
be involved. It is conceivable that the cephalic, post-ingestive, post-
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absorptive, humoral and neural responses relayed through hepatic
afferents will be lost and may influence feeding behaviour.
The proportion of energy derived from fat in both pre-OLT
patients and controls was 35% whereas by six and nine months OLT, this
was increased to 40% representing a qualitative shift in dietary profile.
The observed reduction in energy expenditure and increase in
energy intake following OLT will result in a positive energy balance and
contribute to weight gain. Nine months after OLT, patients' weight
exceeded pre-illness values by 7.5 kg or 8% and is surprising given that
longterm energy homeostasis is tightly controlled (Harris, 1990). In the
present study, the prevalence of overweight and obesity nine months
following OLT was found to be about twice that reported in the United
Kingdom population (HMSO, 1992).
Multiple regression analysis revealed that the strongest predictor of
OLT weight gain is REE. The progressive reduction in REE is difficult to
reconcile since these patients could not be classified as hypermetabolic
befoie transplantation. In addition, the presence of healthy rather than
diseased hepatocyte should increase REE and the normal response to
weight gain is an increase in REE (Leibel et al, 1994). Although activity
levels were not objectively assessed in this study, all but one patient
returned to normal pre-illness activity levels suggesting there should be
an increase in OLT energy expenditure.
Weight gain following liver transplantation cannot be explained on
the basis of drug therapy. A recent quality of life study reported that
weight gain and increased appetite were causes of distress in OLT patients
245
(Belle et al, 1997). Unfortunately, for these patients a further restriction on
intake may act to exacerbate the apparent energy economy. For these
patients, prescribing an energy reduction diet may stimulate feelings of
hunger and the drive to eat. As a result, excessive weight gain may be an
unavoidable consequence of liver transplantation for the majority of these
patients. This represents a challenge for the management of these
patients which should include sympathetic dietetic advice combined with
an exercise programme. Additionally, for those individuals more





Despite considerable interest in the mechanisms involved in
undernutrition in chronic liver disease and its impact on outcome, little
attention has been paid to the causes of anorexia which will detrimentally
affect nutritional status. Therefore, understanding factors that contribute
to the reduced spontaneous dietary intake found in cirrhotic patients will
prove central in the identification of nutritional regimens acceptable to the
patient and at the same time are nutritionally adequate.
The current series of investigations in cirrhotic patients has shown
that traditional dietary treatment modalities and prescriptive dietary
recommendations for cirrhotic patients are inappropriate, unachievable
and as a consequence, unlikely to be clinically effective. It should be noted
that all patients studied were in a clinically stable condition and not
recovering from an acute on chronic complication of their liver disease.
This permitted examination of the effect of cirrhosis per se on host
metabolism, nutritional intake, macronutrient preference and was not
compounded by the physiological responses elicited by a complication
such as a variceal bleed or hepatic encephalopathy. These complications
may make prescriptive dietary recommendations even more
unachievable.
Stratification of cirrhotic patients by primary aetiology has
highlighted differences in nutritional status, post-absorptive substrate
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oxidation rates, metabolic response to feeding, dietary intake and
macronutrient preference. This was not apparent when patients were
sub-divided using Child's Pugh classification but is perhaps unsurprising
given the dynamic and arbitrary nature of this determinant of disease
severity.
Hepatocellular patients' endogenous energy reserves were
significantly depleted when compared with either controls or BC patients.
The HC patients' post-absorptive lipid oxidation rates were also elevated
and reflects an increased reliance on the provision of energy from fat to
maintain energy homeostasis. However, on feeding HC patients avidly
switched to glucose oxidation. It may be speculated that this is an
adaptive response where the reduction in glycogen storage capacity
means that glucose must be immediately oxidised to avoid both
hyperglycaemia and cellular hypertonicity.
In both the fasted and fed state, plasma insulin concentrations were
elevated only in HC patients when compared with controls or BC
patients. Insulin secretion is potentiated by CCK, glucagon-like-peptide
and gastric inhibitory peptide and are hormones involved in the satiety
cascade. Normally in response to feeding these satiety peptides elicit their
effects either directly or indirectly through hepatic afferent fibres and
bring about cessation of an eating episode. In the present study, the
elevated insulin concentrations seen only in HC patients may contribute
to early satiety thereby reducing energy intake and impacting on
nutritional status. Although not determined in the current study, CCK
which is cleared by hepatocytes may be chronically elevated. This
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humoral mediator of satiety may act to reduce dietary intake and future
metabolic studies should involve measurement of peptides involved in
ingestive behaviour.
Energy intakes were found to be lower in BC and HC patient
groups when compared with healthy controls. Perhaps more
importantly, despite receiving professional advice on consumption of a
nutritional intake that meets European guidelines, cirrhotic patients were
unable to meet prescribed targets. This energy deficit was most
pronounced in HC patients in whom intakes of the energy providing
nutrients (CHO and fat) were significantly lower than control subjects.
The findings on dietary intake taken in conjunction with insulin responses
suggest that the metabolic profile of the cirrhotic patient and in particular
in HC disease would negate consumption of a nutritionally adequate diet.
This reduced intake may, in part, account for the lower endogenous
energy reserves observed in patients with HC disease. In light of these
findings, novel strategies that aim to improve the spontaneous nutritional
intake of these patients is required and in particular for patients with HC
disease who appear to be most at nutritional risk.
It could be assumed that the macronutrient preference studies may
go some way toward identifying a nutritional profile that would be
acceptable to HC patients. Overall HC patients preferred the low energy
food product and this was mirrored in their dietary intake, although HC
patients also exhibited a marginal preference for the high fat, high
carbohydrate test stimuli. The preference for the low energy product
may be a result of the inability of the HC patients to handle and store
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glucose. No association between macronutrient preference and substrate
oxidation was observed in HC patients who had the most pronounced
metabolic disturbances.
Whilst BC patients exhibited a preference for the high fat food
product this could be attributed to the development of a fat appetite in a
population where insidious malabsorption is a feature of cholestatic
cirrhosis. However in BC patients the preference for the high fat product
was not directly reflected in intake but it should be emphasised that
dietary fat is a nutrient traditionally restricted in cholestatic liver disease.
The relationship between lipid oxidation rates and low fat high
carbohydrate preference seen in BC patients suggests this may be a
metabolic drive to preserve endogenous lipid reserves. In other words as
reliance on endogenous lipid increases to meet energy demands, there is a
concomitant increase in the preference for low fat, high carbohydrate test
stimuli.
The results of macronutrient preference studies suggest that food
prefcience may not directly reflect quantitative intake. For example,
whilst BC patients may prefer the high fat food product they may
consume only small quantities of these energy dense foods.
The objective in the nutritional management of cirrhotic patients is
to sustain a level of nutritional intake that will maintain and improve
nutritional status. The results of the present series of investigations
suggest that for patients with HC disease the traditional high CHO dietary
regimen may only serve to induce early satiety and reduce dietary intake.
It may be prudent to improve rather than restrict the fat content of the
250
diet prescribed to cirrhotic patients and this may be an appropriate way
forward in improving dietary intake. However, before universally
advocating significant increases in fat, further studies in ingestive
behaviour in cirrhotic patients are required. Studies that use pre-loads
predominantly containing fat or CHO could be considered and
measurement of their effect on subsequent ad libitum intake should be
measured. Determination of the humoral response to feeding and
assessment of appetite and satiety parameters over the time course of the
study would also be required. This study of ingestive behaviour may
permit identification of the optimal nutritional strategies for cirrhotic
patients.
The investigations performed in cirrhotic patients do not
unequivocally demonstrate that altered metabolism including aberrant
hepatic signalling is responsible for the depressed nutritional intake and
status but does strongly suggest that they are contributory. As
electrophysiological recordings from the human hepatic afferents are not
possible it is difficult to determine the contribution made by hepatic neural
input to ingestive behaviour. This also applies to the level of afferent
nerve activation caused by pro-inflammatory cytokines.
In summary examination of integrative ingestive behaviour and
the complementary biological processes that normally act to maintain
energy homeostasis will provide the key to developing clinically effective
nutritional regimens for cirrhotic patients. The investigations presented in
this thesis have for the first time adopted an integrative approach
examining the relationship between energy and substrate metabolism and
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ingestive behaviour in cirrhotic patients where primary aetiology appears
to exert a differential effect. These findings will have a significant bearing
on the future nutritional management of these patients.
Conversely, those patients submitted to OLT and who
subsequently have an uncomplicated postoperative course undergo a
period of prolonged weight gain. Although this finding is not novel
previous investigators have not examined the constituents of post-OLT
weight gain or the physiological process that may be involved.
A particular strength of the present study's methodology is that it
permitted sequential examination of the effects of OLT on energy and
substrate metabolism, nutritional status, spontaneous dietary intake and
macronutrient preference as the impact of inter-subject variability is
limited (i.e. energy/substrate response, environmental factors in dietary
intake).
At surgery, the cirrhotic liver is removed and major blood vessels
anastomosed to the donor liver which, however, remains denervated. In
other words the cephalic, post-ingestive, post absorptive humoral and
neural responses normally relayed through hepatic afferents will be lost
and may influence feeding behaviour. Indeed nine months after OLT
recipients were shown to have exceeded their reported pre-illness weight
by an average of 7.5%, an observation which is not indicative of a simple
return to "set-point" body weight. This increase in body mass was
reflected not only by an increase in lean tissue but by an appreciably
greater accumulation of fat mass.
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The prevalence of overweight and obesity in OLT patients was
found to be almost twice that found in the United Kingdom population
(Department of Health, 1992). The finding that (nine months after OLT)
87% of patients were overweight/obese is of considerable concern given
the fragile nature of many of these patients' cardiovascular and bone
mineral status. The potential increased risk of OLT morbidity and
mortality underlines the significance of identifying mechanisms involved
in OLT weight gain.
After transplantation oxidative metabolism, insulin and glucose
responses were effectively normalised although a progressive decrease in
REE was seen at each OLT study time point. Prior to OLT, patients
exhibited no acute phase response and were not hypermetabolic so it is
unlikely that this energy economy can be explained by a return to
"normal" REE. Furthermore this decrease in energy expenditure was not
short lived and continued 9 months after OLT when there would be no
residual effects of the surgery. In addition, the majority of OLT recipients
returned to a 'normal' level of activity and as a consequence their energy
expenditure would increase rather than decrease. In response to feeding,
energy expenditure was also significantly lower at the nine month OLT
study time point when compared to cirrhotic patients and marginally
significantly lower than control subjects.
The progressive energy economy seen in OLT patients may be a
consequence of the absence of the integrative control of energy
homeostasis. In OLT patients, not only is there a lack of hepatic afferent
signalling but also of efferent output and the latter is important in up-
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regulating energy metabolism. Following OLT, the metabolic information
received by the brain stem would indicate that the host is undergoing a
period of nutrient deprivation and initiate a response that decreases
energy expenditure in order to preserve body mass. Whilst the exact
mechanisms involved in the down-regulation of energy metabolism
cannot clearly be defined from the present series of investigations, further
studies that consider the role of tri-iodothyronine, leptin and uncoupling
proteins in energy metabolism following OLT would confirm or refute the
presence of energy economy.
Following transplantation, patients' dietary intake significantly
increased but was not surprising given the general improvement in
patients' health. However, what was alarming was this was not merely a
quantitative effect as there was qualitative shift in the intake of fat derived
energy. Nine months after OLT, patients were consuming 5% more
energy from fat than control subjects. This occurred despite three-
quarters of OLT patients being prescribed low energy (low fat) diets in
order to instigate weight loss but patients appeared able to reduce their
intake of CHO but not fat.
Following OLT, this increase in total energy and more precisely fat
intake may be driven by the loss of hepatic innervation and also the
duodenal branch of the vagus which courses with the hepatic vagus. The
loss of lipid signalling (CCK, enterostatin and hepatic fuel oxidation) could
result in hyperphagia and development of a fat appetite. This is
supported by the "distressing" increase in appetite reported in large
retrospective studies in OLT patients (at least one year after
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transplantation) but not in other groups submitted to solid organ
transplantation.
Many clinicians consider weight gain after OLT to be a side effect of
immunosuppression and whilst they may contribute to early OLT weight
gain, the current studies suggest their effect may have been overstated.
Indeed multiple regression analysis revealed that the strongest predictor
of OLT weight gain (fat mass, TSF and BMI) is REE followed by dietary fat
intake whereas cumulative drug dose was not predictive. These
observations underline the influence of the liver in metabolic regulation.
Improvements in donor organ preservation, surgical techniques
and immunosuppressive therapy means that the majority of OLT patients
look forward to a normal life expectancy. This will be impeded if
complications such as hypertension, diabetes, atherosclerosis and
osteoporosis develop and will of course be further compounded if
recipients are overweight or obese.
There is no doubt patients find this prolonged period of weight
gain distressing and become alarmed by a rapid change in their
appearance. For example, one subject who had not lost weight prior to
OLT (major criteria for transplantation was lethargy), found that by 9
months after hospital discharge her weight had increased by 20 kg and
was clearly distressed by the fact that despite reducing her food intake she
could not lose weight. Another patient who significantly exceeded their
preillness weight (20%) was disturbed when he felt the doctor did not
believe he was following the prescribed weight reduction diet. These
reports, whilst anecdotal, illustrate the level of anxiety this apparent
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inability to lose weight causes OLT patients and is supported by
accumulating evidence from quality of life studies that show that weight
gain and increased appetite is a negative outcome of OLT. It may be that
reducing the dietary intakes of these patients would bring about a further
reduction in REE adding to the difficulties these OLT patients face in trying
to lose weight. The present study estimates weight gain from OLT energy
economy and increased dietary intake accounts for 0.5 kg/month and 1.2
kg/month respectively. Whilst this exceeds the observed weight gain of
0.8 kg/month, no account is made for the energy expenditure due to
activity or the non-uniformity of post-transplant weight gain.
This unique study has shown that the effect of drugs on post-OLT
weight gain is not as great as first thought and once again, further
longitudinal studies on OLT patients are required. These investigations
should consider patients responses (metabolic and appetite parameters) to
pure macronutrient preloads (protein, fat and carbohydrate) followed by
determination of ad libitum intake. Additionally, genetic characteristics of
the donor organ to predispose the recipient to obesity has, as yet, not
been considered. The use of animal models to pharmacologically
characterise receptors (e.g. ATP) on sensory liver afferents will begin to
unravel the mechanisms involved in OLT weight gain.
Undertaking the aforementoned studies gain some urgency given
the high cardiovascular risk of OLT patients which could be exacerbated in
these patients with accelerated weight gain.
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Influence of the metabolic sequelae of liver cirrhosis on nutritional
intake1-3
Rosemary A Richardson, H Isobel Davidson, Alison Hinds, Steven Cowan, Peter Rae, and 0 James Garden
ABSTRACT
Background: The liver plays a central role in ingestive behav¬
ior; alterations in metabolic signaling to the brain stem as a
result of chronic liver disease could influence intake.
Objective: We examined the influence of metabolic sequelae of
liver disease on nutrient intake and nutritional status.
Design: Nutritional status and spontaneous dietary intake were
examined in 65 cirrhotic patients and 14 control subjects. The
response to feeding was investigated in 14 control subjects and a
subgroup of 31 cirrhotic patients. Comparisons were made
between patients with primary biliary cirrhosis (PBC) and hepa¬
tocellular cirrhosis (HC).
Results: Patients were nutritionally depleted. The fasting rate of
lipid oxidation in the HC group was greater than in the control
group (P < 0.01). In the fasting state, only HC patients were
hyperinsulinemic [121.2 ± 78.5 compared with 41.3 ± 18.6
pmol/L in control subjects (P < 0.001) and 64.7 ± 15.8 pmol/L in
PBC patients (P < 0.05)] and this persisted during the response
to feeding. In the fed state, the magnitude of change in carbohy¬
drate oxidation was greatest in the HC group (HC: 34.6%; con¬
trol: 23.1%; PBC: 25.2%). Carbohydrate and energy intakes of
the HC group were lower than in control subjects (carbohydrate:
193 ± 38.3 compared with 262 + 48.1 g/d, P < 0.05; energy:
6.29 ± 1.40 compared with 9.0 + 2.12 MJ/d, P < 0.05).
Conclusions: Reductions in carbohydrate intake could be medi¬
ated by hyperinsulinemia and compounded by preferential
uptake of carbohydrate. This may enhance gastrointestinal sati¬
ety signaling and contribute to hypophagia. Am J Clin Nutr
1999;69:331-7.
KEY WORDS Liver cirrhosis, primary biliary cirrhosis,
hepatocellular cirrhosis, substrate oxidation, metabolic regula¬
tion, ingestive behavior, carbohydrate intake, humans
INTRODUCTION
The nutritional and metabolic consequences of cirrhosis have
attracted considerable interest over the past decade (1-5); given
the central role of the liver in metabolism, it is not surprising that
undernutrition is common in chronic liver disease (6-8). In
recent years, the focus of research in this area has been on the
identification of clinical or biochemical markers associated with
nutritional risk (9, 10). These studies have predominantly con¬
sidered the relation between factors such as pathology, disease
staging, energy status, body-composition status, and substrate
oxidation (11, 12); most studies were performed in subjects
admitted to the hospital for disease management.
There is emerging interest in the liver as an organ involved in
the metabolic control of eating (13-15). Normally, after the
delivery of nutrient-rich blood from the portal vein to the hepa-
tocytes, the quantity and quality of substrate oxidation activates
hepatic metabolic signaling (via the hepatic afferent nerves) to
the brain stem, which influences eating behavior (16). However,
with progressive damage, pathophysiologic changes produce
alterations in hepatic substrate oxidation, which may cause aber¬
rant metabolic signaling. This phenomenon influences the quan¬
tity and quality of nutrients ingested, which consequently affects
nutritional status.
In cholestatic cirrhosis [primary biliary cirrhosis (PBC)] or
hepatocellular cirrhosis (HC; alcoholic liver disease, hepatitis C,
or cryptogenic cirrhosis) the histologic picture is different. PBC
is characterized by inflammation of the biliary canaliculi and HC
involves primary hepatocellular damage. It was shown previ¬
ously that the metabolic profile of cirrhosis is influenced by eti¬
ology (17, 18). Given that cirrhotic patients represent a hetero¬
geneous population, both the selection and characterization of
patients is important In clinical and metabolic studies. In these
cases in which nutrient handling and substrate metabolism may
influence dietary intake, which in turn would affect nutritional
status, there are limited data on the metabolic response to feed¬
ing in homogeneous groups of cirrhotic patients.
To examine the possible mechanisms responsible for the
undernutrition reported in this patient population, we investi¬
gated the influence of liver disease on nutrient intake. We con¬
sidered nutritional status, metabolic response to a test meal, and
spontaneous nutritional intake in stable cirrhotic patients
referred for assessment of orthotopic liver transplantation and
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made comparisons between PBC and HC patients and with a
matched group of healthy control subjects.
SUBJECTS AND METHODS
Patients admitted to the Scottish Liver Transplant Unit
between October 1996 and August 1997 for consideration of
orthotopic liver transplantation were eligible for the study.
Patients with alcohol-related disease were required to be absti¬
nent for >6 mo. Patients with diabetes, significantly impaired
renal or respiratory function, thyroid dysfunction, active inflam¬
matory bowel disease, sepsis, severe ascites, or grade 3-4
encephalopathy were excluded from the study. A group of 14
healthy volunteers was also recruited. The study protocol was
reviewed and approved by the local ethical committee. All pro¬
cedures relating to the study were explained to subjects, who
were required to give their written consent.
Assessment of disease severity and nutritional status
Disease severity
Disease severity was scored by using Pugh et al's (19) modi¬
fication of Child's classification. All patients underwent ultra¬
sound scanning as part of the assessment; this confirmed the
clinical assessment of the amount of ascites.
Anthropometry
Subjects' heights were measured without shoes by using a sta-
diometer (Docherty Medical, London). Subjects were weighed in
light clothing to an accuracy of 100 g on mobile sitting scales
(Weymed Ltd, London). Body mass index was calculated and
patients were asked to recall any weight loss during the preced¬
ing year; recent weight loss (RWL) was expressed as a percent¬
age of actual body weight. Triceps skinfold thickness (TSF) and
arm muscle circumference (AMC) were measured on 3 occa¬
sions by the same trained observer (RAR) to reduce error.
Results were averaged and expressed as a percentage of standard
values to permit comparisons between men and women (20).
Multifrequency bioelectrical impedance analysis
This was performed on the day of investigation by using a Xitron
4000B analyzer (Xitron Technologies, San Diego) operated at 200
(jlA at previously defined optimal frequencies of 5 and 200 kHz
(21). The alternating current was passed between a set of pregelled
current injection electrodes placed on the right hand and foot, prox¬
imal to the third metacarpal and metatarsal bones, respectively. Sim¬
ilar detection electrodes were placed on the right wrist between the
radius and ulna and on the right ankle between the malleoli. Meas¬
urements were taken on the morning of study with the subject in a
supine position with his or her legs and leads apart. Total body and
extracellular water were calculated from predictive equations
derived previously from isotopic studies of surgical patients per¬
formed in our unit (22) and body cell mass (BCM) was derived from
the equations of Shizgal (23). Bioelectrical impedance analysis in
patients with mild and moderate ascites has been validated as a
method of assessing the metabolically active component of body
composition, the BCM. in a cirrhotic patient population (4).
Indirect calorimetry
Measurements of oxygen consumption (pragmatic oxygen
sensor) and carbon dioxide production (infrared carbon dioxide
sensor) were performed by using a Datex Deltatrac Metabolic
Monitor (Engstrom Ltd. Helsinki). Subjects were placed under a
ventilated plastic hood and room air was delivered at a constant
flow rate (41 L/min). Monthly calibrations to check the flow rate
and respiratory quotient were carried out by using an alcohol
burning kit (variation between calibrations was <2.0%).
Throughout the study, all subjects remained in bed in a quiet area
of the ward. After subjects had fasted overnight (10 h), measure¬
ments were made over 40 min (10 min of acclimatization and 30
ruin of calorimetry); in the fed state, metabolic measurements
were taken at 4 time points over a period of 2 h and 15 min (3
min of acclimatization and 10 min of calorimetry). Minute-by-
minute readings were taken and averaged over each measure¬
ment period. Two timed urine collections were made, one over
the study period to determine protein oxidation and a 24-h col¬
lection to allow calculation of the nonprotein respiratory quo¬
tient (NPRQ) from urinary nitrogen analysis (LECO analyzer,
Chicago). Measured energy expenditure (MEE) and substrate
oxidation were derived from the equations of de Weir (24) and
Acheson et al (25), respectively.
Test meal
After fasting calorimetry was performed, subjects ingested the
meal within a 5-min period. Those subjects being studied in the
fed state (31 patients, 14 control subjects) were given a palatable
and easily prepared dietary challenge (Fortisip and Polycal;
Nutricia Ltd, Trowbridge, United Kingdom: 60% carbohydrate,
30% fat, and 10% protein) that provided 15 kj/kg body wt. This
intake ensured that the maximum metabolic effect of the meal
would be observed within the study time frame.
Dietary intake
To assess subjects' usual dietary intake, food diaries (record¬
ing intake for 2 weekdays and 1 weekend day) were completed
after discharge. Diaries were analyzed with a computerized
dietary analysis program (COMP-EAT; Nutrition Systems, Lon¬
don). To minimize error, subjects were fully instructed on how to
record intake by the research dietitian (RAR). To ensure that
subjects understood how to complete the diet diaries, they were
questioned at the end of their interviews. If the diaries were not
returned within 1 wk of discharge, subjects were reminded twice
to do so by telephone. Diet diaries were analyzed and results
averaged to give an estimate of daily macronutrient and energy
intakes.
Blood analysis
Blood samples were taken from an indwelling cannula (Ven-
flon; Ohmeda, Helsinborg, Sweden) in the brachial vein that was
kept patent with a minimal infusion of normal saline. Blood sam¬
ples were taken to measure glucose at baseline and every 20 min
for 2 h. Insulin was measured at baseline, 60 min, and 120 min.
Plasma glucose was measured by the timed endpoint method
(Cobas MIRA Plus; Roche Diagnostics Ltd, Lewes, United
Kingdom) and plasma insulin was measured by a 2-site immu-
noenzymometric assay (AIA-pack IRI assay, AIA-600 enzyme
immunoassay analyzer; Tosoh Corporation, Tokyo).
Statistics
Data were analyzed by using STATVIEW (version 4.02; Aba¬
cus Concepts, Berkeley, CA). Results are expressed as
means ± SDs. Differences between groups were determined by
INFLUENCES OF LIVER CIRRHOSIS ON DIETARY INTAKE 333
TABLE 1
Clinical and anthropometric assessment of cirrhotic patients and control subjects'
Patients
All
(n = 25 M, 40 F)
PBC


























(« = 22 M, 9 Fj
Control subjects
















' PBC, primary biliary cirrhosis; HC, hepatocellular cirrhosis; RWL, recent weight loss, expressed as percentage of actual body weight; TSF, triceps skin¬
fold thickness, expressed as percentage of standard values (20); AMC, arm muscle circumference, expressed as percentage of standard values; BCM, body
cell mass; Child's score as modified by Pugh et al (19).
2x ± SD.
'"'Significantly different from control subjects: 3P < 0.005, 4P < 0.01,' P < 0.05.
'Significantly different from HC patients, P < 0.005.
using Student's t test for 2 groups and analysis of variance
(ANOVA) for 3 groups. The effects of the test meal were ana¬
lyzed by two-factor repeated-measures ANOVA. Scheffe's test
was used to compare means. The linear relation between MEE
and BCM was determined by using regression analysis and the
method of least squares was used to derive correlation coeffi¬
cients (r). The limit for significance was at the 5% level.
RESULTS
Sixty-five clinically stable patients with histologic confirma¬
tion of the diagnosis of cirrhosis were included in the study of
clinical and nutritional status. Clinical and nutritional data are
shown in Table 1. There were more women in the PBC group
and more men in the HC group. The severity of liver disease was
similar in both patient groups. In the patient groups, pharmaco¬
logic regimens during the assessment period included diuretic
therapy (41 patients), vitamin supplements (13 patients), and lac¬
tulose (12 patients).
Energy expenditure was measured by indirect calorimetry
and, given that BCM is the oxygen-consuming component of
body composition, the relation between MEE and BCM was
examined in both patients and control subjects. There was a
strong, positive correlation between MEE and BCM in both
patients and control subjects. In addition, this relation held in
patients with mild and moderate ascites and there were no signi¬
ficant differences in the slopes of the regression lines between
any groups (Figure 1). This finding confirms that multifre-
quency bioelectrical impedance analysis is of value for estimat¬
ing body composition in populations of cirrhotic patients with
mild and moderate ascites.
Endogenous fat reserves and muscle mass, determined by
measuring TSF and AMC, respectively, were significantly lower
in cirrhotic patients than in control subjects (for all patients com¬
bined: P < 0.005 for TSF and P < 0.05 for AMC; for the PBC
group: P < 0.01 for TSF and P < 0.05 for AMC; and for the HC
group, P < 0.005 for TSF and P < 0.05 for AMC). There was no
significant difference in BCM between control subjects and the
PBC and HC groups. BCM was significantly lower, however, in
the PBC group than in the HC group (P < 0.005) and accounted
for 31% of body weight, which is within the normal range for
women of this age (26). The mean RWL did not exceed 10% of
body weight in any group.
Substrate oxidation rates during fasting and feeding are shown
in Table 2. In the PBC group, the NPRQ and macronutrient
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FIGURE 1. Relation between measured energy expenditure tMEE)
and body cell mass (BCM) in cirrhotic patients and control subjects.
There was a linear relation in all groups and the best-fitting line was
determined by linear regression (O, all patients, r = 0.765. P < 0.0001;
A, patients with no ascites, r = 0.732, P < 0.0001; C. patients with
ascites, r = 0.809, P < 0.0001; O, control subjects, r - 0.952,
P < 0.0001).
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TABLE 2
Substrate oxidation during fasting and feeding in cirrhotic patients and control subjects'
PBC patients (n = 18) HC patients (n = 13) Control subjects (n = 14)
Fasting Feeding Fasting Feeding Fasting Feeding
NPRQ 0.82 ±0.04 0.89 ± 0.06 0.78 ± 0.03-' 0.89 ±0.08 0.84 ± 0.04 0.93 ± 0.06
Carbohydrate
(mg/min) 88.6 ± 32.5 156.2 ±72.6 80.5 ± 34.6 188.0 ±71.6 119.0 ±47.1 186.0 ±59.5
(%) 37.0 ± 12.2 62.2 ±15.1 29.7 ± ll.F' 64.3 ±25.6 46.2 ± 13.8 69.3 ± 13.6
Fat
(mg/min) 46.3 ± 19.5 28.3 ± 17.1 66.7 ± 13.02-* 34.0 ± 27.2 42.1 ± 8.21 18.4 ± 18.6
(%) 47.5 ± 13.7 27.3 ± 16.0 59.1 ± 12.3- 27.5 ± 22.9 39.3 ±11.8 14.7 ± 15.5
Protein
(mg/min) 30.8+ 14.0 29.0 ± 17.9 29.2 ± 16.4 25.2 ± 19.6 36.9 ± 12.5 45.5 ± 23.0
(%) 14.2 ± 6.5 12.0 ±7.6 11.3 ±6.4 9.0 ±9.3 14.6 + 3.4 16.4 ±6.7
'x ± SD. PBC, primary biliary cirrhosis; HC, hepatocellular cirrhosis; NPRQ, nonprotein respiratory quotient.
2Significantly different from control subjects, P < 0.01.
3 Significantly different from PBC patients, P < 0.01.
subjects, whereas in the HC group, the fasting NPRQ was signi¬
ficantly lower than in control subjects. The fasting lipid oxidation
rate of the HC group was significantly higher than in both control
subjects and PBC patients. Additionally, when fasting macronu-
trient oxidation was calculated as a percentage of energy expen¬
diture, the contribution from fat-derived energy was higher and


























group than in control subjects. Two hours after ingestion of the
test meal, there was a switch to carbohydrate oxidation and at this
time no significant differences in NPRQ or substrate utilization
were observed. From the fasted to fed state, the magnitude of
change in carbohydrate oxidation was 23.1% in the control group,
25.2% in the PBC group, and 34.6% in the HC group.
Glucose and insulin responses to the test meal are illustrated
in Figures 2 and 3, respectively. The peak glucose response in
the control group occurred 40 min after ingestion of the test
meal. There was no significant difference in the glucose
response curve between the PBC group and the control group.
There was, however, a significantly higher response in the HC
group than in the control group at 100 (7.2 ± 1.6 compared with
5.6 ± 1.1 mmol/L) and 120 min (6.8 ± 1.5 compared with
5.2 ± 0.95 mmol/L). Fasting plasma insulin concentrations were
significantly higher in the HC group (121.2 ± 78.5 pmol/L) than
in the control group (41.3 ± 18.6 pmol/L) and the PBC group
(64.0 ± 15.8 pmol/L). Plasma insulin concentrations rose sharply
in the HC group 60 min after ingestion of the meal and were
significantly different from concentrations in control subjects
(635.0 ± 641.2 compared with 203.9 ± 86.8 pmol/L). The peak
insulin response to the meal in the control group was at 60 min.
Insulin concentrations in the HC group remained higher and
plateaued over 60-120 min when compared with the average
concentration over this time period in control subjects (at 120
min: 629.5 ± 636.8 compared with 95.0 ± 57.2 pmol/L). At 120
min after the test meal, there were also significant differences in
insulin response between the HC and PBC groups (629.5 ± 636.8
compared with 140.5 ± 97.8 pmol/L, respectively).
As shown in Figure 4, protein intake was significantly lower
in the PBC group than in control subjects (58.7 ± 23.1 compared
with 80.2 ± 22.3 g/d), whereas both protein and carbohydrate
intakes were significantly lower in the HC group than in control
subjects (protein: 50.4 ±11.6 compared with 80.2 ± 22.3 g/d;
carbohydrate: 193 ± 38.3 compared with 262 ± 48.1 g/d). Con¬
sequently, total daily energy intake was lower in the HC group
than in control subjects (6.3 ± 1.39 compared with 9.0 ±2.12
MJ/d; Figure 5).
FIGURE 2. Mean (±SD) glucose response to the test meal in cir¬
rhotic patients and control subjects. HC, hepatocellular cirrhosis; PBC.
primary biliary cirrhosis. "Significantly different from control subjects,
P < 0.05.
DISCUSSION
Undernutrition in cirrhotic patients and its relation with mor¬
bidity and mortality is well documented (7-9). Studies that iden-


























FIGURE 3. Mean (±SD) insulin response to the test meal in cirrhotic patients and control subjects. HC, hepatocellular cirrhosis: PBC, primary bil¬
iary cirrhosis. ' "Significantly different from control subjects: 'P < 0.05, "P < 0.001. 5 5SSignificantly different from PBC patients: 5P < 0.05, iiP <
0.01.
tify the prevalence and degree of undernutrition in chronic liver
disease are important in that they permit the targeting of nutri¬
tional support to undernourished patients. However, as a result of
the metabolic sequelae of cirrhosis, traditional high-energy, high-
carbohydrate regimens may not be tolerated by some patients.
The present study examined the effect of histologically
proven cirrhosis on nutritional intake in stable, chronic cirrhosis
patients being assessed for liver transplantation. Interpretation of
data relating to BMI and RWL can be influenced by the presence
of ascites, but in this study there were no significant differences
in TSF, AMC, or BCM between patients with and without
ascites. The arm was used to estimate fat and muscle reserves
because measurements at this site are less affected by fluid shifts
(9). In the present study, no patient's ascites was severe enough
to warrant drainage, which supports our finding that no patient
was grossly ascitic. This study focused predominantly on the
metabolic sequelae of cirrhosis and their influences on intake;
given that there were no significant differences in those nutri¬
tional indexes unaffected by ascites (ie, arm anthropometry) or
in the relation between MEE and BCM, patients were stratified
by primary diagnosis.
The underlying cause of cirrhosis may influence metabolism.
Alcoholic cirrhosis, cryptogenic cirrhosis, and hepatitis C are
characterized by hepatocellular damage, whereas PBC is a dis¬
ease that predominantly affects women in their middle years and
is cholestatic in nature. All patients in the study were shown to
be depleted in fat and muscle when compared with the normally
nourished control group. BCM was lower in patients with PBC
than in those with HC but was not significantly different from
that in control subjects. This finding may be accounted for by the
predominance of women in the PBC group, who normally have
a higher ratio of fat to lean tissue than do men. It has been sug¬
gested that cirrhotic patients with a BCM <30% of body weight
are undernourished (27), which is within the normal range for
women in their 50s (26). In our study population, BCM as a per¬
centage of body weight accounted for 31% of PBC, reflecting
the sex bias.
The lower fasting NPRQ and higher lipid oxidation rate in the
HC group suggests early depletion of hepatic glycogen stores
with a concomitant switch to lipolysis and indicates an extended
period of fasting. Interestingly, in this study, the HC group had
the smallest endogenous fat reserves but the highest rate of fast¬
ing lipid oxidation. Conversely, the fasting substrate profile in
the PBC group was similar to that in control subjects, suggesting
that hepatic glycogen reserves are better preserved in PBC. This
increased reliance on endogenous lipids to meet energy require¬
ments in the HC group may be an adaptive process, and one that
serves to preserve lean body mass during periods of nutrient
deprivation.
In the postingestive period carbohydrate oxidation predomi¬
nated at rates that were not significantly different between
patients and control subjects. Nonetheless, the magnitude of
change was greatest in the HC group, suggesting that in this
group carbohydrate was preferentially oxidized after ingestion of
a mixed meal. This finding supports the work of Levine et al
(28), who, when supplying a test meal 3 times as large as the one
used in the current study (59 kJ/kg), observed avid oxidation of
carbohydrate by patients with alcohol cirrhosis 2 h after inges¬
tion of the meal.
In the fasted state, only the HC group had elevated plasma
insulin concentrations. After consumption of the test meal, the
PBC group exhibited a normal insulin response that contrasted
markedly with the hyperinsulinemia seen in the HC group. The
pathogenesis of insulin resistance in cirrhosis is still unknown;
several researchers have failed to attribute cirrhotic hyperinsu¬
linemia to portal systemic shunting but rather attributed it to
deficits in binding and postbinding insulin target organ cells (17,
29, 30). Earlier work linked hyperinsulinemia with deficient
hepatic insulin extraction or the shunting of portal venous blood
to the systemic circulation (31). There is, however, no consensus
as to the exact mechanisms involved in the hyperinsulinemia of
cirrhosis but portosystemic shunting seems unlikely because
hyperinsulinemia is not found in patients with portal vein throm¬


















FIGURE 4. Mean (±SD) daily macronutrient intake in cirrhotic
patients and control subjects. PBC, primary biliary cirrhosis; HC, hepa¬
tocellular cirrhosis. ""Significantly different from control subjects:
'P <0.05, "P <0.01.
were no significant differences in insulin concentrations in
patients with (n = 10) and without (n = 21) evidence of por¬
tosystemic shunting.
Blood glucose concentrations were significantly elevated in
the HC group toward the end of the postprandial period, whereas
the glucose response curve was normal in the PBC group. 1 ne
different metabolic response to feeding in HC and PBC is an
important finding that has not been widely reported. Taylor et al
(17) noted impaired glucose tolerance and insulin resistance in
cirrhotic patients but, as in the present study, showed that PBC
patients were less insulin resistant than patients with HC. These
findings support the notion that hepatocyte function is better pre¬
served in PBC. Insulin is known to inhibit dietary intake by stim¬
ulating the satiating effects of cholecystokinin and through its
direct action in the brain (33). When we examined the ad libitum
dietary intake of our study population, all patients—irrespective
of the primary etiology of their disease—had significantly lower
protein intakes than did control subjects. The reason for this is
unclear but could have been the inappropriate prescribing of
low-protein dietary regimens by clinicians (27, 34). Interest¬
ingly, a lower carbohydrate intake was noted only in the HC
group; it can be hypothesized that the defects in carbohydrate
metabolism found in this study could bring about a spontaneous
reduction in the consumption of this macronutrient. Further¬
more, this reduction in carbohydrate intake could have been





FIGURE 5. Mean (±SD) daily energy intake in cirrhotic patients and
control subjects. PBC, primary biliary cirrhosis; HC, hepatocellular cir¬
rhosis. 'Significantly different from control subjects, P < 0.05.
the preferential uptake of carbohydrate. This may enhance sig¬
naling by the gastrointestinal glucosensors and in turn contribute
to hypophagta. Furthermore, the energy intake of the HC group
was only about two-thirds that of the control group and this level
of intake is consistent with the energy consumption of hospital¬
ized cirrhotic patients (35). If continued over a period of months
or years, this reduced intake would contribute significantly to a
deterioration in nutritional status. Note that with regard to diet
diaries, patients referred to a transplant unit are highly compli¬
ant. In addition, through meticulous attention to patient instruc¬
tion, every effort was made to minimize sources of error (ie,
transcription of diaries by RAR).
There is ample evidence from animal studies to support the
central role of the liver in controlling ingestive behavior (36).
Hepatic metabolic sensors continuously monitor substrate oxida¬
tion and relay this information to the brain stem via the hepatic
afferent nerves. In this study, we began to study for the first time
the effects of the metabolic aberrations of chronic liver disease
on eating behavior. The next logical step would be to conduct
controlled studies of ingestive behavior to identify clinically
acceptable and effective dietary regimens. We conclude that it
may be physiologically impossible for patients with HC to fol¬
low dietary advice that advocates increasing carbohydrate intake
because of the initiation of an amplified satiety cascade mediated
by elevated insulin concentrations. Postprandial rises in insulin
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are associated with a reduction of hunger and increasing satiety
(37). In the HC population, the avid switch to carbohydrate oxi¬
dation with feeding, which was maintained in the short-term
postprandial period, suggests intracellular uptake of glucose and
hence functioning insulin. Early and enhanced postprandial rises
in insulin may therefore reduce energy intake through normal
satiety mechanisms, which are enhanced in these patients.
Many researchers have considered the relation between nutri¬
tional status and liver disease (4, 7, 10). However, as we begin
to move into evidence-based nutritional practice, we must
develop acceptable and achievable nutritional strategies for cir¬
rhotic patients. Liver transplantation and the hospitalization of
cirrhotic patients is expensive clinically, socially, and psycho¬
logically. Because research has confirmed that nutritional status
is an outcome factor (38), it is of paramount importance to
understand the disease-specific nutritional requirements of this
patient population. This will only be achieved when the interac¬
tion between the metabolic sequelae of primary liver pathology
and their influence on ingestive behavior is understood. 13
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Macronutrient Preference, Dietary Intake, and Substrate Oxidation
Among Stable Cirrhotic Patients
H. Isobel M. Davidson, Rosemary Richardson, Donald Sutherland, and O. James Garden
Anorexia in liver disease is common; however, its associa¬
tion with aberrant metabolism and the type of cirrhosis has
not been considered. Dietary intake, nutritional status,
fasting substrate oxidation, and macronutrient preference
were examined in controls (n = 18) and 65 patients with
hepatocellular (n = 31) or biliary cirrhosis (n = 34). Energy
intakes were lowest in hepatocellular patients (controls:
9.0 ± 0.48 megajoules/day compared with biliary: 7.0 ±
0.40 MJ/day, P < .05; controls compared with hepatocellu¬
lar 6.5 ± 0.39 megajoules/day, P < .01). Triceps skinfold
was lower only in hepatocellular patients (controls: 109 ±
9.2% compared with hepatocellular 79 ± 5.6%, P < .05).
The fasting rate of lipid oxidation was elevated in hepatocel¬
lular patients when compared with controls and biliary
patients (controls: 40.9 ± 15.1 mg/min compared with
■hepatocellular 62.8 ± 16.8 mg/min, P < .001, and biliary :
45.5 ± 17.0 mg/min compared with hepatocellular, P <
.001). Control subjects exhibited a greater preference for
the high fat, moderate carbohydrate food (controls: median
7.0 IQR 2.0 compared with biliary: median 5.0 interquartile
range [IQR] 4.7, P < .01) (controls compared with hepato¬
cellular: median 6.0 IQR 4.0, P < .01). Cirrhotic patients'
spontaneous dietary intake is lower than that of controls
■and recommended intakes. Although macronutrient prefer¬
ence ratings were different within cirrhotic patient groups it
remains unclear whether associated nutrient deficits are
metabolically driven and dictated by primary cause. (Hepa-
tology 1999;29:1380-1386.)
The metabolic features of chronic liver disease and the
prevalence of undernutrition have been widely reported.1"4
However, there remains some debate as to the impact of
disease severity, primary cause, and metabolic indices on
nutritional status.5"8 It is clear that the presence of undernutri¬
tion will impact negatively on clinical outcome.910 Given this
hgnificance of nutritional status, it is surprising that few
jtudies have examined the relationship of chronic liver
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.irrhosis; R.R., Rosemary Richardson; BM1, body mass index; IQR, inter-quartile range;
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disease with anorexia, a factor contributing to poor nutri¬
tional status.11 Poor dietary intake in patients with chronic
liver disease has been identified as a major concern and one
that is difficult to resolve.12'13 This may, in part, be a result of
the complex interaction between aberrant metabolism occur¬
ring in liver disease and ingestive behavior.
It is evident that the liver plays a central role in ingestive
behavior14 acting as a sensor for the metabolic control of
eating.15 Under normal conditions, hepatic oxidation of lipid
and glucose results in changes in hepatocyte membrane
potential and modulation of spike frequency in afferent
pathways, resulting in satiety.16 Ultimately, it is the conver¬
gence in the central nervous system of these neural signals, as
well as other humoral and cognitive influences, that deter¬
mines the size and duration of an eating episode. Impairment
of hepatic nerve function and/or alterations in the fuel mix
being oxidized may be present in liver disease and could
contribute to alterations in ingestive behavior. It has also
been suggested that impaired functional capacity of the liver
may lead to reduced clearance of humoral mediators of satiety
such as cholecystokinin (CCK).17 This may also contribute to
a reduced satiety threshold and bring about early meal
termination. In the context of patients with chronic liver
disease, the mechanisms involved in the metabolic control of
eating may be altered and could contribute to anorexia.
Changes in ingestive behavior could also be mediated through
hepatic cytokine production.18 For example, IL-1(3 has been
shown to alter activity in the hepatic vagus,19 which w_uld
cause changes in central processing and be interpreted by the
brain as an increase in nutrient availability.
It is apparent that bizarre food preferences exist in the
presence of chronic liver disease, with the development of
cravings for specific foods such as grapefruit having been
documented.20 In a similar study by Madden et al.21 no
preference for specific foods was evident; however, they
highlighted a significant increase in the use of vinegar in their
cirrhotic patients. The development of these preferences
cannot consistently be attributed to any single biochemical
parameter and as such has been related with the disease
process per sc. The contribution that these changes in food
choice make to total energy intake is difficult to. quantify.
However, the development of preferences, not for specific
food types but for the specific macronutrient composition of
that food, may contribute to low energy intake. If this is the
case then a reduction in food quality may result in an energy
deficit and contribute to the undernutrition found in this
population. The palatability of fat and carbohydrate mixtures
as real food is more appropriate for studies on macronutrient
preference,22 rather than methodologies that examine detec¬
tion and recognition taste thresholds,2123 or food frequency
1380
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questionnaires but has not been examined in this population
to date.
Preference for a specific macronutrient composition of a
food has not previously been investigated in chronic liver
disease. This may be an important determinant of quantita¬
tive food intake in chronic liver disease where, as a result of
aberrant metabolism, central integration ofmetabolic informa¬
tion is disrupted. This study examined food preference,
macronutrient intake, and fasting substrate oxidation in a
group of stable cirrhotic patients.
PATIENTS AND METHODS
Patients admitted for consideration of orthotopic liver transplan¬
tation to the Scottish Liver Transplant Unit between October 1996
and December 1997 were eligible for the study. Patients with
alcohol-related disease were required to be abstinent for a minimum
of 6 months. Patients with diabetes, significantly impaired renal or
respiratory function, thyroid dysfunction, active inflammatory bowel
disease, sepsis, severe ascites, and grade 3 to 4 encephalopathy were
excluded from the study. A group of 18 healthy volunteers were
recruited from hospital staff, none of whom were smokers or on any
medication or dietary restriction. Disease severity was based on
Pugh's modified Child's classification24 and use the criteriat^lasma
bilirubin concentration, prothrombin time, presence of ascites, and
degree of encephalopathy. Patients were divided into those with
predominantly cholestatic (BC) and hepatocellular (HC) liver
cirrhosis to enable assessment of the relationship between the type
of cirrhosis, nutrient preference, and nutritional status. The study
protocol was reviewed and approved by the local ethics committee.
All procedures relating to the study were explained to subjects who
were required to give written consent.
Energy and Macronutrient Intake
To estimate macronutrient intake subjects were asked to complete
a 3-day dietary diary (2 weekdays and 1 day at the weekend). In the
present study it was neither practical or logistically possible to
determine variance in diet diaries against weighed intakes. However,
in a population of a similar size this methodology has previously
shown good agreement with weighed intakes.23 Detailed verbal and
written instructions on the completion of diet diaries was issued. A
telephone reminder was made if the diary was not returned within
10 days. Transcription of diet diaries was undertaken by the research
dietiti".. (R.R.) and analyzed using a dietary analysis computer
program (Comp-eat, Nutrition Systems, London, UK).
Nutritional Status
All subjects were weighed and measured for height to enable
calculation of body mass index (weight [kg]/height [m2]; BM1).
Patients were asked to recall any weight loss during the preceding
year and this was expressed as a percentage of actual body weight
(pre-illness weight loss). An index of endogenous fat and muscle
reserves was estimated from triceps skinfold thickness and arm
muscle circumference measurements and these were compared with
standard values.26 Arm anthropometry results were expressed as a
percentage of standard to normalize for gender differences in body
composition. All anthropometric measurements were performed on
three occasions by the same skilled observer (R.R.) and the average
taken as the absolute value. Values for a single parameter less than
80% were used to classify undernutrition.27
Substrate Oxidation
In all subjects substrate oxidation rates were calculated from
gaseous exchange measurements using indirect calorimetry (Datex,
Engstrom, Kent) and nitrogen excretion.28 To ensure accurate gas
exchange measurements calibration of gas sensors using Carbogen
(5% C02, 95% 02; Datex, Helsinki, Finland) was performed at the
beginning of each measurement period. The flow rate and respira¬
tor)' quotient of the calorimeter was checked on a monthly basis
using the manufacturer's alcohol burning kit (Datex, Helsinki,
Finland) and throughout the study the CV was less than 3%.
Following an overnight fast, subjects were placed under a perspex
hood and measurements of oxygen consumption and carbon diox¬
ide production were taken ever)' minute for a total of 40 minutes (10
minutes' acclimatization and 30 minutes' calorimetry). All subjects
remained in bed in a quiet area of the ward throughout the study
period. Urinary nitrogen was measured from a 24-hour urine
collection (LECO analyzer, Chicago, IL).
Macronutrient Preference
Four commercially available ice creams (a real food combining fat
and carbohydrate) were used as the test stimuli to determine
macronutrient preference, using methodology adapted from
Drewnowski and Greenwood.29 Each ice cream varied in macronutri¬
ent content but all were vanilla in flavor. The composition of the ice
creams used did not change over the study period. On the morning
of study approximately 15 mL of ice cream was presented in a plastic
beaker which was coded (Table 1) and subjects consumed approxi¬
mately a third of each sample. Subjects randomly selected samples
for tasting and eye shades were worn during the tasting procedure to
mask any visual differences. Hedonic responses (degree of liking)
were recorded for each coded sample on a nine-point hedonic scale30
anchored by the responses "dislike extremely" and "like extremely."
Therefore the higher the score awarded to the test stimuli the greater
the degree of liking for the food. Subjects tasted and swallowed
samples and were asked subsequently to elicit pleasantness ratings.
Retasting was permitted. Subjects were instructed on palate cleans¬
ing that involved rinsing the mouth with bottled water (Evian,
France) and this was performed before each tasting session and
following ingestion of each sample. A resting period of two minutes
was enforced between tasting of each test stimulus. At least 3 hours
after study macronutrient preference was re-examined in all subjects
and no differences between the first and second tasting were
observed.
Statistical Analysis
Data were analyzed using Statview 4.02 (Albucus Concepts, CA).
Substrate oxidation rates, nutritional status, and dietary analysis are
expressed as mean (± SEM). Differences between groups were
evaluated using Student's t-test and one way analysis of variance
(ANOVA). Scheffe's test was used in comparing means. Food
preference results were expressed as median and interquartile range
(1QR) and values out with the 25,h and 75th percentiles were
represented in figures individually. Differences between groups were
determined using Kruskal-Wallis one-way analysis of variance and
Mann-Whitney U test. Differences within groups were determined
using Friedman's two-way analysis and Wilcoxon signed rank test.
Linear regression analysis was performed using the method of least
Table 1. Macronutrient Values for Ice Creams (/100 mL)
Sample Wt/100 Protein Fat CHO Energy
Code mL (g) (g) (g) (KJ), (kcal) Type
A 166 6.5 19.0 29.7 1339 High fat, high CHO
(321)
B 114 4.5 18.4 20.0 1078 High fat, mod CHO
(258)
C 181 3.8 0.9 27.8 564 Low fat, high CHO
(135!
D 217 2.8 4.8 20.8 589 Low fat, mod CHO
(141)
NOTE. A, Mackie's Traditional; Westertown, Aberdeen, UK; B, Haagan
Dazs, Middlesex, UK; C, Walls Too Good To Be True, Birds Eye Walls Ltd.,
Surrey, UK; D, Heinz Weight Watchers, HJ Heinz Co. Ltd., Middlesex, UK.
squares and correlation coefficients (r) derived (Spearman Rank).
The limit for significance was at the 5% level.
RESULTS
Sixty-five patients with histological confirmation of cirrho¬
sis were included in the study. Demographic, clinical, and
nutritional assessment details are shown in Tables 2 and 3. In
the HC group, 24 patients had alcohol-related disease, 5 had
cryptogenic cirrhosis, and 2 hepatitis C. Three patients (5%)
admitted to being smokers and all control subjects were
nonsmokers. Thirty patients were classified as normally
nourished (16 BC, 14 HC) and 35 undernourished (18 BC, 17
HC). Comparative analysis of nutritional assessment data
showed that undernourished patients had significantly lower
triceps skinfold measurements when compared with their
normally nourished counterparts (normally nourished:
105.3 ± 5.9% versus undernourished: 57.6 ± 2.8%, P <
.0001). No difference in arm muscle circumference was seen.
No patient had severe ascites at the time of study and
although there were differences in nutritional indices com¬
pared with the control group these did not reach statistical
significance. Patients with BC were significantly lighter than
control subjects but there were no differences between groups
when BMI was calculated. Triceps skinfold thickness was
significantly lower in the HC group compared with controls.
No significant differences in any of the other nutritional
variables were observed.
Completed diet diaries were returned from 52 patients
(80%). The subject's dietary analysis was compared with the
recommended intake for a 67-kg patient with cirrhosis
(average weight of patient in current study) using ESPEN
(European Society of Parenteral and Enteral Nutrition)
nutritional guidelines31 (Table 4). When compared with
controls, cirrhotic patients had lower protein (P < .001), fat
(P < .01), carbohydrate (P < .01), and energy (P < .001)
intakes. In addition when patients were stratified by primary
etiology, energy and protein intakes were significantly lower
in both BC and HC patients when compared with controls
(energy: BC, P < .05; HC, P < .01; protein: BC, P < .05; HC,
P < .001). The HC group exhibited significantly lower fat
(P < .05) and CHO intakes (P < .05) when compared with
control subjects. The energy and protein intakes of cirrhotic
Table 2. Demographic, Clinical, and Nutritional Status of Control









n 18 65 34 31
Male:Female 9:9 25:40 3:31 22:9
Age (years) 50.2 (2.7) 54.6 (2.2) 57.7 (1.6) 51.2(1.7)
Child's Pugh score — 8.7 (0.4) 8.3 (0.4) 9.0 (0.4)
Weight (kg) 76.9 (2.9) 66.7 (2.2) 62.0 (2.3)* 71.9 (2.0)
Body mass index 26.0 (0.9) 24.1 (0.8) 23.5 (0.9) 24.7 (0.6)
Pre-illness weight
loss 0 -7.0 (1.3) -7.7(1.4) -6.3 (2.0)
Triceps skin¬
fold (%) 109 (9.2) 81 (4.2) 83 (6.2) 79 (5.6)+
Arm muscle cir¬
cumference (%) 102 (3.3) 94 (1.6) 94 (2.5) 93 (1.8)
NOTE. Mean (±SEM).
*P < .001 versus controls.
tP < .05 versus controls.
patients were suboptimal when compared with ESPEN guide¬
lines. No differences in dietary intake were seen between
cirrhotic patients classified as normally nourished or unde
nourished.
Fasting protein and glucose oxidation rates were signil •
cantly lower in the cirrhotic group when compared with
controls (protein: controls, 38.3 ± 3.4 mg/min versus cir¬
rhotic patients, 27.8 ± 3.6 mg/min, P < .01; glucose:
controls, 120.9 ± 10.7 mg/min versus cirrhotic patients.
87.1 ± 3.9 mg/min, P < .001) and the lipid oxidation rate
was significantly higher in cirrhotic patients (lipid: controls,
40.9 ± 3.6 mg/min versus cirrhotic patients, 53.4 ± 2.6
mg/min, P < .05). No effect of disease severity on substrate
oxidation rate was observed when patients were stratified
using Pughs modified Child's score (Fig. 1). In addition no
differences in fasting fuel oxidation rates were observed when
patients were subdivided by nutritional status (Fig. 1). When
cirrhotic patients were grouped by primary diagnosis, the BC
group exhibited a depressed rate of glucose oxidation when
compared with control subjects (controls, 120.9 ± 10.7
mg/min versus BC, 87.8 ± 5.6 mg/min, P < .01). There was
no difference in the rate of lipid oxidation between controls
and BC patients. The HC patients had decreased rates of
protein and glucose oxidation (protein: controls, 38.3 ± 3.4
mg/min vs. HC, 26.3 ± 2.6 mg/min, P < .05; glucose:
controls, 120.9 ± 10.7 vs. HC, 86.4 ± 5.6 mg/min, P < .01).
Additionally, the fasting rate of lipid oxidation rate was
elevated in the HC group compared with control subjects or
BC patients (controls, 40.9 ± 2.9 mg/min vs. HC, 62.8 ± 2.5,
P < .001; HC vs. BC, 45.4 ± 2.9 mg/min, P < .001). Given
these differences in substrate oxidation rates by primary
diagnosis, analysis ofmacronutrient preference are presented
using this stratification.
Macronutrient Preference
Analysis Between Groups. Studies showed that when compari¬
sons were made between groups the control group exhibited a
significantly greater preference for the high fat, moderate
CHO (carbohydrate) product than either of the patient
groups (controls: median, 7.0,1QR = 2.0 compared with BC:
median, 5.0, IQR = 4.7, P < .01; controls compared with HC:
median, 6.0, IQR = 4.0, P < .01). No differences in
macronutrient preference between the BC and HC group was
apparent.
Analysis Within Groups. Macronutrient preference was also
examined within each group studied. The control group
showed no significant preference for any macronutrient
combination. The BC group showed a significant preference
for the high fat, high CHO product (preferred high fat, high
CHO to low fat, high CHO, P < .05: preferred high fat, high
CHO to high fat, moderate CHO, P < .01). Hepatocellular
patients showed a preference for low fat, moderate CHO
when compared with low fat, high CHO (P < 0.05) and high
fat, moderate CHO (P < .01). Additionally, the HC group
preferred high fat, high CHO to high fat, moderate CHO (P <
.05) (Fig. 2).
To examine the association between fuel oxidation and
macronutrient preference the relationship between oxidation
rates and hedonic ratings was examined. In the control group
a significant association was observed between the low fat,
low CHO test stimuli and post-absorptive rate of glucose
oxidation (r = .58, P < .05). In other words, the higher the
rate of glucose oxidation the greater the preference for the ice
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Table 3. Cirrhotic Patients Stratified by Etiology and Nutritional Status
Cirrhotic Biliary Hepatocellular Normally Under¬
Patients Cirrhosis Cirrhosis Nourished nourished
; A 15 8 i 10 5
; B 26 15 11 13 12
; C 24 11 13 11 14
albumin (g/L) (reference >35 g/L) 30.8 (0.3) 32.2 (0.9) 30.0 (0.91 30.3 (1.0) 30.8 (0.9)
bilirubin (pmol/L) (reference 2-17 pmol/L) 101.2 (11.1) 148.3 (17.7)* 54.2 (5.8) 108.3 (14.7) 92.9 (17.0)
ombin ratiot 1.3 (0.04) 1.2 (0.05)t 1.2 (0.05) 1.3 (0.05) 1.3 (0.05)
ctive protein (mg/L) (reference <10 mg/L) 10.2 (2.1) 11.4 (2.7) 8.7 (3.4) 11.7 (3.5) 8.5 (2.3)
rE. Mean (±SEM).
; .0001 versus hepatocellular.
C .01 versus hepatocellular,
tient value/control value.
i with the lowest energy content (low fat moderate
). In the BC group, a significant relationship was
ved between the rate of lipid oxidation and preference
le low fat, high CHO test stimuli (r = .36, P < .05),
fore, as the rate of lipid oxidation increases the prefe£
for Low fat, high CHO increases. In HC patients no
onship between lipid or carbohydrate oxidation rates
nacronutrient preference were observed. In addition, no
onship between substrate oxidation rates and dietary
e was seen in any study group. Similarly, no association
een dietary intake and macronutrient preference was
ved in control subjects or any patient group.
DISCUSSION
e evidence that undernutrition is prevalent in chronic
disease is unequivocal.32 In this study, fat and lean tissue
yes were determined by arm anthropometry, a technique
remains sensitive in cirrhotic patients in whom there
be a degree of fluid shift.33 Preservation of muscle mass
be explained by the fact that no patient had an acute
ilication of his or her disease or were recovering from an
tive episode. The lower protein oxidation rates observed
i clinically stable cirrhotic patients along with anthropo-
c results Suggest endogenous protein sparing. Other
rchers have reported depleted muscle mass in their
3tic patients. However, these have invariably been per-
:d in patients recovering from a complication of liver
se34-35 and loss ofmuscle mass is not a consistent finding
ig cirrhotic patients.4
ergy and macronutrient intakes were significantly lower
i cirrhotic patient group when compared with controls,
iteresting finding was the differences in dietary profiles
observed in patients with different causes of cirrhosis. Accept¬
ing that there are clinical similarities between patients with
predominantly hepatocellular and cholestatic liver disease,
the present study does suggest there are important metabolic
differences between the studied groups. This is supported by
a recent study which examined the influence of etiology on
the response to feeding.36
Compared with control subjects energy intakes were lower
in BC (P < .05) and HC patients (P < .01). Whereas daily
energy intake was depressed in both patient groups, only HC
revealed all macronutrients and total energy to be different
from controls. In BC patients only protein and energy were
different to controls. Consumption of the major metabolic
fuels (fat and CHO) was not significantly different. Analysis
of macronutrient intake between patient groups was not
significantly different but all intakes of dietary components
were lowest in HC patients. If extrapolated over a 9-month
period, this would result in an energy deficit of 30 megajoules
or a loss of approximately 1 kg of adipose tissue.37 Clearly this
is an oversimplification of long term energy dynamics in
these patients with chronic disease but it may in part explain
the greater loss of fat mass found in HC patients. The inability
of cLrhotic patients to achieve an adequate energy intake was
also implied from between-group food preference studies
with control subjects exhibiting a preference for the high fat,
moderate carbohydrate test stimuli than either patient group.
In the present study, the reduced CHO intake found,
particularly in HC patients, suggests that emphasis on a high
CHO dietary regimen may be unacceptable to these patients.
Disturbances in carbohydrate metabolism and the metabolic
sequelae in response to feeding have been widely reported in
liver cirrhosis.36 38"40 However, increased emphasis on exog-
Table 4. Energy and Macronutrient Intake in Controls, Biliary Cirrhosis, and Hepatocellular Cirrhosis
ESPEN Guidelines All Cirrhotic Biliary Hepatocellular
(based on 67-kg pt) Controls Patients Cirrhosis Cirrhosis
16 52 26 26
i (g) 85.0 81.3 ± 2.9 58.3 ± 2.94 61.4 ± 3.9* 55.6 ± 4.14
— 83.7 ± 6.2 63.2 ± 3.2t 65.3 ± 4.8 61.3 ± 4.4*
rydrate (g) — 259 ± 11.4 203 ± lO.Ot 211 ± 15.6 195 ± 13.3*
'■ (g) 19.7 ± 5.7 0 0 0
•(MJ) 11.1 9.0 ± 0.5 6.8 ± 0.34 *Tt"o+1o 6.5 ± 0.4t
n (±SEM).
: .05 versus controls,
t .01 versus controls.
: .001 versus controls.
t
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Normal (n=31) Undernourished (n=34)
mean (± SEM)
Fig. 1. Fasting substrate oxidation rates in cirrhotic patients classified by
Child's Pugh Score and nutritional status. E3, protein (mg/min); 0, lipid
(mg/min >: ■. glucose (mg/min).
enous fat intake may facilitate patient compliance and
consequently increase energy intake, there does remain some
concern as to the ability of cirrhotic patients to handle this
macronutrient. Previous research has suggested that defects
in fat metabolism found in cirrhotic patients are a result of
impaired clearance of triglycerides, carnitine deficiency, or
reduced bile flow.41"43 There is, however, no substantive
clinical evidence to support the restriction of exogenous fat in
these patients,43 particularly when it has been shown that
lipid clearance rates are normal in cirrhotics.44
The depressed rate of glucose oxidation observed in fasting
BC patients may reflect reduced hepatic glycogen capacity
but appears not to be as exaggerated as the fasting profile
observed in patients with HC cirrhosis, although this cannot
be confirmed. The significant increase in postabsorptive rates
of lipid oxidation found in HC patients is similar to that
found by other investigators1-45 and may be attributed to
exhausted rather than depleted glycogen reserves. It is likely
that this increased rate of lipid oxidation is an adaptive
process, acting to offset the reduction in energy normally
available through glycogenolysis. This adaptive mechanism
will serve to preserve lean body mass at the expense of
endogenous fat stores.4 Increased lipolysis in the presence of
an energy deficit will deplete body fat reserves. This ma\
explain the lower endogenous fat reserves found in HC
patients, exhibiting greater rates of lipolysis. No significant
depression of muscle mass was observed in this group of
stable cirrhotic patients in whom there was no evidence of an
inflammatory response.
In healthy subjects, changes in physiological state lead to
alterations in food preference, as evidenced, for example,
with nutrient deprivation and weight loss, where there is an
increased preference for fat.46"49 In the current study, between-
group analysis revealed that controls exhibited a preference
for the high fat, moderate CHO food compared with cirrhotic
patients. This may simply reflect the highly palatable proper¬
ties of fat to this healthy population.50 However, macronutri¬
ent preference within patient groups showed the BC group to
have a preference for the high fat, high CHO food. This
finding was surprising, as the dietary intake of fat is often
prescriptively reduced in this patient group. It may be
postulated that the insidious malabsorption of cholestatic
disease could lead to the development of an appetite for high
fat foods. The results of the present study are in contrast to
the findings of Deems and Friedman,42 who reported a
reduction in fat intake in bile duct-ligated rats when com¬
pared with a group of control animals. It should be empha¬
sized that ligation of the bile duct will induce acute cholesta¬
sis and does not mimic the slow, progressive cholestatic-
picture found in BC patients. In the present study, the
preference for the high fat, high CHO stimuli evident in BC
patients may reflect a drive to consume sufficient energy to
maintain endogenous energy reserves.49 However, the energy
intake of BC patients was significantly lower than control
subjects and suggests that in liver disease sensory food
preference is not reflected in quantitative intake.
The macronutrient preference and dietary intake was
different in HC patients. A significant preference for the low
fat, moderate CHO food product was observed and only a
marginal preference for high fat, high CHO when compared
with the high fat, moderate CHO product. The latter finding
could be due to the palatability attributes of the high fat, high
CHO test stimuli that may act by masking the CHO content
of test stimuli29 and may not directly be associated with
quantitative intake. This is supported by the finding that
dietary analysis showed that the CHO and fat intake of HC
group was significantly lower than controls and implies that
these patients may consume energy-dense foods but only in
small quantities. This may reflect a physiological inability by
HC patients to normally metabolize these energy providing

















































* = p<0.05; preferred to low fat high carbohydrate
**= p<0.01; preferred to high fat moderate carbohydrate



















































* = p<0.05; preferred to low fat high carbohydrate
**= p<0.01; preferred to high fat moderate carbohydrate
Fig. 2. Hedonic rating for macronutrient preference in biliary and hepatocellular cirrhotic patients. Data are represented as median and IQR with those
ratings out with the 25th and 75th percentile represented individually. E3, protein (mg/min); E3, lipid (mg/min); ■ glucose (mg/min).
macronutrients and calls into question the effectiveness of
the high-energy dietary regimen traditionally prescribed for
patients with cirrhosis.
The relationship between substrate oxidation and macronu¬
trient selection has been an area of considerable interest in
obesity research.51 The present study revealed that an associa¬
tion between fasting glucose oxidation rate and preference for
the low fat, low CHO food in control subjects. This suggests
that as the availability of glucose increases the preference for
the low-energy food product increases but is not reflected in
the dietary intake of these unrestrained eaters. In BC patients
the association between lipid oxidation rate and preference
for low fat, high CHO food suggests they may select these
foods after periods of fasting when lipid oxidation rates
increase. It is tempting to speculate that their improved
ability to handle CHO52 reflects better glycogen storage
compared with HC patients and may be beneficial in preserv¬
ing fat stores. This may also explain the fact that CHO intakes
were not significantly lower in BC patients compared with
controls, but the HC intakes were. Further studies are
required to clarify these associations.
The significant relationship between rates of oxidative
metabolism and food preference observed in the current
study is impressive. After all, substrate oxidation is dictated
by the body's requirement to regenerate adenosine tri¬
phosphate (ATP).51 Fasted control subjects would continue
to rely on hepatic glycogen reserves as an efficient ATP
provider and may account for the association between CHO
oxidation and low fat, moderate CHO food preference. It is
not surprising that no relationship between fasting substrate
oxidation and dietary intake was seen in the present study as
a relationship between these variables is only observed when
oxidation rates are determined over a 24-hour period.53
Further clinical studies are required to examine the relation¬
ship between substrate utilization and intake but the accept¬
ability of the required methodology may prove an obstacle to
patient recruitment. In addition, the melee of biological
processes which accompany cirrhosis may serve to distort the
relationship between oxidative metabolism and qualitative
and quantitative components of ingestive behavior.
There has been considerable interest in the mechanisms
involved in hepatic undernutrition and its impact on out¬
come. Although little attention has been paid to the causes of
anorexia in chronic liver disease, it will, in the long term,
detrimentally impact on nutritional status. There remains
some debate as to exactly how the brain regulates food intake
and indeed how the mechanisms involved in the integration
of ingestive behavior and complementary biological pro¬
cesses act to maintain energy balance.54 The present study has
for the first time adopted an integrative approach in examin¬
ing the association between whole body fuel oxidation rates
and ingestive behavior in cirrhotic patients. It remains
unclear whether associated nutrient deficits are metabolically
driven and dictated by primary etiology.
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